<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73080</article-id><article-id pub-id-type="doi">10.7554/eLife.73080</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title><italic>Anopheles</italic> salivary antigens as serological biomarkers of vector exposure and malaria transmission: A systematic review with multilevel modelling</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-252198"><name><surname>Kearney</surname><given-names>Ellen A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8912-8067</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252199"><name><surname>Agius</surname><given-names>Paul A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-120477"><name><surname>Chaumeau</surname><given-names>Victor</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0171-2176</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-252200"><name><surname>Cutts</surname><given-names>Julia C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-97658"><name><surname>Simpson</surname><given-names>Julie A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2660-2013</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-249867"><name><surname>Fowkes</surname><given-names>Freya JI</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5832-9464</contrib-id><email>fowkes@burnet.edu.au</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>The McFarlane Burnet Institute of Medical Research and Public Health</institution><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02bfwt286</institution-id><institution>Department of Epidemiology and Preventive Medicine, Monash University</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03fs9z545</institution-id><institution>Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University</institution></institution-wrap><addr-line><named-content content-type="city">Mae Sot</named-content></addr-line><country>Thailand</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford</institution></institution-wrap><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>Department of Medicine at the Doherty Institute, The University of Melbourne</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Wesolowski</surname><given-names>Amy</given-names></name><role>Reviewing Editor</role><aff><institution>Johns Hopkins Bloomberg School of Public Health</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Serwadda</surname><given-names>David M</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dmz0111</institution-id><institution>Makerere University School of Public Health</institution></institution-wrap><country>Uganda</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>23</day><month>12</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e73080</elocation-id><history><date date-type="received" iso-8601-date="2021-08-16"><day>16</day><month>08</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-12-21"><day>21</day><month>12</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-09-17"><day>17</day><month>09</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.09.14.21263589"/></event></pub-history><permissions><copyright-statement>© 2021, Kearney et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Kearney et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73080-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-73080-figures-v2.pdf"/><abstract><sec id="abs1"><title>Background:</title><p>Entomological surveillance for malaria is inherently resource-intensive and produces crude population-level measures of vector exposure which are insensitive in low-transmission settings. Antibodies against <italic>Anopheles</italic> salivary proteins measured at the individual level may serve as proxy biomarkers for vector exposure and malaria transmission, but their relationship is yet to be quantified.</p></sec><sec id="abs2"><title>Methods:</title><p>A systematic review of studies measuring antibodies against <italic>Anopheles</italic> salivary antigens (PROSPERO: CRD42020185449). Multilevel modelling (to account for multiple study-specific observations [level 1], nested within study [level 2], and study nested within country [level 3]) estimated associations between seroprevalence with <italic>Anopheles</italic> human biting rate (HBR) and malaria transmission measures.</p></sec><sec id="abs3"><title>Results:</title><p>From 3981 studies identified in literature searches, 42 studies across 16 countries were included contributing 393 study-specific observations of anti-<italic>Anopheles</italic> salivary antibodies determined in 42,764 samples. A positive association between HBR (log transformed) and seroprevalence was found; overall a twofold (100% relative) increase in HBR was associated with a 23% increase in odds of seropositivity (OR: 1.23, 95% CI: 1.10–1.37; p&lt;0.001). The association between HBR and <italic>Anopheles</italic> salivary antibodies was strongest with concordant, rather than discordant, <italic>Anopheles</italic> species. Seroprevalence was also significantly positively associated with established epidemiological measures of malaria transmission: entomological inoculation rate, <italic>Plasmodium</italic> spp. prevalence, and malarial endemicity class.</p></sec><sec id="abs4"><title>Conclusions:</title><p><italic>Anopheles</italic> salivary antibody biomarkers can serve as a proxy measure for HBR and malaria transmission, and could monitor malaria receptivity of a population to sustain malaria transmission. Validation of <italic>Anopheles</italic> species-specific biomarkers is important given the global heterogeneity in the distribution of <italic>Anopheles</italic> species. Salivary biomarkers have the potential to transform surveillance by replacing impractical, inaccurate entomological investigations, especially in areas progressing towards malaria elimination.</p></sec><sec id="abs5"><title>Funding:</title><p>Australian National Health and Medical Research Council, Wellcome Trust.</p></sec></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>Anopheles</italic></kwd><kwd>salivary antigens</kwd><kwd>systematic review</kwd><kwd>SG6</kwd><kwd>salivary biomarkers</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>P. falciparum</italic></kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>1134989</award-id><principal-award-recipient><name><surname>Simpson</surname><given-names>Julie A</given-names></name><name><surname>Fowkes</surname><given-names>Freya JI</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>1166753</award-id><principal-award-recipient><name><surname>Fowkes</surname><given-names>Freya JI</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>1196068</award-id><principal-award-recipient><name><surname>Simpson</surname><given-names>Julie A</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Australian Government</institution></institution-wrap></funding-source><award-id>Australian Government Research Training Program Scholarship</award-id><principal-award-recipient><name><surname>Kearney</surname><given-names>Ellen A</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>220211</award-id><principal-award-recipient><name><surname>Chaumeau</surname><given-names>Victor</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Victorian State Government</institution></institution-wrap></funding-source><award-id>Operational Infrastructure Support Program received by the Burnet Institute.</award-id><principal-award-recipient><name><surname>Kearney</surname><given-names>Ellen A</given-names></name><name><surname>Agius</surname><given-names>Paul A</given-names></name><name><surname>Cutts</surname><given-names>Julia C</given-names></name><name><surname>Fowkes</surname><given-names>Freya JI</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A systematic review with multilevel modelling quantified the positive association between human antibodies to <italic>Anopheles</italic> salivary proteins with <italic>Anopheles</italic>-human biting rate and epidemiological measures of malaria transmission, highlighting their potential as a tool to measure vector exposure and malaria transmission.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Sensitive and accurate tools to measure and monitor changes in malaria transmission are essential to track progress towards malaria control and elimination goals. Currently, the gold standard measurement of malaria transmission intensity is the entomological inoculation rate (EIR), a population measure defined as the number of infective <italic>Anopheles</italic> mosquito bites a person receives per unit of time. EIR is calculated as the human biting rate (HBR; measured at the population level by entomological vector-sampling methodologies [gold standard: human landing catch]) multiplied by the sporozoite index (proportion of captured <italic>Anopheles</italic> with sporozoites present in their salivary glands). However, estimation of EIR and HBR via entomological investigations is inherently labour and resource intensive, requiring trained collectors, specialised laboratories, and skilled entomologists. Furthermore, these approaches provide a crude population-level estimate of total vector exposure at a particular time and location, precluding investigation of heterogeneity and natural transmission dynamics of individual-level vector–human interactions (<xref ref-type="bibr" rid="bib104">Monroe et al., 2020</xref>). For example, indoor human landing catches provide poor estimates of outdoor biting and thus total vector exposure (<xref ref-type="bibr" rid="bib100">Mathenge et al., 2005</xref>). The sensitivity of EIR is further compromised in low transmission settings where the number of <italic>Plasmodium-</italic>infected specimens detected is low and often zero.</p><p>Evaluation of the human antibody response to <italic>Anopheles</italic> spp. salivary proteins has the potential to be a logistically practical approach to estimate levels of exposure to vector bites at an individual level. Several <italic>Anopheles</italic> salivary proteins have been shown to be immunogenic in individuals naturally exposed to the bites of <italic>Anopheles</italic> vectors and have been investigated as serological biomarkers to measure <italic>Anopheles</italic> exposure (<xref ref-type="bibr" rid="bib15">Badu et al., 2012b</xref>; <xref ref-type="bibr" rid="bib49">Drame et al., 2013a</xref>; <xref ref-type="bibr" rid="bib45">Drame et al., 2010a</xref>; <xref ref-type="bibr" rid="bib46">Drame et al., 2010b</xref>; <xref ref-type="bibr" rid="bib51">Drame et al., 2015</xref>; <xref ref-type="bibr" rid="bib135">Rizzo et al., 2011a</xref>; <xref ref-type="bibr" rid="bib136">Rizzo et al., 2011b</xref>; <xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib48">Drame et al., 2012</xref>), malaria transmission (<xref ref-type="bibr" rid="bib88">Londono-Renteria et al., 2015a</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib107">Noukpo et al., 2016</xref>), and as an outcome for vector control intervention studies (<xref ref-type="bibr" rid="bib49">Drame et al., 2013a</xref>; <xref ref-type="bibr" rid="bib45">Drame et al., 2010a</xref>; <xref ref-type="bibr" rid="bib46">Drame et al., 2010b</xref>; <xref ref-type="bibr" rid="bib107">Noukpo et al., 2016</xref>; <xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>). However, a major shortcoming of the literature is that studies are largely descriptive and do not quantify the association between entomological and malariometric measures and anti-<italic>Anopheles</italic> salivary antibody responses. We undertook a systematic review with multilevel modelling to quantify the association between HBR, EIR, and other markers of malaria transmission, with anti-<italic>Anopheles</italic> salivary antibody responses, and to understand how these associations vary according to transmission setting and dominant <italic>Anopheles</italic> vectors which can exhibit different biting behaviours. In particular, we were interested in comparing the African context (where <italic>Anopheles gambiae</italic> and <italic>Plasmodium falciparum</italic> predominates) to non-African settings (where <italic>An. gambiae</italic> is absent and where both <italic>P. falciparum</italic> and <italic>Plasmodium vivax</italic> are prevalent). This knowledge is pertinent to advance the use of salivary antibody biomarkers as a vector and malaria transmission serosurveillance tool.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Search strategy and selection criteria</title><p>We performed a systematic review with multilevel modelling according to the Meta-analysis of Observational Studies in Epidemiology (MOOSE) and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (<xref ref-type="bibr" rid="bib103">Moher et al., 2009</xref>; <xref ref-type="bibr" rid="bib164">Stroup et al., 2000</xref>) (Reporting Standards Document). Five databases were searched for published studies investigating antibodies to <italic>Anopheles</italic> salivary antigens as a biomarker for mosquito exposure or malaria transmission published before 30 June 2020. The protocol (Appendix 1) was registered with PROSPERO (CRD42020185449).</p><p>The primary criterion for inclusion in this systematic review was the reporting of estimates of seroprevalence or total levels of immunoglobulin (Ig) in human sera against <italic>Anopheles</italic> salivary antigens. We considered for inclusion cross-sectional, cohort, intervention, and case–control studies of individuals or populations living in all geographies with natural exposure to <italic>Anopheles</italic> mosquitoes. Studies that were solely performed in participants not representative of the wider naturally exposed population (i.e. mosquito-allergic patients, soldiers, returned travellers) were excluded.</p></sec><sec id="s2-2"><title>Measures</title><sec id="s2-2-1"><title>Outcomes</title><p>The primary outcome of our systematic review was antibodies (seroprevalence or levels, including all Ig isotypes and subclasses) against any <italic>Anopheles</italic> salivary antigens (full-length recombinant proteins, peptides, and crude salivary extract). Study-reported salivary antibody data was extracted at the most granular level (i.e. for each site; time point), with each observation of seroprevalence or levels included as a study-specific salivary antibody observation. As measurement of antibody levels does not produce a common metric between studies, only values of seroprevalence could be included in multilevel modelling analyses. Therefore, to maximise data, authors of studies that reported only antibody levels were contacted and asked to classify their participants as ‘responders’ or ‘non-responders’ according to seropositivity (antibody level relative to unexposed sera). Studies that provided antibody levels or categorised seropositivity based upon arbitrary cut-offs are included in narrative terms only.</p></sec><sec id="s2-2-2"><title>Exposures</title><p>The primary exposures of interest were the entomological metrics HBR (average number of bites received per person per night) and EIR (infectious bites received per person per year). Secondary exposures included study-reported prevalence of <italic>Plasmodium</italic> spp. infection (confirmed by either microscopy, rapid diagnostic test (RDT), or polymerase chain reaction [PCR]) and seroprevalence of antimalarial antibodies against pre-erythrocytic and blood stage <italic>Plasmodium</italic> spp. antigens. Where exposure estimates were not provided, we attempted to source data from other publications by the authors or used the site geolocation (longitude and latitude) and year to obtain estimates of EIR from the Pangaea dataset (<xref ref-type="bibr" rid="bib181">Yamba et al., 2018</xref>), <italic>P. falciparum</italic> rates in 2–10 year olds (<italic>Pf</italic>PR<sub>2-10</sub>), and dominant vector species (DVS) from the Malaria Atlas Project (MAP; <xref ref-type="bibr" rid="bib166">The Malaria Atlas, 2017</xref>). Malarial endemicity classes were derived by applying established endemicity cut-offs to MAP <italic>Pf</italic>PR<sub>2-10</sub> estimates (<xref ref-type="bibr" rid="bib17">Bhatt et al., 2015</xref>). For the purposes of the modelling analyses, we defined DVS as where <italic>An. gambiae</italic> sensu lato (s.l.) was the only DVS, where <italic>An. gambiae</italic> s.l. was present with additional DVS, or where <italic>An. gambiae</italic> s.l. was absent. Studies of salivary antigens where exposure variables could not be sourced and data could not be extracted were excluded.</p></sec></sec><sec id="s2-3"><title>Statistical analysis</title><p>Where observations of the seroprevalence of antibodies against the same salivary antigen and exposure of interest were reported in more than one study, generalised linear multilevel modelling (mixed effects, logistic) was used to quantify associations between the exposures of interest and salivary antibody seroprevalence measurements (<xref ref-type="bibr" rid="bib160">Song et al., 2019</xref>). Random intercepts for study and country were estimated to account for nested dependencies induced from multiple study-specific salivary antibody observations (level 1) from the same study (level 2) and studies from the same country (level 3). Additionally, study-level random slopes for the entomological and malariometric exposure parameters were estimated to model study-specific heterogeneity in the effect of the exposure of interest (HBR/EIR/malaria prevalence/antimalarial antibody seroprevalence). The associations between the various exposures and the different salivary antigens were analysed separately; however, observations of IgG seroprevalence against the recombinant full-length protein (gSG6) and synthetic peptide (gSG6-P1, the one peptide determined in all studies utilising peptides) form of the gSG6 antigen were analysed together.</p><p>Potential effect modification of the associations between exposures and anti-<italic>Anopheles</italic> salivary antibody responses was explored. In analyses quantifying the associations between HBR, as well as EIR, and seropositivity, we included an interaction term with DVS and for vector collection method (human landing catch or other indirect measures, e.g. light traps, spray catches, etc.). For the association between <italic>Plasmodium</italic> spp. prevalence and seropositivity, interaction terms with malaria detection methodology (light microscopy or PCR) and malarial species (<italic>P. falciparum</italic> only, or <italic>P. falciparum</italic> and <italic>P. vivax</italic>) were estimated.</p><p>For the exposure measures (HBR, EIR, malaria prevalence, and antimalarial antibody seroprevalence), the data were log transformed since there were non-linear associations between the exposure measures on the original scale and seroprevalence – supported empirically by superior model fit as indicated by Akaike’s information criterion (AIC) and Bayesian information criterion (BIC) fit indices (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>). To aid interpretation, we present our results as a relative increase in the odds of the gSG6 IgG seropositivity for a twofold or, in other words, a 100% relative increase in the exposures. Intraclass correlation coefficients (ICCs) were estimated for country- and study-specific heterogeneity using estimated model variance components. In order to explore the presence of study-level influence in (HBR and EIR) effect estimate modelling, the Generalised Linear Latent and Mixed Models (gllamm) package (<xref ref-type="bibr" rid="bib131">Rabe-Hesketh et al., 2000</xref>) was used to produce Cooks distance statistics (<xref ref-type="bibr" rid="bib29">Cook, 1977</xref>) at the study level from the generalised linear multilevel models. A conservative cut-off threshold for Cooks distance (4 <italic>/n</italic>) was used to guide sensitivity analyses, where studies were excluded, in turn, to assess outlier influence. All statistical analyses were performed using STATA v15.1.</p></sec><sec id="s2-4"><title>Risk of bias in individual studies</title><p>Risk of bias was assessed by one reviewer using the Risk of Bias in Prevalence Studies tool (<xref ref-type="bibr" rid="bib64">Hoy et al., 2012</xref>). The risk of bias pertains to the reported observations of anti-<italic>Anopheles</italic> salivary antibody seroprevalence included in the multilevel modelling.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><p>Literature searches identified 158 potentially relevant studies, of which 42 studies were included in the systematic review (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and are described in <xref ref-type="table" rid="table1">Table 1</xref>. From these studies, we extracted n = 393 study-specific observations of anti-<italic>Anopheles</italic> salivary antibodies determined from antibody measurements in a total of 42,764 sera samples. These studies were performed in 16 countries mostly in hypo- or mesoendemic areas of Africa (32 studies), with a minority performed in South America (four studies), Asia (four studies), and the Pacific (two studies). Studies were classified according to their DVS which reflected the region where the study was conducted. <italic>An. gambiae</italic> s.l. was a DVS in all African study sites (n = 151 study-specific observations from 23 studies where <italic>An. gambiae</italic> s.l. was the only DVS and n = 68 from 16 studies where <italic>An. gambiae</italic> s.l. was present with additional DVS [i.e. <italic>Anopheles funestus</italic>, <italic>Anopheles pharoensis</italic>]), with the exception of one study, which together with the 10 non-African studies contributed n = 174 study-specific estimates where <italic>An. gambiae</italic> s.l. was absent. Most observations came from cross-sectional (n = 191 from 16 studies) or repeated cross-sectional studies (n = 137 from 18 studies), with n = 60 from cohort studies (six studies) and n = 5 from case–control studies (two studies).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Flow diagram of study identification.</title><p>Excluded studies are detailed in Appendix 3.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-fig1-v2.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Key descriptive information from included studies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Study year</th><th align="left" valign="bottom">Country</th><th align="left" valign="bottom">Malarial endemicity class</th><th align="left" valign="bottom">Dominant malaria vector species</th><th align="left" valign="bottom">Study design</th><th align="left" valign="bottom">No.participants(samples)</th><th align="left" valign="bottom">Study-specific n</th><th align="left" valign="bottom">Vector and malariometric variables</th><th align="left" valign="bottom">Salivary antibody outcomes(seroprevalence [%];[L]evels)</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Africa</italic></td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib20">Brosseau et al., 2012</xref></td><td align="left" valign="bottom">Angola</td><td align="left" valign="bottom">Hypoendemic;mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.<italic>;</italic><italic>An. funestus</italic></td><td align="left" valign="bottom">Cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">-(1584)</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>LM</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SGE IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib45">Drame et al., 2010a</xref></td><td align="left" valign="bottom">Angola</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Cohort</td><td align="left" valign="bottom">105(1470)</td><td align="char" char="." valign="bottom">12</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib46">Drame et al., 2010b</xref></td><td align="left" valign="bottom">Angola</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Cohort</td><td align="left" valign="bottom">109(1279)</td><td align="char" char="." valign="bottom">12</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SGE IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib98">Marie et al., 2015</xref></td><td align="left" valign="bottom">Angola</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Cohort</td><td align="left" valign="bottom">71(852)</td><td align="char" char="." valign="bottom">12</td><td align="left" valign="bottom">HBR; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>cE5 IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib51">Drame et al., 2015</xref></td><td align="left" valign="bottom">Benin</td><td align="left" valign="bottom">Hyperendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.;<italic>An. funestus</italic></td><td align="left" valign="bottom">Cohort<sup>‡</sup></td><td align="left" valign="bottom">133(532)</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">HBR; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG and IgM [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib136">Rizzo et al., 2011b</xref></td><td align="left" valign="bottom">Burkina Faso</td><td align="left" valign="bottom">Hyperendemic<sup>*</sup></td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">-(2066)</td><td align="char" char="." valign="bottom">14</td><td align="left" valign="bottom">HBR; EIR; <italic>Plas</italic>+<sup>LM§</sup></td><td align="left" valign="bottom"><italic>g</italic>SG6 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib135">Rizzo et al., 2011a</xref></td><td align="left" valign="bottom">Burkina Faso</td><td align="left" valign="bottom">Hyperendemic<sup>*</sup></td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">335(335)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">HBR</td><td align="left" valign="bottom"><italic>f</italic>SG6 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib137">Rizzo et al., 2014a</xref></td><td align="left" valign="bottom">Burkina Faso</td><td align="left" valign="bottom">Hyperendemic<sup>*</sup></td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">-(359)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">HBR</td><td align="left" valign="bottom"><italic>g</italic>cE5 IgG [%; L]; IgG1 and IgG4 [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib138">Rizzo et al., 2014b</xref></td><td align="left" valign="bottom">Burkina Faso</td><td align="left" valign="bottom">Hyperendemic<sup>*</sup></td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">270(270)</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">HBR</td><td align="left" valign="bottom"><italic>g</italic>SG6 IgG1 and IgG4 [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib159">Soma et al., 2018</xref></td><td align="left" valign="bottom">Burkina Faso</td><td align="left" valign="bottom">Mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Cross-sectional</td><td align="left" valign="bottom">1,728(273)</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">HBR; EIR; <italic>Plas</italic>+<sup>LM</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref></td><td align="left" valign="bottom">Cote d'Ivoire</td><td align="left" valign="bottom">Hypoendemic;mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.<italic>;</italic><italic>An. funestus</italic><bold><sup><italic>†</italic></sup></bold></td><td align="left" valign="bottom">Cross-sectional</td><td align="left" valign="bottom">94(94)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>LM</sup>; <italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref></td><td align="left" valign="bottom">Cote d'Ivoire</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.<italic>;</italic><italic>An. funestus</italic><bold><sup>†</sup></bold></td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">234(234)</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom"><italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib167">Traoré et al., 2018</xref></td><td align="left" valign="bottom">Cote d'Ivoire</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Repeated cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">89 (178)</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib168">Traoré et al., 2019</xref></td><td align="left" valign="bottom">Cote d'Ivoire</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l<italic>.;</italic><italic>An. funestus</italic><bold><sup>†</sup></bold></td><td align="left" valign="bottom">Repeated cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">-(442)</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib141">Sadia-Kacou et al., 2019</xref></td><td align="left" valign="bottom">Cote d'Ivoire</td><td align="left" valign="bottom">Mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Repeated cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">775(775)</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom"><italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Badu et al., 2015</xref></td><td align="left" valign="bottom">Ghana</td><td align="left" valign="bottom">Mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.<italic>;</italic><italic>An. funestus</italic><bold><sup>†</sup></bold></td><td align="left" valign="bottom">Repeated cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">295(885)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>LM</sup>; <italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Badu et al., 2012b</xref></td><td align="left" valign="bottom">Kenya</td><td align="left" valign="bottom">Hypoendemic;mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">-(1366)</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">EIR; <italic>Plas</italic>+<sup>LM§</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib143">Sagna et al., 2013b</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Hypoendemic;mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Cohort<sup>‡</sup></td><td align="left" valign="bottom">265(1325)</td><td align="char" char="." valign="bottom">25</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM§</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Drame et al., 2012</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Cross-sectional</td><td align="left" valign="bottom">1010(1010)</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">HBR; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib127">Poinsignon et al., 2010b</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. funestus</italic></td><td align="left" valign="bottom">Cohort<sup>‡</sup></td><td align="left" valign="bottom">87(261)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM§</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib150">Sarr et al., 2012</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Hypoendemic;mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l<italic>.;</italic><italic>An. funestus</italic><bold><sup>†</sup></bold></td><td align="left" valign="bottom">Repeated cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">-(401)</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM§</sup>; <italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib82">Lawaly et al., 2012</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l<italic>.</italic></td><td align="left" valign="bottom">Cohort</td><td align="left" valign="bottom">387(711)</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM§</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SGE IgG, IgG4 and IgE [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Hypoendemic;<sup>*</sup>mesoendemic;<sup>*</sup>hyperendemic<sup>*</sup></td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l<italic>.;</italic><italic>An. funestus;</italic><italic>An. pharoensis</italic></td><td align="left" valign="bottom">Cross-sectional</td><td align="left" valign="bottom">-(134)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">HBR; EIR</td><td align="left" valign="bottom"><italic>g</italic>SG6 IgG [%; L] <italic>f</italic>SG6 IgG [%; L]; <italic>f</italic>5’nuc IgG [%; L]; <italic>g</italic>5’nuc IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Hypoendemic;<sup>*</sup>mesoendemic;<sup>*</sup>hyperendemic<sup>*</sup></td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l<italic>.;</italic><italic>An. funestus;</italic><italic>An. pharoensis</italic></td><td align="left" valign="bottom">Cross-sectional</td><td align="left" valign="bottom">-(123)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">EIR; <italic>Pf</italic>-IgG</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%]; <italic>g</italic>SG6-P2 IgG [%]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Hypoendemic;mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.<italic>; An. funestus</italic></td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">-(798)</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">EIR; <italic>Plas</italic>+<sup>LM</sup>; <italic>Plas</italic>+<sup>PCR</sup>; <italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib123">Poinsignon et al., 2008a</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l<italic>.</italic></td><td align="left" valign="bottom">Cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">241(241)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">HBR; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [L]; <italic>g</italic>SG6-P2 IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib125">Poinsignon et al., 2009</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Repeated cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">61 (122)</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM§</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib133">Remoue et al., 2006</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">448(448)</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>LM§</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SGE IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib146">Sagna et al., 2019</xref></td><td align="left" valign="bottom">Senegal</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.<bold><sup>†</sup></bold></td><td align="left" valign="bottom">Cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">809(809)</td><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom"><italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref></td><td align="left" valign="bottom">Tanzania</td><td align="left" valign="bottom">Mesoendemic;hyperendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.</td><td align="left" valign="bottom">Cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">636(636)</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">HBR; <italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib182">Yman et al., 2016</xref></td><td align="left" valign="bottom">Tanzania</td><td align="left" valign="bottom">Mesoendemic;holoendemic*</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.<italic>;</italic><italic>An. funestus</italic></td><td align="left" valign="bottom">Repeated cross-sectional<sup>‡</sup></td><td align="left" valign="bottom">668(668)</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom"><italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6 IgG [%]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib130">Proietti et al., 2013</xref></td><td align="left" valign="bottom">Uganda</td><td align="left" valign="bottom">Mesoendemic</td><td align="left" valign="bottom"><italic>An. gambiae</italic> s.l.<italic>;</italic><italic>An. funestus</italic><bold><sup>†</sup></bold></td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">509(509)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom"><italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6 IgG [%]</td></tr><tr><td align="left" valign="bottom"><italic>South America</italic></td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Andrade et al., 2009</xref></td><td align="left" valign="bottom">Brazil</td><td align="left" valign="bottom">Eliminating;hypoendemic</td><td align="left" valign="bottom"><italic>An. darlingi</italic></td><td align="left" valign="bottom">Cross-sectional</td><td align="left" valign="bottom">204(204)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>LM¶</sup>; <italic>Plas+</italic><sup>PCR¶</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>d</italic>SGE IgG [L<sup>||</sup>]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib88">Londono-Renteria et al., 2015a</xref></td><td align="left" valign="bottom">Colombia</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"><italic>An. albimanus</italic></td><td align="left" valign="bottom">Cross-sectional</td><td align="left" valign="bottom">42(42)</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>PCR¶</sup></td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [L<sup>||</sup>]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib91">Londono-Renteria et al., 2020a</xref></td><td align="left" valign="bottom">Colombia</td><td align="left" valign="bottom">Eliminating</td><td align="left" valign="bottom"><italic>An. albimanus</italic></td><td align="left" valign="bottom">Cross-sectional</td><td align="left" valign="bottom">337(337)</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>PCR</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>a</italic>PEROX-P1, P2 and P3 IgG [L]; <italic>a</italic>TRANS-P1 and P2 IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib105">Montiel et al., 2020</xref></td><td align="left" valign="bottom">Colombia</td><td align="left" valign="bottom">Eliminating</td><td align="left" valign="bottom"><italic>An. albimanus</italic></td><td align="left" valign="bottom">Case–control</td><td align="left" valign="bottom">113(113)</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>LM</sup>; <italic>Plas</italic>+<sup>PCR¶</sup>; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [L <sup>||</sup>]; <italic>d</italic>SGE IgG [L <sup>||</sup>]; <italic>a</italic>STECLA SGE IgG [L <sup>||</sup>]; <italic>a</italic>Cartagena SGE IgG [L <sup>||</sup>]</td></tr><tr><td align="left" valign="bottom"><italic>Asia</italic></td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref></td><td align="left" valign="bottom">Cambodia</td><td align="left" valign="bottom">Hypoendemic</td><td align="left" valign="bottom"><italic>An. dirus</italic></td><td align="left" valign="bottom">Cross-sectional</td><td align="left" valign="bottom">-(8438)</td><td align="char" char="." valign="bottom">113</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>PCR</sup>; <italic>Pf</italic>-IgG; <italic>Pv</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]; <italic>g</italic>SG6-P2 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Charlwood et al., 2017</xref></td><td align="left" valign="bottom">Cambodia</td><td align="left" valign="bottom">Eliminating</td><td align="left" valign="bottom"><italic>An. dirus</italic></td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">454(1180)</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">HBR; <italic>Plas</italic>+<sup>PCR</sup>; <italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6 IgG [L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref></td><td align="left" valign="bottom">Myanmar</td><td align="left" valign="bottom">Eliminating</td><td align="left" valign="bottom"><italic>An. minimus;</italic><italic>An. maculatus;</italic><italic>An. dirus</italic> s.l.</td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">2602(9425)</td><td align="char" char="." valign="bottom">28</td><td align="left" valign="bottom">HBR; EIR;<italic>Plas</italic>+<sup>PCR</sup>;<italic>Pf</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib174">Waitayakul et al., 2006</xref></td><td align="left" valign="bottom">Thailand</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"><italic>An. dirus</italic></td><td align="left" valign="bottom">Case–control</td><td align="left" valign="bottom">139 (139)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>LM</sup></td><td align="left" valign="bottom"><italic>dir</italic>SGE IgG and IgM [L <sup>||</sup>]</td></tr><tr><td align="left" valign="bottom"><italic>Pacific</italic></td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib129">Pollard et al., 2019</xref></td><td align="left" valign="bottom">Solomon Islands</td><td align="left" valign="bottom">Eliminating;hypoendemic</td><td align="left" valign="bottom"><italic>An. farauti</italic></td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">686(791)</td><td align="char" char="." valign="bottom">9</td><td align="left" valign="bottom">HBR; EIR; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6-P1 IgG [%; L]</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref></td><td align="left" valign="bottom">Vanuatu</td><td align="left" valign="bottom">Eliminating;hypoendemic;mesoendemic</td><td align="left" valign="bottom"><italic>An. farauti</italic></td><td align="left" valign="bottom">Repeated cross-sectional</td><td align="left" valign="bottom">905(905)</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom"><italic>Plas</italic>+<sup>LM</sup>; <italic>Pf</italic>-IgG; <italic>Pv</italic>-IgG; <italic>Pf</italic>PR</td><td align="left" valign="bottom"><italic>g</italic>SG6 IgG [%; L]</td></tr></tbody></table><table-wrap-foot><fn><p>Data are given as study, year of publication, country, malarial endemicity class, malarial DVS, study design (‡ indicates that study was performed solely in children), number of participants and number of samples, number of study-specific salivary antibody outcome observations (study-specific n), entomological and malariometric parameters, and salivary antibody outcomes assessed. Malarial endemicity class (categorical) is derived from <italic>P. falciparum</italic> prevalence rate in 2–10 year olds (<italic>Pf</italic>PR) extracted from MAP using site geolocations and year of study, and applying established cut-offs reported in <xref ref-type="bibr" rid="bib17">Bhatt et al., 2015</xref>. If <italic>Pf</italic>PR data were not available (e.g. surveys prior to 2000; or unable to determine study site geolocation and year), endemicity class is given as stated in the study (indicated by *). DVS is as stated in the study or extracted from MAP (indicated by †). Of note, <italic>An. gambiae</italic> sensu lato (s.l.) includes both <italic>An. gambiae</italic> sensu stricto and <italic>An. arabiensis</italic>. Entomological and malariometric parameters include HBR, EIR, prevalence estimates of <italic>Plasmodium</italic> spp. (<italic>Plas</italic>+): detected by LM, or PCR, with § indicating prevalence of <italic>P. falciparum</italic> only and ¶ indicating prevalence of <italic>P. vivax</italic> only (no footnote indicates <italic>P. falciparum</italic> and <italic>P. vivax</italic> co-endemic), as well as <italic>Pf</italic>PR extracted from MAP (<xref ref-type="bibr" rid="bib166">The Malaria Atlas, 2017</xref>). Salivary antibody outcomes are indicated as either seroprevalence [%] or levels [L], or both [%; L], with <sup>||</sup> indicating that studies reported results stratified by malarial infection status. Salivary antigens include recombinant full-length proteins, synthetic peptides, and whole SGE. Italicised prefix of salivary antigen indicates species: <italic>An. gambiae</italic> (<italic>g</italic>), <italic>An. funestus</italic> (<italic>f</italic>), <italic>An. darlingi</italic> (<italic>d</italic>), <italic>An. albimanus</italic> (<italic>a</italic>), <italic>An. dirus</italic> (<italic>dir</italic>).</p></fn><fn><p>DVS: dominant vector species; MAP: Malaria Atlas Project; HBR: human biting rate; EIR: entomological inoculation rate; LM: light microscopy; PCR: polymerase chain reaction; SGE: salivary gland extracts.</p></fn></table-wrap-foot></table-wrap><p>The salivary antigen most commonly assessed was <italic>An. gambiae</italic> salivary gland 6 (gSG6), as a full-length protein (n = 67 from 8 studies) and synthetic peptide (<italic>An. gambiae</italic> salivary gland 6 peptide 1 [gSG6-P1]; n = 270 from 24 studies). Additional salivary antigens assessed included <italic>An. gambiae</italic> gSG6-P2 (n = 119 from three studies), recombinant cE5 (n = 15 from two studies), g-5’nuc (n = 3 from one study), and recombinant <italic>An. funestus</italic> fSG6 (n = 6 from two studies) and f-5’nuc (n = 3 from one study). Seven studies measured antibodies to whole salivary gland extracts (SGE) from <italic>An. gambiae</italic> (n = 24 from four studies), <italic>Anopheles darlingi</italic> (n = 5 from two studies), <italic>Anopheles albimanus</italic> (n = 2 from one study), and <italic>Anopheles dirus</italic> (n = 3 from one study), while one study assessed antibodies against synthetic peptides of <italic>An. albimanus</italic> (n = 2) (<xref ref-type="table" rid="table1">Table 1</xref>). All studies investigated total IgG and only five determined an additional isotype or subclass (<xref ref-type="bibr" rid="bib51">Drame et al., 2015</xref>; <xref ref-type="bibr" rid="bib82">Lawaly et al., 2012</xref>; <xref ref-type="bibr" rid="bib137">Rizzo et al., 2014a</xref>; <xref ref-type="bibr" rid="bib138">Rizzo et al., 2014b</xref>; <xref ref-type="bibr" rid="bib174">Waitayakul et al., 2006</xref>). The paucity of studies investigating these latter-mentioned antibody types and <italic>Anopheles</italic> salivary biomarkers precluded extensive multilevel analyses; instead, we present their associations in narrative terms in Appendix 10. Analyses reported below focus on quantifying the relationships between HBR, EIR, and markers of malaria transmission with total IgG to <italic>An. gambiae</italic> gSG6. The distributions of exposure observations were: HBR (n = 197 from 24 studies, median: 3.0 bites per person per night, IQR: 0.9–12.1; range: 0–121.4), EIR (n = 60 from 8 studies, median: 7.3 infectious bites received per person per year, IQR: 0–36.4; range: 0–585.6), and <italic>Plasmodium</italic> spp. prevalence (n = 266 from 22 studies, median: 9.1%; IQR: 4–22%; range: 0–94.6%).</p><p>Generalised linear multilevel modelling (mixed effects, logistic) of n = 132 study-specific observations from 12 studies estimated a positive association between <italic>Anopheles</italic> spp.-HBR (log transformed) and seroprevalence of IgG to <italic>An. gambiae</italic> gSG6 salivary antigen (<xref ref-type="bibr" rid="bib45">Drame et al., 2010a</xref>; <xref ref-type="bibr" rid="bib51">Drame et al., 2015</xref>; <xref ref-type="bibr" rid="bib135">Rizzo et al., 2011a</xref>; <xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib48">Drame et al., 2012</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib159">Soma et al., 2018</xref>; <xref ref-type="bibr" rid="bib168">Traoré et al., 2019</xref>; <xref ref-type="bibr" rid="bib143">Sagna et al., 2013b</xref>; <xref ref-type="bibr" rid="bib150">Sarr et al., 2012</xref>; <xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref>; <xref ref-type="bibr" rid="bib129">Pollard et al., 2019</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="table" rid="app4table1">Appendix 4—table 1</xref>). As we have log transformed HBR to account for the non-linear relationship between HBR and log odds of gSG6 IgG seropositivity, we have presented estimated odds ratios for different incremental percent increases in HBR (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). For example, the magnitude of the association was such that a twofold (100% relative) increase in HBR was associated with a 23% increase (OR: 1.23; 95% CI: 1.10–1.37; p&lt;0.001) in the odds of anti-gSG6 IgG seropositivity (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Heterogeneity in the effect of HBR on gSG6 across studies was observed (likelihood ratio χ<sup>2</sup>(1) = 109.25, p&lt;0.001); the 95% reference range of study-specific effects for a twofold increase in HBR ranged from a 12% reduction to a 70% increase in odds (OR: 0.88–1.70). There was no evidence that the association between HBR and gSG6 IgG varied according to vector collection method (human landing catch or other indirect methods; p=0.443) or study design (longitudinal cohort or cross-sectional/repeated cross-sectional; p=0.138). Given the global heterogeneity in the distribution of <italic>Anopheles</italic> species, we sought to quantify the extent to which the association between <italic>An. gambiae</italic> gSG6 IgG seropositivity and HBR is moderated by DVS. We observed that the magnitude of the association between <italic>An. gambiae</italic> gSG6 IgG seropositivity and HBR was greatest in African studies where <italic>An. gambiae</italic> s.l. was the only dominant vector (p&lt;0.001, Appendix 5); a twofold increase in HBR was associated with a 37% increase (OR: 1.37; 95% CI: 1.19–1.58; p&lt;0.001) in the odds of gSG6 IgG seropositivity compared to an attenuated association for African studies where <italic>An. gambiae</italic> s.l. was not the only DVS (OR: 1.14 per twofold increase in HBR; 95% CI: 0.98–1.33; p=0.079) and non-African studies where <italic>An. gambiae</italic> s.l. was absent (OR: 1.05 per twofold increase in HBR; 95% CI: 1.03–1.08; p&lt;0.001). In order to quantify the relationship between gSG6 IgG seroprevalence and HBR, for given HBR values we estimated gSG6 IgG seroprevalence by producing model-based predicted probabilities overall and by DVS (<xref ref-type="fig" rid="fig3">Figure 3</xref>). In African studies where <italic>An. gambiae</italic> s.l. is the only DVS, predicted seroprevalence of <italic>An. gambiae</italic> gSG6 ranged from 21% (95% CI: 0–45%) to 86% (95% CI: 67–100%) for an HBR of 0.1–100 bites per person per night, respectively (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Association between anti-gSG6 IgG seroprevalence and log<sub>2</sub> human biting rate (HBR).</title><p>Figure shows the observed anti-gSG6 (either recombinant or peptide form) IgG seroprevalence (%) and HBR for each study-specific observation, as well as the predicted average anti-gSG6 IgG seroprevalence (predicted probability for the average study and country) with 95% confidence intervals (95% CI). Circles are proportional to the size of the sample for each study-specific observation, with colours indicating sample size: black (&lt;50), red (50–100), navy (100–150), and green (&gt;150). Association estimated using generalised linear multilevel modelling (mixed effects, logistic) to account for the hierarchical nature of the data, where study-specific anti-gSG6 IgG observations are nested within study and study is nested within country (model output shown in Appendix 4; p&lt;0.001).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Estimated relative change in odds of anti-gSG6 IgG seropositivity (95% confidence interval) for given relative percent increases in human biting rate (HBR) (bites/person/night).</title><p>HBR has been log transformed to account for the non-linear relationship between HBR and log odds of gSG6 IgG seropositivity, where a 100% relative increase in HBR corresponds to a twofold increase in HBR. Estimated using generalised linear multilevel modelling (mixed effects, logistic) of the association between anti-gSG6 IgG seropositivity and log HBR, with random effects for country-specific and study-specific heterogeneity in gSG6 IgG seroprevalence and study-specific heterogeneity in effect of HBR (see Appendix 4).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-fig2-figsupp1-v2.tif"/></fig></fig-group><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Forest plots of predicted anti-gSG6 IgG seroprevalence (%) and <italic>Anopheles</italic> species-specific human biting rate (HBR).</title><p>Panels show the predicted average anti-gSG6 IgG seroprevalence (predicted probability for the average study and country) with 95% confidence intervals for given HBR, for all <italic>Anopheles</italic> spp. (using model output from Appendix 4) and for specific-dominant vector species (DVS): where <italic>An. gambiae</italic> s.l. is the only DVS, where other DVS were present in addition to <italic>An. gambiae</italic> s.l. and where <italic>An. gambiae</italic> s.l. was absent (using model output from Appendix 5).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Association between anti-gSG6 IgG seroprevalence and <italic>Anopheles</italic> species-specific log<sub>2</sub> human biting rate (HBR).</title><p>Figure shows the observed anti-gSG6 (either recombinant or peptide form) IgG seroprevalence (%) and HBR for each study-specific observation coloured by dominant vector species (DVS), as well as the predicted average anti-gSG6 IgG seroprevalence (predicted probability for the average study and country) with 95% confidence intervals (95% CI). Coloured circles and lines denote DVS, with red indicating where <italic>An. gambiae</italic> s.l<italic>.</italic> is the only DVS, navy where other DVS were present in addition to <italic>An. gambiae</italic> s.l<italic>.,</italic> and green where <italic>An. gambiae</italic> s.l<italic>.</italic> was absent. Circles are proportional to the size of the sample for each study-specific estimate. Association estimated using generalised linear multilevel modelling (mixed effects, logistic) to account for the hierarchical nature of the data, where study-specific anti-gSG6 IgG observations, are nested within study, and study is nested within country.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-fig3-figsupp1-v2.tif"/></fig></fig-group><p>A positive association was also found between seroprevalence of anti-gSG6 IgG antibodies and EIR in analysis of n = 38 study-specific observations from eight studies (<xref ref-type="fig" rid="fig4">Figure 4</xref>, Appendix 6) [<xref ref-type="bibr" rid="bib136">Rizzo et al., 2011b</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib159">Soma et al., 2018</xref>; <xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref>; <xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib129">Pollard et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Badu et al., 2012b</xref>]. For a twofold increase in EIR, the odds of anti-gSG6 IgG seropositivity increased by 11% (OR: 1.11; 95% CI: 1.05–1.17; p&lt;0.001), with heterogeneity in the study-specific effects (95% reference range: 1.00–1.24; likelihood ratio χ<sup>2</sup>(1) = 15.02, p&lt;0.001). There was no evidence of effect modification by either vector collection method (p=0.095) or DVS (p=0.080) on the association between seroprevalence of anti-gSG6 IgG and EIR.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Association between anti-gSG6 IgG seroprevalence and log<sub>2</sub> entomological inoculation rate (EIR).</title><p>Figure shows the observed anti-gSG6 (either recombinant or peptide form) IgG seroprevalence (%) and EIR for each study-specific observation, as well as the predicted average anti-gSG6 IgG seroprevalence (predicted probability for the average study and country) with 95% confidence intervals (95% CI). Circles are proportional to the size of the sample for each study-specific estimate, with colours indicating sample size: black (&lt;50), red (50–100), navy (100–150), and green (&gt;150). Association estimated using generalised linear multilevel modelling (mixed effects, logistic) to account for the hierarchical nature of the data, where study-specific anti-gSG6 IgG observations are nested within study and study is nested within country (model output shown in Appendix 6; p&lt;0.001).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Estimated change in odds of anti-gSG6 IgG seropositivity (95% confidence interval) for given relative percent increases in entomological inoculation rate (EIR) (infective bites/person/night).</title><p>EIR has been log transformed to account for the non-linear relationship between EIR and log odds of gSG6 IgG seropositivity, where a 100% relative increase in EIR corresponds to a twofold increase in EIR. Estimated using generalised linear multilevel modelling (mixed effects, logistic) of the association between anti-gSG6 IgG seropositivity and log EIR, with random effects for country-specific and study-specific heterogeneity in gSG6 IgG seroprevalence and study-specific heterogeneity in effect of EIR (see Appendix 6).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Similar positive associations were also found between anti-gSG6 IgG levels, HBR, and EIR in 11 studies [<xref ref-type="bibr" rid="bib51">Drame et al., 2015</xref>; <xref ref-type="bibr" rid="bib48">Drame et al., 2012</xref>; <xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib159">Soma et al., 2018</xref>; <xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref>; <xref ref-type="bibr" rid="bib135">Rizzo et al., 2011a</xref>; <xref ref-type="bibr" rid="bib136">Rizzo et al., 2011b</xref>; <xref ref-type="bibr" rid="bib127">Poinsignon et al., 2010b</xref>; <xref ref-type="bibr" rid="bib123">Poinsignon et al., 2008a</xref>; <xref ref-type="bibr" rid="bib26">Charlwood et al., 2017</xref>; <xref ref-type="bibr" rid="bib143">Sagna et al., 2013b</xref>] and 3 studies [<xref ref-type="bibr" rid="bib136">Rizzo et al., 2011b</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref>], respectively, but 7 studies showed no association between HBR and levels of IgG to gSG6 [<xref ref-type="bibr" rid="bib45">Drame et al., 2010a</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib167">Traoré et al., 2018</xref>; <xref ref-type="bibr" rid="bib168">Traoré et al., 2019</xref>; <xref ref-type="bibr" rid="bib150">Sarr et al., 2012</xref>; <xref ref-type="bibr" rid="bib125">Poinsignon et al., 2009</xref>; <xref ref-type="bibr" rid="bib129">Pollard et al., 2019</xref>].</p><p>The association between anti-gSG6 IgG seroprevalence and population-level prevalence of <italic>Plasmodium</italic> spp. infection was investigated. Generalised linear multilevel modelling (mixed effects, logistic) of n = 212 from 14 studies that measured <italic>Plasmodium</italic> spp. prevalence contemporaneously in their study [<xref ref-type="bibr" rid="bib15">Badu et al., 2012b</xref>; <xref ref-type="bibr" rid="bib136">Rizzo et al., 2011b</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib159">Soma et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib168">Traoré et al., 2019</xref>; <xref ref-type="bibr" rid="bib16">Badu et al., 2015</xref>; <xref ref-type="bibr" rid="bib143">Sagna et al., 2013b</xref>; <xref ref-type="bibr" rid="bib150">Sarr et al., 2012</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Drame et al., 2010a</xref>; <xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib130">Proietti et al., 2013</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>] showed that for a twofold increase in the prevalence of <italic>Plasmodium</italic> spp. infection the odds of gSG6 IgG seropositivity increased by 38%, although the confidence intervals were wide (OR: 1.38; 95% CI: 0.89–2.12; p=0.148) and heterogeneity in the study-specific effects was observed (95% reference range: 0.30–6.37; likelihood ratio χ<sup>2</sup>(1) = 235.5, p&lt;0.001) (<xref ref-type="fig" rid="fig5">Figure 5</xref> and Appendix 7). In the association between gSG6 IgG seropositivity and <italic>Plasmodium</italic> spp. infection, there was no evidence for a moderating effect of <italic>Plasmodium</italic> spp. detection method (light microscopy or PCR, p=0.968), or species (African studies with <italic>P. falciparum</italic> versus non-African studies where <italic>P. falciparum</italic> and <italic>P. vivax</italic> are co-prevalent<italic>,</italic> p=0.538).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The association between anti-gSG6 IgG seroprevalence (%) and log<sub>2</sub> <italic>Plasmodium</italic> spp. prevalence (%).</title><p>Figure shows the observed anti-gSG6 (either recombinant or peptide form) IgG seroprevalence (%) and prevalence of any <italic>Plasmodium</italic> spp. infection (%) for each study-specific observation, as well as the predicted average anti-gSG6 IgG seroprevalence (predicted probability for average study) with 95% confidence intervals (95% CI). Circles are proportional to the size of the sample for each study-specific observation, with colours indicating sample size: black (&lt;50), red (50–100), navy (100–150), and green (&gt;150). Association estimated using generalised linear multilevel modelling (mixed effects, logistic) to account for the hierarchical nature of the data, where study-specific anti-gSG6 IgG observations are nested within study. See Appendix 7 for model output.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-fig5-v2.tif"/></fig><p>Additionally, 14 studies reported observations of anti-gSG6 IgG levels and the prevalence of <italic>Plasmodium</italic> spp. infections measured contemporaneously in their study. The median anti-gSG6 IgG antibody levels increased with increasing <italic>Plasmodium</italic> spp. prevalence in six of these studies (<xref ref-type="bibr" rid="bib45">Drame et al., 2010a</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib127">Poinsignon et al., 2010b</xref>; <xref ref-type="bibr" rid="bib150">Sarr et al., 2012</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>), or in <italic>Plasmodium</italic> spp.-infected compared to non-infected individuals (<xref ref-type="bibr" rid="bib88">Londono-Renteria et al., 2015a</xref>; <xref ref-type="bibr" rid="bib105">Montiel et al., 2020</xref>), but showed no association in eight studies (<xref ref-type="bibr" rid="bib136">Rizzo et al., 2011b</xref>; <xref ref-type="bibr" rid="bib159">Soma et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib167">Traoré et al., 2018</xref>; <xref ref-type="bibr" rid="bib168">Traoré et al., 2019</xref>; <xref ref-type="bibr" rid="bib16">Badu et al., 2015</xref>; <xref ref-type="bibr" rid="bib143">Sagna et al., 2013b</xref>; <xref ref-type="bibr" rid="bib125">Poinsignon et al., 2009</xref>). Furthermore, we also investigated associations with serological measures of malaria exposure and found that for a twofold increase in pre-erythrocytic and blood stage antigen seroprevalence there was a 2.19-fold (OR: 2.19; 95% CI: 1.18–4.04; p=0.013) and 41% to 5.69-fold (OR range: 1.41–5.69; p range: &lt;0.001 to 0.523) increase in the odds of anti-gSG6 IgG seropositivity, respectively (Appendix 8).</p><p>To give epidemiological context, we estimated anti-gSG6 seroprevalence by producing model-based predicted probabilities by malarial endemicity class (a categorical variable derived by applying established cut-off values for the <italic>Pf</italic>PR<sub>2-10</sub> extracted from MAP). Generalised linear multilevel modelling (mixed effects, logistic) on 297 study-specific salivary antibody observations from 22 studies shows that the estimated anti-gSG6 IgG seroprevalence is higher for the higher endemicity classes (eliminating malaria: 20% [95% CI: 8–31%]; hypoendemic: 34% [95% CI: 19–49%]; mesoendemic: 52% [95 CI: 35–68%]; hyperendemic settings: 47% [95% CI: 27–64%]; holoendemic: 78% [95% CI: 67–90%]; p&lt;0.001; <xref ref-type="table" rid="table2">Table 2</xref>). Interactions with DVS or region (Africa/non-Africa) could not be explored due to collinearity with malaria endemicity class. Therefore, in addition using Bayes best linear unbiased predictions (BLUPs) we estimated country-specific gSG6 IgG seroprevalence from an intercept-only multilevel model fitted to 301 study-specific salivary antibody observations from 22 studies. It showed that IgG seroprevalence to <italic>An. gambiae</italic> gSG6 was lowest in countries in the Pacific region where <italic>An. gambiae</italic> is absent (Vanuatu [31%] and Solomon Islands [32%]) and highest in countries where <italic>An. gambiae</italic> is a DVS (Benin [72%] and Burkina Faso [65%]; Appendix 9).</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Association between gSG6 IgG seroprevalence (%) and malarial endemicity (<italic>Pf</italic>PR<sub>2-10</sub>).</title><p>Table shows the odds ratio (OR), 95% confidence interval (95% CI), p-value, as well as the predicted gSG6 IgG seroprevalence and associated 95%CI<sup>†</sup> for associations between endemicity class (categorical: derived from <italic>P. falciparum</italic> parasite rates in 2–10 year olds [<italic>Pf</italic>PR]) and anti-gSG6 IgG seropositivity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Malaria endemicity class*</th><th align="left" valign="bottom">OR</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">p-Value</th><th align="left" valign="bottom">Predicted gSG6 IgG seroprevalence (%)</th><th align="left" valign="bottom">95% CI</th></tr></thead><tbody><tr><td align="left" valign="bottom">Eliminating malaria<sub>(<italic>Pf</italic>PR &lt;1%)</sub></td><td align="left" valign="bottom">Ref.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">20.0</td><td align="char" char="." valign="bottom">8.3–31.7</td></tr><tr><td align="left" valign="bottom">Hypoendemic<sub>(<italic>Pf</italic>PR 1-10%)</sub></td><td align="left" valign="bottom">2.04</td><td align="char" char="." valign="bottom">1.43–2.90</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">33.7</td><td align="char" char="." valign="bottom">18.9–48.5</td></tr><tr><td align="left" valign="bottom">Mesoendemic<sub>(<italic>Pf</italic>PR 10-50%)</sub></td><td align="left" valign="bottom">4.19</td><td align="char" char="." valign="bottom">2.80–6.08</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">51.5</td><td align="char" char="." valign="bottom">34.6–67.7</td></tr><tr><td align="left" valign="bottom">Hyperendemic<sub>(<italic>Pf</italic>PR 50-75%)</sub></td><td align="left" valign="bottom">3.36</td><td align="char" char="." valign="bottom">1.98–5.71</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">46.5</td><td align="char" char="." valign="bottom">27.4–63.8</td></tr><tr><td align="left" valign="bottom">Holoendemic<sub>(<italic>Pf</italic>PR &gt;75%)</sub></td><td align="left" valign="bottom">14.4</td><td align="char" char="." valign="bottom">9.72–21.36</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">78.2</td><td align="char" char="." valign="bottom">66.8–89.7</td></tr></tbody></table><table-wrap-foot><fn><p>*Generalised linear multilevel modelling (mixed effects, logistic) estimating the association between anti-gSG6 IgG seropositivity and endemicity class with random effects for study-specific heterogeneity in gSG6 IgG. Model fitted to n = 297 study-specific observations from 22 studies. Of note, nine studies that measured <italic>Plasmodium</italic> spp. prevalence and IgG antibodies to gSG6 were excluded from this analysis as eight only reported gSG6 IgG levels and one was a case–control study. Endemicity class membership is derived from <italic>Pf</italic>PR from <xref ref-type="bibr" rid="bib166">The Malaria Atlas, 2017</xref> (MAP) using cut-offs taken from <xref ref-type="bibr" rid="bib17">Bhatt et al., 2015</xref>, or where MAP data were unavailable, endemicity was included as indicated in the study.</p></fn><fn><p><sup>†</sup>Predicted gSG6 IgG seroprevalence (predicted probability in the average study) is estimated from generalised linear multilevel modelling (mixed effects, logistic).</p></fn></table-wrap-foot></table-wrap><p>Assessments of internal and external study validity revealed there was a moderate risk of selection bias (Appendix 2) due to the study-specific inclusion criteria of populations at higher risk of malaria which contributed gSG6 seroprevalence observations. Sensitivity analyses exploring potential study-level outlier influence on the estimated associations between anti-gSG6 IgG seroprevalence, HBR, and EIR showed no evidence of bias (effect estimates for each sensitivity analysis were consistent with model estimates overall) for studies identified as exhibiting potential influence (HBR: n = 6; EIR: n = 6).</p></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>This systematic review and multilevel modelling analysis provides the first quantification of a positive non-linear association between seroprevalence of <italic>An. gambiae</italic> gSG6 IgG antibodies and HBR and demonstrated that its magnitude varied with respect to the DVS present in the area. Importantly, this review identified a paucity of studies conducted outside of Africa, as well as investigating salivary antigens representing different <italic>Anopheles</italic> spp. and antigenic targets. gSG6 antibodies were positively associated with the prevalence of <italic>Plasmodium</italic> spp. infection as well as established epidemiological measures of malaria transmission: malaria endemicity class and EIR. Overall, our results demonstrate that antibody seroprevalence specific for <italic>Anopheles</italic> spp. salivary antigens has the potential to be an effective measure of vector exposure and malaria transmission at the population and, potentially, individual level.</p><p><italic>An. gambiae</italic> gSG6 IgG seropositivity increased with increasing HBR, although these increases had diminishing impact on <italic>An. gambiae</italic> gSG6 IgG seropositivity at higher levels of HBR (approximately greater than two bites per person per night). In our study, 17 studies performed across Africa (Angola, Benin, Burkina Faso, Cote d’Ivoire, and Senegal) and the Asia Pacific (Cambodia, Myanmar, and the Solomon Islands) reported an HBR &lt; 2, demonstrating the applicability of gSG6 as a biomarker of HBR across a broad range of malaria-endemic regions. We also observed that the association was strongest in areas where <italic>An. gambiae</italic> s.l<italic>.</italic> was the only DVS (i.e. concordant <italic>An. gambiae</italic> species-specific HBR with <italic>An. gambiae</italic> gSG6 antibodies). Associations, albeit weaker, were also observed between discordant species-specific HBR and gSG6, most likely because the <italic>An. gambiae SG6</italic> gene shares moderate sequence identity with vector species that are dominant in other regions (Africa: 80% <italic>An. funestus</italic>; Asia: 79% <italic>Anopheles stephensi</italic> and <italic>Anopheles maculatus</italic>; 54% <italic>An. dirus</italic>; Pacific: 52.5% <italic>Anopheles farauti</italic>), and is absent from the DVS of the Americas (<italic>An. albimanus</italic> and <italic>An. darlingi</italic>) (<xref ref-type="bibr" rid="bib11">Arcà et al., 2017</xref>). The generalisability of <italic>An. gambiae</italic> gSG6 IgG as a biomarker of exposure to other <italic>Anopheles</italic> spp. may therefore be limited. However, our review also identified a paucity of studies investigating additional salivary antigenic targets and <italic>Anopheles</italic> species not present in Africa. The identification of novel salivary antigens that are species-specific will be valuable in quantifying exposure to the other <italic>Anopheles</italic> vectors that share limited identity with <italic>An. gambiae SG6</italic> (such as <italic>An. farauti</italic> and <italic>An. dirus</italic>), as well as <italic>Anopheles</italic> spp. which lack <italic>SG6</italic> (as done for <italic>An. albimanus</italic> and <italic>An. darlingi;</italic> <xref ref-type="bibr" rid="bib91">Londono-Renteria et al., 2020a</xref>; <xref ref-type="bibr" rid="bib92">Londono-Renteria et al., 2020b</xref>). An <italic>Anopheles</italic> species-specific serological platform could advance vector surveillance by more accurately capturing exposure to DVS in the South American and Asia Pacific regions which exhibit diverse biting behaviours and vector competence (DVS typically bite outdoors during the night and day, respectively; <xref ref-type="bibr" rid="bib166">The Malaria Atlas, 2017</xref>; <xref ref-type="bibr" rid="bib155">Sinka et al., 2012</xref>; <xref ref-type="bibr" rid="bib154">Sinka et al., 2010</xref>; <xref ref-type="bibr" rid="bib169">Trung et al., 2005</xref>; <xref ref-type="bibr" rid="bib62">Herrera et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Chaumeau et al., 2018</xref>), as well as the increasing threat of urban malaria from <italic>An. stephensi</italic> in Africa (<xref ref-type="bibr" rid="bib165">Takken and Lindsay, 2019</xref>; <xref ref-type="bibr" rid="bib156">Sinka et al., 2020</xref>).</p><p>This review demonstrated that the prevalence of <italic>Anopheles</italic> salivary antibodies increased with increasing prevalence of <italic>Plasmodium</italic> spp. infection (although confidence intervals were wide and we observed heterogeneity in the effect between studies) as well as established epidemiological measures of malaria transmission: malaria endemicity class and EIR. Anti-salivary antibodies, such as SG6 IgG, may therefore have the potential to serve as a proxy measure for receptivity of a population to sustain malaria transmission. Their application could be particularly relevant in pre-elimination areas, or non-endemic areas under threat of imported malaria, where <italic>Anopheles</italic> salivary antibodies are more readily detectable than parasites; salivary antibodies were predicted to be prevalent (20%) in areas defined as eliminating malaria (&lt;1% <italic>Pf</italic>PR<sub>2-10</sub>). Furthermore, if SG6 IgG seroprevalence can be effectively combined with a measurement of the sporozoite index, salivary antibodies as a marker of HBR could help overcome sensitivity limitations of EIR in low transmission areas. Additional measures could include estimates of malaria prevalence or serological biomarkers that are species- or life stage-specific (e.g. <italic>Plasmodium</italic> spp. pre-erythrocytic antigens as biomarkers for recent parasite inoculation). Indeed, positive associations between antibodies specific for <italic>Plasmodium</italic> spp. pre-erythrocytic and blood stage antigens with gSG6 were demonstrated in analyses of data from diverse malaria-endemic areas. Serological tools combining salivary antigens with antigens specific for the different <italic>Plasmodium</italic> spp. could be easy to employ and complement malaria surveillance programmes. These tools may be particularly useful in the Asia Pacific, a region of relatively low malaria transmission with goals of elimination, but the highest burden of <italic>P. vivax</italic> malaria where blood stage infection can be caused by relapses from dormant liver stages. In these areas, parasite prevalence may therefore overestimate ongoing malaria transmission, making vector surveillance tools essential to informing elimination strategies in the Asia Pacific and other regions where <italic>P. vivax</italic> is endemic.</p><p>The gold standard entomological measures HBR and EIR provide crude population-level estimates of vector and malaria exposure that are specific in space and time and preclude investigation of individual-level heterogeneity and natural transmission dynamics. Our study demonstrated that salivary biomarkers measured at the individual level, such as gSG6 IgG, can be used to quantify total vector exposure at the population level, without requiring laborious entomological experiments. However, validating an individual-level serological measure, which demonstrates considerable individual-level variation, against the imperfect population-level gold standards of HBR and EIR is challenging and reflected in the variation in study-specific estimates in the association between gSG6 IgG and HBR in modelling analyses. However, the accuracy of salivary antibodies to measure individual-level exposure to <italic>Anopheles</italic> bites is yet to be validated; literature searches identified no studies investigating this association at the individual level. Without detailed measurements of individual-level vector exposure, or a detailed knowledge of the half-life of <italic>Anopheles</italic> salivary antibodies post biting event, the true accuracy of salivary antibodies, such as SG6 IgG, to measure individual-level HBR remains unknown. This knowledge is particularly pertinent where <italic>Anopheles</italic> salivary biomarkers might be applied to assess the effectiveness of a vector control intervention or used to measure temporal changes in malaria transmission; particularly in areas or populations where there is considerable heterogeneity in individual-level risk of <italic>Anopheles</italic> exposure (e.g<italic>.</italic> unmeasured outdoor biting due to occupational exposure for forest workers; <xref ref-type="bibr" rid="bib147">Sandfort et al., 2020</xref>).</p><p>The broad nature of our inclusion and quality criteria was a key strength of our systematic review, which aimed to provide a comprehensive analysis of all <italic>Anopheles</italic> salivary biomarkers and determine their associations with entomological and malariometric measures of transmission. However, this review has two main limitations. First, despite the inclusive nature, assessment of the external validity of the review revealed a moderate risk of bias; some studies exhibited a high risk of selection bias as they were performed in specific high-risk populations not representative of the overall population (i.e<italic>.</italic> children only). This is accounted for to some degree by specification of a random effect (i.e<italic>.</italic> intercept) for study, which accounts for unmeasured study-specific factors that may introduce study-specific measurement error to measurement of the outcome. Second, with respect to internal validity, there may be potential selection bias introduced by the exclusion of studies reporting zero HBR (7 observations from three studies; <xref ref-type="bibr" rid="bib136">Rizzo et al., 2011b</xref>; <xref ref-type="bibr" rid="bib129">Pollard et al., 2019</xref>; <xref ref-type="bibr" rid="bib143">Sagna et al., 2013b</xref>), EIR (22 observations from three studies; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib136">Rizzo et al., 2011b</xref>; <xref ref-type="bibr" rid="bib159">Soma et al., 2018</xref>), and malaria prevalence (15 observations from three studies; <xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib143">Sagna et al., 2013b</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>) estimates, given we modelled the log of these factors. However, adding a small constant (e.g<italic>.</italic> 0.001) to a zero value to permit modelling of a log estimate can also introduce considerable bias (i.e. seemingly small differences between values become very large on the log scale). In light of this, we also chose to provide estimates of association and gSG6 IgG seroprevalence according to a selected range of epidemiologically relevant hypothetical HBRs (no widely accepted HBR classification exists in the literature) and according to widely accepted, discrete, endemicity classes according to MAP estimates (which permitted inclusion of all studies) to provide epidemiological context. However, there is the potential for misclassification of malarial endemicity class derived from geospatially extracted MAP predictions of <italic>Pf</italic>PR<sub>2-10</sub> which increase in uncertainty in areas with scarce data. Similarly, we used MAP vector occurrence data to inform DVS categories for 7 (out of 42) studies. Cross-referencing these 7 studies with a 2017 updated database for African vectors (using data for the nearest neighbouring village) identified 10 discrepant datapoints from 3 studies (from a total of 28 datapoints from 7 studies) (<xref ref-type="bibr" rid="bib158">Snow, 2017</xref>). Any misclassification events may cause us to underestimate the standard error in the effect of malaria endemicity class and DVS on gSG6 IgG.</p><sec id="s4-1"><title>Conclusions</title><p>In order to advance progress towards malaria elimination, the World Health Organization has called for innovative tools and improved approaches to enhance vector surveillance and monitoring and evaluation of interventions (<xref ref-type="bibr" rid="bib178">World Health Organization, 2017</xref>). Our systematic review has provided evidence that <italic>Anopheles</italic> salivary antibodies are serological biomarkers of vector and malaria exposure, by quantifying their positive association with <italic>Anopheles</italic>-HBR and established epidemiological measures of malaria transmission. These salivary biomarkers have the potential to replace crude population-level estimates of entomological indices with a precise and scalable tool that measures <italic>Anopheles</italic> vector exposure at the individual level. This approach could be expanded into a serosurveillance tool to assess the effectiveness of vector control interventions, define heterogeneity in malaria transmission, and inform efficient resource allocation that would ultimately accelerate progress towards elimination.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology, Supervision, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-73080-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The current manuscript is a systematic review with multilevel modelling of study level data. The constructed dataset and associated code used for analyses are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/ellenakearney/Anopheles_salivary_biomarker_systematic_review">https://github.com/ellenakearney/Anopheles_salivary_biomarker_systematic_review</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:c39de4896e4aebd1b49afb6b49a0c611a536ce7e;origin=https://github.com/ellenakearney/Anopheles_salivary_biomarker_systematic_review;visit=swh:1:snp:3aa8a463cef194d3bf6dbd07da3ef14e77d967fb;anchor=swh:1:rev:eadb7ab1cbf93c730fb463f43e1b13b9ae16ddd3">swh:1:rev:eadb7ab1cbf93c730fb463f43e1b13b9ae16ddd3</ext-link>). Data for 'Dominant malaria vector species globally, 2010' (Sinka et al., 2012) and '<italic>Plasmodium falciparum</italic> parasite rate in 2-10 year olds globally, 2000-2017' (Weiss et al., 2019) can be accessed from the Malaria Atlas Project Explorer (<ext-link ext-link-type="uri" xlink:href="https://malariaatlas.org/explorer/#/">https://malariaatlas.org/explorer/#/</ext-link>).</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>EA</given-names></name><name><surname>Agius</surname><given-names>PA</given-names></name><name><surname>Chaumeau</surname><given-names>V</given-names></name><name><surname>Cutts</surname><given-names>JC</given-names></name><name><surname>Simpson</surname><given-names>JA</given-names></name><name><surname>Fowkes</surname><given-names>FJI</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Anopheles salivary biomarkers review.dta</data-title><source>GitHub</source><pub-id pub-id-type="accession" xlink:href="https://github.com/ellenakearney/Anopheles_salivary_biomarker_systematic_review">Anopheles_salivary_biomarker_systematic_review</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Franck Remoue, Anne Poinsignon, Bruno Arcà, Vincent Corbel, Richard Paul, André Sagna, Kingsley Badu, Berlin Londono-Renteria, Jacques Derek Charlwood, William Stone, Chris Drakeley, Karen Kerkhof, Sylvie Manguin, and Yunita Armiyanti for responding to requests for further information/data for the systematic review.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abonuusum</surname><given-names>A</given-names></name><name><surname>Owusu-Daako</surname><given-names>K</given-names></name><name><surname>Tannich</surname><given-names>E</given-names></name><name><surname>May</surname><given-names>J</given-names></name><name><surname>Garms</surname><given-names>R</given-names></name><name><surname>Kruppa</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Malaria transmission in two rural communities in the forest zone of Ghana</article-title><source>Parasitology Research</source><volume>108</volume><fpage>1465</fpage><lpage>1471</lpage><pub-id pub-id-type="doi">10.1007/s00436-010-2195-1</pub-id><pub-id pub-id-type="pmid">21153839</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aka</surname><given-names>KG</given-names></name><name><surname>Traoré</surname><given-names>DF</given-names></name><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Zoh</surname><given-names>DD</given-names></name><name><surname>Assi</surname><given-names>SB</given-names></name><name><surname>Tchiekoi</surname><given-names>BN</given-names></name><name><surname>Adja</surname><given-names>AM</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pattern of antibody responses to <italic>Plasmodium falciparum</italic> antigens in individuals differentially exposed to Anopheles bites</article-title><source>Malaria Journal</source><volume>19</volume><elocation-id>83</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-020-03160-5</pub-id><pub-id pub-id-type="pmid">32085710</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>ZMI</given-names></name><name><surname>Bakli</surname><given-names>M</given-names></name><name><surname>Fontaine</surname><given-names>A</given-names></name><name><surname>Bakkali</surname><given-names>N</given-names></name><name><surname>Vu Hai</surname><given-names>V</given-names></name><name><surname>Audebert</surname><given-names>S</given-names></name><name><surname>Boublik</surname><given-names>Y</given-names></name><name><surname>Pagès</surname><given-names>F</given-names></name><name><surname>Remoué</surname><given-names>F</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name><name><surname>Fraisier</surname><given-names>C</given-names></name><name><surname>Almeras</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Assessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bites</article-title><source>Malaria Journal</source><volume>11</volume><elocation-id>439</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-11-439</pub-id><pub-id pub-id-type="pmid">23276246</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>AP</given-names></name><name><surname>Billingsley</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Induced immunity against the mosquito Anopheles stephensi: reactivity characteristics of immune sera</article-title><source>Medical and Veterinary Entomology</source><volume>13</volume><fpage>53</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2915.1999.00143.x</pub-id><pub-id pub-id-type="pmid">10194750</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarenga</surname><given-names>PH</given-names></name><name><surname>Francischetti</surname><given-names>IMB</given-names></name><name><surname>Calvo</surname><given-names>E</given-names></name><name><surname>Sá-Nunes</surname><given-names>A</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name><name><surname>Andersen</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The function and three-dimensional structure of a thromboxane A2/cysteinyl leukotriene-binding protein from the saliva of a mosquito vector of the malaria parasite</article-title><source>PLOS Biology</source><volume>8</volume><elocation-id>e1000547</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000547</pub-id><pub-id pub-id-type="pmid">21152418</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosino</surname><given-names>E</given-names></name><name><surname>Dumoulin</surname><given-names>C</given-names></name><name><surname>Orlandi-Pradines</surname><given-names>E</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Toure-Baldé</surname><given-names>A</given-names></name><name><surname>Tall</surname><given-names>A</given-names></name><name><surname>Sarr</surname><given-names>JB</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Puget</surname><given-names>K</given-names></name><name><surname>Trape</surname><given-names>JF</given-names></name><name><surname>Pascual</surname><given-names>A</given-names></name><name><surname>Druilhe</surname><given-names>P</given-names></name><name><surname>Fusai</surname><given-names>T</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A multiplex assay for the simultaneous detection of antibodies against 15 <italic>Plasmodium falciparum</italic> and Anopheles gambiae saliva antigens</article-title><source>Malaria Journal</source><volume>9</volume><elocation-id>317</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-9-317</pub-id><pub-id pub-id-type="pmid">21059211</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Teixeira</surname><given-names>CR</given-names></name><name><surname>Barral</surname><given-names>A</given-names></name><name><surname>Barral-Netto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Haematophagous arthropod saliva and host defense system: a tale of tear and blood</article-title><source>Anais Da Academia Brasileira de Ciencias</source><volume>77</volume><fpage>665</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1590/s0001-37652005000400008</pub-id><pub-id pub-id-type="pmid">16341443</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Rocha</surname><given-names>BC</given-names></name><name><surname>Reis-Filho</surname><given-names>A</given-names></name><name><surname>Camargo</surname><given-names>LMA</given-names></name><name><surname>Tadei</surname><given-names>WP</given-names></name><name><surname>Moreira</surname><given-names>LA</given-names></name><name><surname>Barral</surname><given-names>A</given-names></name><name><surname>Barral-Netto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon</article-title><source>Malaria Journal</source><volume>8</volume><elocation-id>121</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-8-121</pub-id><pub-id pub-id-type="pmid">19500362</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Barral-Netto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Biomarkers for susceptibility to infection and disease severity in human malaria</article-title><source>Memorias Do Instituto Oswaldo Cruz</source><volume>106 Suppl 1</volume><fpage>70</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1590/s0074-02762011000900009</pub-id><pub-id pub-id-type="pmid">21881759</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Valenzuela</surname><given-names>JG</given-names></name><name><surname>Francischetti</surname><given-names>IMB</given-names></name><name><surname>Marinotti</surname><given-names>O</given-names></name><name><surname>Coluzzi</surname><given-names>M</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>An updated catalogue of salivary gland transcripts in the adult female mosquito, Anopheles gambiae</article-title><source>The Journal of Experimental Biology</source><volume>208</volume><fpage>3971</fpage><lpage>3986</lpage><pub-id pub-id-type="doi">10.1242/jeb.01849</pub-id><pub-id pub-id-type="pmid">16215223</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Struchiner</surname><given-names>CJ</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Anopheline salivary protein genes and gene families: an evolutionary overview after the whole genome sequence of sixteen Anopheles species</article-title><source>BMC Genomics</source><volume>18</volume><elocation-id>153</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-017-3579-8</pub-id><pub-id pub-id-type="pmid">28193177</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armiyanti</surname><given-names>Y</given-names></name><name><surname>Nuryady</surname><given-names>MM</given-names></name><name><surname>Arifianto</surname><given-names>RP</given-names></name><name><surname>Nurmariana</surname><given-names>E</given-names></name><name><surname>Senjarini</surname><given-names>K</given-names></name><name><surname>Fitri</surname><given-names>LE</given-names></name><name><surname>Sardjono</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Detection of immunogenic proteins from Anopheles sundaicus salivary glands in the human serum</article-title><source>Revista Da Sociedade Brasileira de Medicina Tropical</source><volume>48</volume><fpage>410</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1590/0037-8682-0185-2015</pub-id><pub-id pub-id-type="pmid">26312930</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armiyanti</surname><given-names>Y</given-names></name><name><surname>Arifianto</surname><given-names>RP</given-names></name><name><surname>Riana</surname><given-names>EN</given-names></name><name><surname>Senjarini</surname><given-names>K</given-names></name><name><surname>Widodo</surname><given-names>W</given-names></name><name><surname>Fitri</surname><given-names>LE</given-names></name><name><surname>Sardjono</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identification of antigenic proteins from salivary glands of female Anopheles maculatus by proteomic analysis</article-title><source>Asian Pacific Journal of Tropical Biomedicine</source><volume>6</volume><fpage>924</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1016/j.apjtb.2016.08.012</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badu</surname><given-names>K</given-names></name><name><surname>Afrane</surname><given-names>YA</given-names></name><name><surname>Larbi</surname><given-names>J</given-names></name><name><surname>Stewart</surname><given-names>VA</given-names></name><name><surname>Waitumbi</surname><given-names>J</given-names></name><name><surname>Angov</surname><given-names>E</given-names></name><name><surname>Ong’echa</surname><given-names>JM</given-names></name><name><surname>Perkins</surname><given-names>DJ</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Githeko</surname><given-names>A</given-names></name><name><surname>Yan</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands</article-title><source>BMC Infectious Diseases</source><volume>12</volume><elocation-id>50</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-12-50</pub-id><pub-id pub-id-type="pmid">22380785</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badu</surname><given-names>K</given-names></name><name><surname>Siangla</surname><given-names>J</given-names></name><name><surname>Larbi</surname><given-names>J</given-names></name><name><surname>Lawson</surname><given-names>BW</given-names></name><name><surname>Afrane</surname><given-names>Y</given-names></name><name><surname>Ong’echa</surname><given-names>J</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Githeko</surname><given-names>AK</given-names></name><name><surname>Yan</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands</article-title><source>Malaria Journal</source><volume>11</volume><elocation-id>318</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-11-318</pub-id><pub-id pub-id-type="pmid">22963464</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badu</surname><given-names>K</given-names></name><name><surname>Gyan</surname><given-names>B</given-names></name><name><surname>Appawu</surname><given-names>M</given-names></name><name><surname>Mensah</surname><given-names>D</given-names></name><name><surname>Dodoo</surname><given-names>D</given-names></name><name><surname>Yan</surname><given-names>G</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Owusu-Dabo</surname><given-names>E</given-names></name><name><surname>Koram</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Serological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity</article-title><source>Parasites &amp; Vectors</source><volume>8</volume><elocation-id>251</elocation-id><pub-id pub-id-type="doi">10.1186/s13071-015-0861-y</pub-id><pub-id pub-id-type="pmid">25928847</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>DJ</given-names></name><name><surname>Cameron</surname><given-names>E</given-names></name><name><surname>Bisanzio</surname><given-names>D</given-names></name><name><surname>Mappin</surname><given-names>B</given-names></name><name><surname>Dalrymple</surname><given-names>U</given-names></name><name><surname>Battle</surname><given-names>K</given-names></name><name><surname>Moyes</surname><given-names>CL</given-names></name><name><surname>Henry</surname><given-names>A</given-names></name><name><surname>Eckhoff</surname><given-names>PA</given-names></name><name><surname>Wenger</surname><given-names>EA</given-names></name><name><surname>Briët</surname><given-names>O</given-names></name><name><surname>Penny</surname><given-names>MA</given-names></name><name><surname>Smith</surname><given-names>TA</given-names></name><name><surname>Bennett</surname><given-names>A</given-names></name><name><surname>Yukich</surname><given-names>J</given-names></name><name><surname>Eisele</surname><given-names>TP</given-names></name><name><surname>Griffin</surname><given-names>JT</given-names></name><name><surname>Fergus</surname><given-names>CA</given-names></name><name><surname>Lynch</surname><given-names>M</given-names></name><name><surname>Lindgren</surname><given-names>F</given-names></name><name><surname>Cohen</surname><given-names>JM</given-names></name><name><surname>Murray</surname><given-names>CLJ</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name><name><surname>Cibulskis</surname><given-names>RE</given-names></name><name><surname>Gething</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The effect of malaria control on <italic>Plasmodium falciparum</italic> in Africa between 2000 and 2015</article-title><source>Nature</source><volume>526</volume><fpage>207</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1038/nature15535</pub-id><pub-id pub-id-type="pmid">26375008</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billingsley</surname><given-names>PF</given-names></name><name><surname>Baird</surname><given-names>J</given-names></name><name><surname>Mitchell</surname><given-names>JA</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Immune interactions between mosquitoes and their hosts</article-title><source>Parasite Immunology</source><volume>28</volume><fpage>143</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3024.2006.00805.x</pub-id><pub-id pub-id-type="pmid">16542316</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulanger</surname><given-names>D</given-names></name><name><surname>Doucoure</surname><given-names>S</given-names></name><name><surname>Grout</surname><given-names>L</given-names></name><name><surname>Ngom</surname><given-names>A</given-names></name><name><surname>Rogerie</surname><given-names>F</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Mouchet</surname><given-names>F</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Remoue</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Immunoglobulin G antibody profiles against Anopheles salivary proteins in domestic animals in Senegal</article-title><source>Journal of Medical Entomology</source><volume>48</volume><fpage>691</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1603/me10183</pub-id><pub-id pub-id-type="pmid">21661332</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brosseau</surname><given-names>L</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Besnard</surname><given-names>P</given-names></name><name><surname>Toto</surname><given-names>JC</given-names></name><name><surname>Foumane</surname><given-names>V</given-names></name><name><surname>Le Mire</surname><given-names>J</given-names></name><name><surname>Mouchet</surname><given-names>F</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Allan</surname><given-names>R</given-names></name><name><surname>Fortes</surname><given-names>F</given-names></name><name><surname>Carnevale</surname><given-names>P</given-names></name><name><surname>Manguin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Human antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e44189</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0044189</pub-id><pub-id pub-id-type="pmid">23028499</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brummer-Korvenkontio</surname><given-names>H</given-names></name><name><surname>Palosuo</surname><given-names>T</given-names></name><name><surname>François</surname><given-names>G</given-names></name><name><surname>Reunala</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Characterization of Aedes communis, Aedes aegypti and Anopheles stephensi mosquito saliva antigens by immunoblotting</article-title><source>International Archives of Allergy and Immunology</source><volume>112</volume><fpage>169</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1159/000237450</pub-id><pub-id pub-id-type="pmid">9030098</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvo</surname><given-names>E</given-names></name><name><surname>Mans</surname><given-names>BJ</given-names></name><name><surname>Andersen</surname><given-names>JF</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Function and evolution of a mosquito salivary protein family</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>1935</fpage><lpage>1942</lpage><pub-id pub-id-type="doi">10.1074/jbc.M510359200</pub-id><pub-id pub-id-type="pmid">16301315</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvo</surname><given-names>E</given-names></name><name><surname>Dao</surname><given-names>A</given-names></name><name><surname>Pham</surname><given-names>VM</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>An insight into the sialome of Anopheles funestus reveals an emerging pattern in anopheline salivary protein families</article-title><source>Insect Biochemistry and Molecular Biology</source><volume>37</volume><fpage>164</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.ibmb.2006.11.005</pub-id><pub-id pub-id-type="pmid">17244545</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantillo</surname><given-names>JF</given-names></name><name><surname>Fernández-Caldas</surname><given-names>E</given-names></name><name><surname>Puerta</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Immunological aspects of the immune response induced by mosquito allergens</article-title><source>International Archives of Allergy and Immunology</source><volume>165</volume><fpage>271</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1159/000371349</pub-id><pub-id pub-id-type="pmid">25661054</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaccour</surname><given-names>CJ</given-names></name><name><surname>Kobylinski</surname><given-names>KC</given-names></name><name><surname>Bassat</surname><given-names>Q</given-names></name><name><surname>Bousema</surname><given-names>T</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Alonso</surname><given-names>P</given-names></name><name><surname>Foy</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination</article-title><source>Malaria Journal</source><volume>12</volume><elocation-id>153</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-12-153</pub-id><pub-id pub-id-type="pmid">23647969</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charlwood</surname><given-names>JD</given-names></name><name><surname>Hall</surname><given-names>T</given-names></name><name><surname>Nenhep</surname><given-names>S</given-names></name><name><surname>Rippon</surname><given-names>E</given-names></name><name><surname>Branca-Lopes</surname><given-names>A</given-names></name><name><surname>Steen</surname><given-names>K</given-names></name><name><surname>Arca</surname><given-names>B</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Spatial repellents and malaria transmission in an endemic area of Cambodia with high mosquito net usage</article-title><source>MalariaWorld Journal</source><volume>8</volume><elocation-id>11</elocation-id><pub-id pub-id-type="pmid">34532234</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaumeau</surname><given-names>V</given-names></name><name><surname>Fustec</surname><given-names>B</given-names></name><name><surname>Nay Hsel</surname><given-names>S</given-names></name><name><surname>Montazeau</surname><given-names>C</given-names></name><name><surname>Naw Nyo</surname><given-names>S</given-names></name><name><surname>Metaane</surname><given-names>S</given-names></name><name><surname>Sawasdichai</surname><given-names>S</given-names></name><name><surname>Kittiphanakun</surname><given-names>P</given-names></name><name><surname>Phatharakokordbun</surname><given-names>P</given-names></name><name><surname>Kwansomboon</surname><given-names>N</given-names></name><name><surname>Andolina</surname><given-names>C</given-names></name><name><surname>Cerqueira</surname><given-names>D</given-names></name><name><surname>Chareonviriyaphap</surname><given-names>T</given-names></name><name><surname>Nosten</surname><given-names>FH</given-names></name><name><surname>Corbel</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages</article-title><source>Wellcome Open Research</source><volume>3</volume><elocation-id>109</elocation-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.14761.4</pub-id><pub-id pub-id-type="pmid">31206035</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choumet</surname><given-names>V</given-names></name><name><surname>Carmi-Leroy</surname><given-names>A</given-names></name><name><surname>Laurent</surname><given-names>C</given-names></name><name><surname>Lenormand</surname><given-names>P</given-names></name><name><surname>Rousselle</surname><given-names>JC</given-names></name><name><surname>Namane</surname><given-names>A</given-names></name><name><surname>Roth</surname><given-names>C</given-names></name><name><surname>Brey</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The salivary glands and saliva of Anopheles gambiae as an essential step in the Plasmodium life cycle: a global proteomic study</article-title><source>Proteomics</source><volume>7</volume><fpage>3384</fpage><lpage>3394</lpage><pub-id pub-id-type="doi">10.1002/pmic.200700334</pub-id><pub-id pub-id-type="pmid">17849406</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Detection of influential observation in linear regression</article-title><source>Technometrics: A Journal of Statistics for the Physical, Chemical, and Engineering Sciences</source><volume>19</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.2307/1268249</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Doucoure</surname><given-names>S</given-names></name><name><surname>Ndiaye</surname><given-names>T</given-names></name><name><surname>Sauvage</surname><given-names>FX</given-names></name><name><surname>Boulanger</surname><given-names>D</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>An insight into immunogenic salivary proteins of Anopheles gambiae in African children</article-title><source>Malaria Journal</source><volume>6</volume><elocation-id>75</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-6-75</pub-id><pub-id pub-id-type="pmid">17550586</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Senglat</surname><given-names>M</given-names></name><name><surname>Doucoure</surname><given-names>S</given-names></name><name><surname>Demettre</surname><given-names>E</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Characterization of immunogenic proteins in Anopheles gambiae salivary glands and their potential use as a marker of exposure to malaria</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>79</volume><elocation-id>320</elocation-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coulibaly</surname><given-names>D</given-names></name><name><surname>Travassos</surname><given-names>MA</given-names></name><name><surname>Tolo</surname><given-names>Y</given-names></name><name><surname>Laurens</surname><given-names>MB</given-names></name><name><surname>Kone</surname><given-names>AK</given-names></name><name><surname>Traore</surname><given-names>K</given-names></name><name><surname>Sissoko</surname><given-names>M</given-names></name><name><surname>Niangaly</surname><given-names>A</given-names></name><name><surname>Diarra</surname><given-names>I</given-names></name><name><surname>Daou</surname><given-names>M</given-names></name><name><surname>Guindo</surname><given-names>B</given-names></name><name><surname>Rebaudet</surname><given-names>S</given-names></name><name><surname>Kouriba</surname><given-names>B</given-names></name><name><surname>Dessay</surname><given-names>N</given-names></name><name><surname>Piarroux</surname><given-names>R</given-names></name><name><surname>Plowe</surname><given-names>CV</given-names></name><name><surname>Doumbo</surname><given-names>OK</given-names></name><name><surname>Thera</surname><given-names>MA</given-names></name><name><surname>Gaudart</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Spatio-temporal dynamics of asymptomatic Malaria: bridging the gap between annual Malaria resurgences in a sahelian environment</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>97</volume><fpage>1761</fpage><lpage>1769</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.17-0074</pub-id><pub-id pub-id-type="pmid">29141722</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coutinho-Abreu</surname><given-names>IV</given-names></name><name><surname>Guimaraes-Costa</surname><given-names>AB</given-names></name><name><surname>Valenzuela</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Impact of insect salivary proteins in blood feeding, host immunity, disease, and in the development of biomarkers for vector exposure</article-title><source>Current Opinion in Insect Science</source><volume>10</volume><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.cois.2015.04.014</pub-id><pub-id pub-id-type="pmid">26339571</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutts</surname><given-names>JC</given-names></name><name><surname>Powell</surname><given-names>R</given-names></name><name><surname>Agius</surname><given-names>PA</given-names></name><name><surname>Beeson</surname><given-names>JG</given-names></name><name><surname>Simpson</surname><given-names>JA</given-names></name><name><surname>Fowkes</surname><given-names>FJI</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis</article-title><source>BMC Medicine</source><volume>12</volume><elocation-id>150</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-014-0150-1</pub-id><pub-id pub-id-type="pmid">25199532</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutts</surname><given-names>JC</given-names></name><name><surname>Agius</surname><given-names>PA</given-names></name><name><surname>Powell</surname><given-names>R</given-names></name><name><surname>Moore</surname><given-names>K</given-names></name><name><surname>Draper</surname><given-names>B</given-names></name><name><surname>Simpson</surname><given-names>JA</given-names></name><name><surname>Fowkes</surname><given-names>FJI</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review</article-title><source>BMC Medicine</source><volume>18</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-019-1467-6</pub-id><pub-id pub-id-type="pmid">31941488</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Radtke</surname><given-names>A</given-names></name><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Mendes</surname><given-names>AM</given-names></name><name><surname>Valenzuela</surname><given-names>JG</given-names></name><name><surname>Dimopoulos</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Transcriptomic and functional analysis of the Anopheles gambiae salivary gland in relation to blood feeding</article-title><source>BMC Genomics</source><volume>11</volume><elocation-id>566</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-11-566</pub-id><pub-id pub-id-type="pmid">20946652</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhawan</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Mohanty</surname><given-names>AK</given-names></name><name><surname>Dey</surname><given-names>G</given-names></name><name><surname>Advani</surname><given-names>J</given-names></name><name><surname>Prasad</surname><given-names>TSK</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mosquito-borne diseases and omics: salivary gland proteome of the female aedes aegypti mosquito</article-title><source>Omics : A Journal of Integrative Biology</source><volume>21</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1089/omi.2016.0160</pub-id><pub-id pub-id-type="pmid">28271980</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Gaetano</surname><given-names>S</given-names></name><name><surname>Del Gatto</surname><given-names>A</given-names></name><name><surname>Pirone</surname><given-names>L</given-names></name><name><surname>Comegna</surname><given-names>D</given-names></name><name><surname>Zaccaro</surname><given-names>L</given-names></name><name><surname>Saviano</surname><given-names>M</given-names></name><name><surname>Arca</surname><given-names>B</given-names></name><name><surname>Capasso</surname><given-names>D</given-names></name><name><surname>Pedone</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A selective alpha(v)beta(5) integrin antagonist hidden into the anophelin family protein cE5 from the malaria vector Anopheles gambiae</article-title><source>Peptide Science</source><volume>110</volume><elocation-id>e24054</elocation-id><pub-id pub-id-type="doi">10.1002/pep2.24054</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Mourya</surname><given-names>DT</given-names></name><name><surname>Kamaraju</surname><given-names>R</given-names></name><name><surname>Patole</surname><given-names>MS</given-names></name><name><surname>Shouche</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Salivary gland transcriptome analysis during Plasmodium infection in malaria vector Anopheles stephensi</article-title><source>International Journal of Infectious Diseases</source><volume>13</volume><fpage>636</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2008.07.027</pub-id><pub-id pub-id-type="pmid">19128996</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domingos</surname><given-names>A</given-names></name><name><surname>Pinheiro-Silva</surname><given-names>R</given-names></name><name><surname>Couto</surname><given-names>J</given-names></name><name><surname>do Rosário</surname><given-names>V</given-names></name><name><surname>de la Fuente</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Anopheles gambiae transcriptome - a turning point for malaria control</article-title><source>Insect Molecular Biology</source><volume>26</volume><fpage>140</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1111/imb.12289</pub-id><pub-id pub-id-type="pmid">28067439</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doucoure</surname><given-names>S</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Marie</surname><given-names>A</given-names></name><name><surname>Ndille</surname><given-names>EE</given-names></name><name><surname>Mathieu-Daudé</surname><given-names>F</given-names></name><name><surname>Mouchet</surname><given-names>F</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Biomarkers of vector bites: Arthropod immunogenic salivary proteins in vector-borne diseases control</article-title><source>General Methods in Biomarker Research and Their Applications</source><volume>1</volume><fpage>1177</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1007/978-94-007-7696-8</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doucoure</surname><given-names>S</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Salivary biomarkers in the control of mosquito-borne diseases</article-title><source>Insects</source><volume>6</volume><fpage>961</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.3390/insects6040961</pub-id><pub-id pub-id-type="pmid">26593952</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragovic</surname><given-names>SM</given-names></name><name><surname>Agunbiade</surname><given-names>TA</given-names></name><name><surname>Freudzon</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Hastings</surname><given-names>AK</given-names></name><name><surname>Schleicher</surname><given-names>TR</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Craft</surname><given-names>S</given-names></name><name><surname>Chuang</surname><given-names>YM</given-names></name><name><surname>Gonzalez</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Hrebikova</surname><given-names>G</given-names></name><name><surname>Tripathi</surname><given-names>A</given-names></name><name><surname>Mlambo</surname><given-names>G</given-names></name><name><surname>Almeras</surname><given-names>L</given-names></name><name><surname>Ploss</surname><given-names>A</given-names></name><name><surname>Dimopoulos</surname><given-names>G</given-names></name><name><surname>Fikrig</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Immunization with AgTRIO, a protein in anopheles saliva, contributes to protection against plasmodium infection in mice</article-title><source>Cell Host &amp; Microbe</source><volume>23</volume><fpage>523</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2018.03.008</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Besnard</surname><given-names>P</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Foumane</surname><given-names>V</given-names></name><name><surname>Sow</surname><given-names>CS</given-names></name><name><surname>Le Mire</surname><given-names>J</given-names></name><name><surname>Fortes</surname><given-names>F</given-names></name><name><surname>Boulanger</surname><given-names>D</given-names></name><name><surname>Carnevale</surname><given-names>P</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Human antibody response to Anopheles gambiae saliva: A new immuno-epidemiological marker to evaluate the effectiveness of insecticides treated nets (ITNs)</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>79</volume><elocation-id>358</elocation-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Besnard</surname><given-names>P</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Le Mire</surname><given-names>J</given-names></name><name><surname>Toto</surname><given-names>JC</given-names></name><name><surname>Foumane</surname><given-names>V</given-names></name><name><surname>Dos-Santos</surname><given-names>MA</given-names></name><name><surname>Sembène</surname><given-names>M</given-names></name><name><surname>Fortes</surname><given-names>F</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Carnevale</surname><given-names>P</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010a</year><article-title>Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e15596</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0015596</pub-id><pub-id pub-id-type="pmid">21179476</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Besnard</surname><given-names>P</given-names></name><name><surname>Le Mire</surname><given-names>J</given-names></name><name><surname>Dos-Santos</surname><given-names>MA</given-names></name><name><surname>Sow</surname><given-names>CS</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Foumane</surname><given-names>V</given-names></name><name><surname>Toto</surname><given-names>JC</given-names></name><name><surname>Sembene</surname><given-names>M</given-names></name><name><surname>Boulanger</surname><given-names>D</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Fortes</surname><given-names>F</given-names></name><name><surname>Carnevale</surname><given-names>P</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010b</year><article-title>Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>83</volume><fpage>115</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0684</pub-id><pub-id pub-id-type="pmid">20595489</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Besnard</surname><given-names>P</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Le Mire</surname><given-names>J</given-names></name><name><surname>Fortes</surname><given-names>F</given-names></name><name><surname>Toto</surname><given-names>JC</given-names></name><name><surname>Sembene</surname><given-names>M</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Carnevale</surname><given-names>P</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010c</year><article-title>Human antibody response to Anopheles salivary gSG6-P1 peptide: New immuno-epidemiological tool for evaluating the efficacy of insecticides treated nets (ITNs) in malaria vector control</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>83</volume><elocation-id>260</elocation-id><pub-id pub-id-type="doi">10.4269/ajtmh.2010.83.211</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Machault</surname><given-names>V</given-names></name><name><surname>Diallo</surname><given-names>A</given-names></name><name><surname>Cornélie</surname><given-names>S</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Lalou</surname><given-names>R</given-names></name><name><surname>Sembène</surname><given-names>M</given-names></name><name><surname>Dos Santos</surname><given-names>S</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name><name><surname>Pagès</surname><given-names>F</given-names></name><name><surname>Le Hesran</surname><given-names>JY</given-names></name><name><surname>Remoué</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal</article-title><source>Malaria Journal</source><volume>11</volume><elocation-id>72</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-11-72</pub-id><pub-id pub-id-type="pmid">22424570</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Diallo</surname><given-names>A</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Boussari</surname><given-names>O</given-names></name><name><surname>Dos Santos</surname><given-names>S</given-names></name><name><surname>Machault</surname><given-names>V</given-names></name><name><surname>Lalou</surname><given-names>R</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>LeHesran</surname><given-names>JY</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e66354</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0066354</pub-id><pub-id pub-id-type="pmid">23840448</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Marie</surname><given-names>A</given-names></name><name><surname>Noukpo</surname><given-names>H</given-names></name><name><surname>Doucoure</surname><given-names>S</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Manguin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>New salivary biomarkers of human exposure to malaria vector bites</article-title><source>Anopheles Mosquitoes: New Insights into Malaria Vectors</source><volume>1</volume><fpage>755</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.5772/3392</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Dechavanne</surname><given-names>C</given-names></name><name><surname>Cottrell</surname><given-names>G</given-names></name><name><surname>Farce</surname><given-names>M</given-names></name><name><surname>Ladekpo</surname><given-names>R</given-names></name><name><surname>Massougbodji</surname><given-names>A</given-names></name><name><surname>Cornélie</surname><given-names>S</given-names></name><name><surname>Courtin</surname><given-names>D</given-names></name><name><surname>Migot-Nabias</surname><given-names>F</given-names></name><name><surname>Garcia</surname><given-names>A</given-names></name><name><surname>Remoué</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites</article-title><source>Malaria Journal</source><volume>14</volume><elocation-id>285</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-015-0800-6</pub-id><pub-id pub-id-type="pmid">26198354</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>A</given-names></name><name><surname>Diouf</surname><given-names>I</given-names></name><name><surname>Bakkali</surname><given-names>N</given-names></name><name><surname>Missé</surname><given-names>D</given-names></name><name><surname>Pagès</surname><given-names>F</given-names></name><name><surname>Fusai</surname><given-names>T</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name><name><surname>Almeras</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011a</year><article-title>Implication of haematophagous arthropod salivary proteins in host-vector interactions</article-title><source>Parasites &amp; Vectors</source><volume>4</volume><elocation-id>187</elocation-id><pub-id pub-id-type="doi">10.1186/1756-3305-4-187</pub-id><pub-id pub-id-type="pmid">21951834</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>A</given-names></name><name><surname>Pascual</surname><given-names>A</given-names></name><name><surname>Orlandi-Pradines</surname><given-names>E</given-names></name><name><surname>Diouf</surname><given-names>I</given-names></name><name><surname>Remoué</surname><given-names>F</given-names></name><name><surname>Pagès</surname><given-names>F</given-names></name><name><surname>Fusaï</surname><given-names>T</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name><name><surname>Almeras</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011b</year><article-title>Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e29107</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0029107</pub-id><pub-id pub-id-type="pmid">22195000</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>A</given-names></name><name><surname>Pascual</surname><given-names>A</given-names></name><name><surname>Diouf</surname><given-names>I</given-names></name><name><surname>Bakkali</surname><given-names>N</given-names></name><name><surname>Bourdon</surname><given-names>S</given-names></name><name><surname>Fusai</surname><given-names>T</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name><name><surname>Almeras</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011c</year><article-title>Mosquito salivary gland protein preservation in the field for immunological and biochemical analysis</article-title><source>Parasites &amp; Vectors</source><volume>4</volume><elocation-id>33</elocation-id><pub-id pub-id-type="doi">10.1186/1756-3305-4-33</pub-id><pub-id pub-id-type="pmid">21385450</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>A</given-names></name><name><surname>Fusaï</surname><given-names>T</given-names></name><name><surname>Briolant</surname><given-names>S</given-names></name><name><surname>Buffet</surname><given-names>S</given-names></name><name><surname>Villard</surname><given-names>C</given-names></name><name><surname>Baudelet</surname><given-names>E</given-names></name><name><surname>Pophillat</surname><given-names>M</given-names></name><name><surname>Granjeaud</surname><given-names>S</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name><name><surname>Almeras</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Anopheles salivary gland proteomes from major malaria vectors</article-title><source>BMC Genomics</source><volume>13</volume><elocation-id>614</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-13-614</pub-id><pub-id pub-id-type="pmid">23148599</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowkes</surname><given-names>FJI</given-names></name><name><surname>Richards</surname><given-names>JS</given-names></name><name><surname>Simpson</surname><given-names>JA</given-names></name><name><surname>Beeson</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The relationship between anti-merozoite antibodies and incidence of <italic>Plasmodium falciparum</italic> malaria: A systematic review and meta-analysis</article-title><source>PLOS Medicine</source><volume>7</volume><elocation-id>e1000218</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1000218</pub-id><pub-id pub-id-type="pmid">20098724</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foy</surname><given-names>BD</given-names></name><name><surname>Killeen</surname><given-names>GF</given-names></name><name><surname>Magalhaes</surname><given-names>T</given-names></name><name><surname>Beier</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Immunological targeting of critical insect Antigens</article-title><source>American Entomologist</source><volume>48</volume><fpage>150</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1093/ae/48.3.150</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francischetti</surname><given-names>IMB</given-names></name><name><surname>Valenzuela</surname><given-names>JG</given-names></name><name><surname>Pham</surname><given-names>VM</given-names></name><name><surname>Garfield</surname><given-names>MK</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Toward a catalog for the transcripts and proteins (sialome) from the salivary gland of the malaria vector Anopheles gambiae</article-title><source>The Journal of Experimental Biology</source><volume>205</volume><fpage>2429</fpage><lpage>2451</lpage><pub-id pub-id-type="doi">10.1242/jeb.205.16.2429</pub-id><pub-id pub-id-type="pmid">12124367</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francischetti</surname><given-names>IMB</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><name><surname>Andersen</surname><given-names>JF</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Evidence for a lectin specific for sulfated glycans in the salivary gland of the malaria vector, Anopheles gambiae</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e107295</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0107295</pub-id><pub-id pub-id-type="pmid">25207644</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>AK</given-names></name><name><surname>Devenport</surname><given-names>M</given-names></name><name><surname>Jethwaney</surname><given-names>D</given-names></name><name><surname>Kalume</surname><given-names>DE</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>VE</given-names></name><name><surname>Sultan</surname><given-names>AA</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Jacobs-Lorena</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Malaria parasite invasion of the mosquito salivary gland requires interaction between the Plasmodium TRAP and the Anopheles saglin proteins</article-title><source>PLOS Pathogens</source><volume>5</volume><elocation-id>e1000265</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000265</pub-id><pub-id pub-id-type="pmid">19148273</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillespie</surname><given-names>RD</given-names></name><name><surname>Mbow</surname><given-names>ML</given-names></name><name><surname>Titus</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The immunomodulatory factors of bloodfeeding arthropod saliva</article-title><source>Parasite Immunology</source><volume>22</volume><fpage>319</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1046/j.1365-3024.2000.00309.x</pub-id><pub-id pub-id-type="pmid">10886716</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>S</given-names></name><name><surname>Ochoa-Orozco</surname><given-names>SA</given-names></name><name><surname>González</surname><given-names>IJ</given-names></name><name><surname>Peinado</surname><given-names>L</given-names></name><name><surname>Quiñones</surname><given-names>ML</given-names></name><name><surname>Arévalo-Herrera</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Prospects for malaria elimination in Mesoamerica and Hispaniola</article-title><source>PLOS Neglected Tropical Diseases</source><volume>9</volume><elocation-id>e0003700</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0003700</pub-id><pub-id pub-id-type="pmid">25973753</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopp</surname><given-names>CS</given-names></name><name><surname>Sinnis</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The innate and adaptive response to mosquito saliva and Plasmodium sporozoites in the skin</article-title><source>Annals of the New York Academy of Sciences</source><volume>1342</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1111/nyas.12661</pub-id><pub-id pub-id-type="pmid">25694058</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoy</surname><given-names>D</given-names></name><name><surname>Brooks</surname><given-names>P</given-names></name><name><surname>Woolf</surname><given-names>A</given-names></name><name><surname>Blyth</surname><given-names>F</given-names></name><name><surname>March</surname><given-names>L</given-names></name><name><surname>Bain</surname><given-names>C</given-names></name><name><surname>Baker</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Buchbinder</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement</article-title><source>Journal of Clinical Epidemiology</source><volume>65</volume><fpage>934</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2011.11.014</pub-id><pub-id pub-id-type="pmid">22742910</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugo</surname><given-names>RLE</given-names></name><name><surname>Birrell</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Proteomics of anopheles vectors of malaria</article-title><source>Trends in Parasitology</source><volume>34</volume><fpage>961</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2018.08.009</pub-id><pub-id pub-id-type="pmid">30195635</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Idris</surname><given-names>ZM</given-names></name><name><surname>Chan</surname><given-names>CW</given-names></name><name><surname>Mohammed</surname><given-names>M</given-names></name><name><surname>Kalkoa</surname><given-names>M</given-names></name><name><surname>Taleo</surname><given-names>G</given-names></name><name><surname>Junker</surname><given-names>K</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Kaneko</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Serological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu</article-title><source>Parasites &amp; Vectors</source><volume>10</volume><elocation-id>204</elocation-id><pub-id pub-id-type="doi">10.1186/s13071-017-2139-z</pub-id><pub-id pub-id-type="pmid">28441959</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>AT</given-names></name><name><surname>Mawejje</surname><given-names>HD</given-names></name><name><surname>Tomlinson</surname><given-names>S</given-names></name><name><surname>Rigden</surname><given-names>DJ</given-names></name><name><surname>Donnelly</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genome-wide transcriptional analyses in Anopheles mosquitoes reveal an unexpected association between salivary gland gene expression and insecticide resistance</article-title><source>BMC Genomics</source><volume>19</volume><elocation-id>225</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-018-4605-1</pub-id><pub-id pub-id-type="pmid">29587635</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jariyapan</surname><given-names>N</given-names></name><name><surname>Choochote</surname><given-names>W</given-names></name><name><surname>Jitpakdi</surname><given-names>A</given-names></name><name><surname>Harnnoi</surname><given-names>T</given-names></name><name><surname>Siriyasatein</surname><given-names>P</given-names></name><name><surname>Wilkinson</surname><given-names>MC</given-names></name><name><surname>Bates</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A glycine- and glutamate-rich protein is female salivary gland-specific and abundant in the malaria vector Anopheles dirus B (Diptera: Culicidae)</article-title><source>Journal of Medical Entomology</source><volume>43</volume><fpage>867</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1603/0022-2585(2006)43[867:agagpi]2.0.co;2</pub-id><pub-id pub-id-type="pmid">17017221</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jariyapan</surname><given-names>N</given-names></name><name><surname>Baimai</surname><given-names>V</given-names></name><name><surname>Poovorawan</surname><given-names>Y</given-names></name><name><surname>Roytrakul</surname><given-names>S</given-names></name><name><surname>Saeung</surname><given-names>A</given-names></name><name><surname>Thongsahuan</surname><given-names>S</given-names></name><name><surname>Suwannamit</surname><given-names>S</given-names></name><name><surname>Otsuka</surname><given-names>Y</given-names></name><name><surname>Choochote</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Analysis of female salivary gland proteins of the Anopheles barbirostris complex (Diptera: Culicidae) in Thailand</article-title><source>Parasitology Research</source><volume>107</volume><fpage>509</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1007/s00436-010-1883-1</pub-id><pub-id pub-id-type="pmid">20428888</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jariyapan</surname><given-names>N</given-names></name><name><surname>Roytrakul</surname><given-names>S</given-names></name><name><surname>Paemanee</surname><given-names>A</given-names></name><name><surname>Junkum</surname><given-names>A</given-names></name><name><surname>Saeung</surname><given-names>A</given-names></name><name><surname>Thongsahuan</surname><given-names>S</given-names></name><name><surname>Sor-suwan</surname><given-names>S</given-names></name><name><surname>Phattanawiboon</surname><given-names>B</given-names></name><name><surname>Poovorawan</surname><given-names>Y</given-names></name><name><surname>Choochote</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Proteomic analysis of salivary glands of female Anopheles barbirostris species A2 (Diptera: Culicidae) by two-dimensional gel electrophoresis and mass spectrometry</article-title><source>Parasitology Research</source><volume>111</volume><fpage>1239</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.1007/s00436-012-2958-y</pub-id><pub-id pub-id-type="pmid">22584379</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Characterization of human IgE and mouse IgG1 responses to allergens in three mosquito species by immunoblotting and ELISA</article-title><source>International Archives of Allergy and Immunology</source><volume>126</volume><fpage>206</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1159/000049515</pub-id><pub-id pub-id-type="pmid">11752877</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>T</given-names></name><name><surname>Greischar</surname><given-names>MA</given-names></name><name><surname>Mideo</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epidemiological consequences of immune sensitisation by pre-exposure to vector saliva</article-title><source>PLOS Neglected Tropical Diseases</source><volume>11</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005956</pub-id><pub-id pub-id-type="pmid">28991904</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly-Hope</surname><given-names>LA</given-names></name><name><surname>McKenzie</surname><given-names>FE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa</article-title><source>Malaria Journal</source><volume>8</volume><elocation-id>19</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-8-19</pub-id><pub-id pub-id-type="pmid">19166589</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerkhof</surname><given-names>K</given-names></name><name><surname>Canier</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Heng</surname><given-names>S</given-names></name><name><surname>Sochantha</surname><given-names>T</given-names></name><name><surname>Sovannaroth</surname><given-names>S</given-names></name><name><surname>Vigan-Womas</surname><given-names>I</given-names></name><name><surname>Coosemans</surname><given-names>M</given-names></name><name><surname>Sluydts</surname><given-names>V</given-names></name><name><surname>Ménard</surname><given-names>D</given-names></name><name><surname>Durnez</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Implementation and application of a multiplex assay to detect malaria-specific antibodies: a promising tool for assessing malaria transmission in Southeast Asian pre-elimination areas</article-title><source>Malaria Journal</source><volume>14</volume><elocation-id>338</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-015-0868-z</pub-id><pub-id pub-id-type="pmid">26337785</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerkhof</surname><given-names>K</given-names></name><name><surname>Sluydts</surname><given-names>V</given-names></name><name><surname>Willen</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Canier</surname><given-names>L</given-names></name><name><surname>Heng</surname><given-names>S</given-names></name><name><surname>Tsuboi</surname><given-names>T</given-names></name><name><surname>Sochantha</surname><given-names>T</given-names></name><name><surname>Sovannaroth</surname><given-names>S</given-names></name><name><surname>Ménard</surname><given-names>D</given-names></name><name><surname>Coosemans</surname><given-names>M</given-names></name><name><surname>Durnez</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Serological markers to measure recent changes in malaria at population level in Cambodia</article-title><source>Malaria Journal</source><volume>15</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1186/s12936-016-1576-z</pub-id><pub-id pub-id-type="pmid">27809852</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaireh</surname><given-names>BA</given-names></name><name><surname>Briolant</surname><given-names>S</given-names></name><name><surname>Pascual</surname><given-names>A</given-names></name><name><surname>Mokrane</surname><given-names>M</given-names></name><name><surname>Machault</surname><given-names>V</given-names></name><name><surname>Travaillé</surname><given-names>C</given-names></name><name><surname>Khaireh</surname><given-names>MA</given-names></name><name><surname>Farah</surname><given-names>IH</given-names></name><name><surname>Ali</surname><given-names>HM</given-names></name><name><surname>Abdi</surname><given-names>A-IA</given-names></name><name><surname>Ayeh</surname><given-names>SN</given-names></name><name><surname>Darar</surname><given-names>HY</given-names></name><name><surname>Ollivier</surname><given-names>L</given-names></name><name><surname>Waiss</surname><given-names>MK</given-names></name><name><surname>Bogreau</surname><given-names>H</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name><name><surname>Pradines</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Plasmodium vivax and <italic>Plasmodium falciparum</italic> infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants</article-title><source>Malaria Journal</source><volume>11</volume><elocation-id>395</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-11-395</pub-id><pub-id pub-id-type="pmid">23190709</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>JG</given-names></name><name><surname>Vernick</surname><given-names>KD</given-names></name><name><surname>Hillyer</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Members of the salivary gland surface protein (SGS) family are major immunogenic components of mosquito saliva</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>40824</fpage><lpage>40834</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.280552</pub-id><pub-id pub-id-type="pmid">21965675</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koffi</surname><given-names>D</given-names></name><name><surname>Touré</surname><given-names>AO</given-names></name><name><surname>Varela</surname><given-names>ML</given-names></name><name><surname>Vigan-Womas</surname><given-names>I</given-names></name><name><surname>Béourou</surname><given-names>S</given-names></name><name><surname>Brou</surname><given-names>S</given-names></name><name><surname>Ehouman</surname><given-names>MF</given-names></name><name><surname>Gnamien</surname><given-names>L</given-names></name><name><surname>Richard</surname><given-names>V</given-names></name><name><surname>Djaman</surname><given-names>JA</given-names></name><name><surname>Perraut</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Analysis of antibody profiles in symptomatic malaria in three sentinel sites of Ivory Coast by using multiplex, fluorescent, magnetic, bead-based serological assay (MAGPIX</article-title><source>Malaria Journal</source><volume>14</volume><elocation-id>509</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-015-1043-2</pub-id><pub-id pub-id-type="pmid">26692284</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koffi</surname><given-names>D</given-names></name><name><surname>Varela</surname><given-names>ML</given-names></name><name><surname>Loucoubar</surname><given-names>C</given-names></name><name><surname>Beourou</surname><given-names>S</given-names></name><name><surname>Vigan-Womas</surname><given-names>I</given-names></name><name><surname>Touré</surname><given-names>A</given-names></name><name><surname>Djaman</surname><given-names>JA</given-names></name><name><surname>Touré</surname><given-names>AO</given-names></name><name><surname>Perraut</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Longitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d’Ivoire between 2010 and 2013</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0172899</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0172899</pub-id><pub-id pub-id-type="pmid">28245264</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korochkina</surname><given-names>S</given-names></name><name><surname>Barreau</surname><given-names>C</given-names></name><name><surname>Pradel</surname><given-names>G</given-names></name><name><surname>Jeffery</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Natarajan</surname><given-names>R</given-names></name><name><surname>Shabanowitz</surname><given-names>J</given-names></name><name><surname>Hunt</surname><given-names>D</given-names></name><name><surname>Frevert</surname><given-names>U</given-names></name><name><surname>Vernick</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A mosquito-specific protein family includes candidate receptors for malaria sporozoite invasion of salivary glands</article-title><source>Cellular Microbiology</source><volume>8</volume><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00611.x</pub-id><pub-id pub-id-type="pmid">16367875</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusi</surname><given-names>KA</given-names></name><name><surname>Bosomprah</surname><given-names>S</given-names></name><name><surname>Dodoo</surname><given-names>D</given-names></name><name><surname>Kyei-Baafour</surname><given-names>E</given-names></name><name><surname>Dickson</surname><given-names>EK</given-names></name><name><surname>Mensah</surname><given-names>D</given-names></name><name><surname>Angov</surname><given-names>E</given-names></name><name><surname>Dutta</surname><given-names>S</given-names></name><name><surname>Sedegah</surname><given-names>M</given-names></name><name><surname>Koram</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation</article-title><source>Malaria Journal</source><volume>13</volume><elocation-id>103</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-13-103</pub-id><pub-id pub-id-type="pmid">24635830</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawaly</surname><given-names>R</given-names></name><name><surname>Konate</surname><given-names>L</given-names></name><name><surname>Marrama</surname><given-names>L</given-names></name><name><surname>Dia</surname><given-names>I</given-names></name><name><surname>Diallo</surname><given-names>D</given-names></name><name><surname>Diène Sarr</surname><given-names>F</given-names></name><name><surname>Schneider</surname><given-names>BS</given-names></name><name><surname>Casademont</surname><given-names>I</given-names></name><name><surname>Diallo</surname><given-names>M</given-names></name><name><surname>Brey</surname><given-names>PT</given-names></name><name><surname>Sakuntabhai</surname><given-names>A</given-names></name><name><surname>Mecheri</surname><given-names>S</given-names></name><name><surname>Paul</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Impact of mosquito bites on asexual parasite density and gametocyte prevalence in asymptomatic chronic <italic>Plasmodium falciparum</italic> infections and correlation with IgE and IgG titers</article-title><source>Infection and Immunity</source><volume>80</volume><fpage>2240</fpage><lpage>2246</lpage><pub-id pub-id-type="doi">10.1128/IAI.06414-11</pub-id><pub-id pub-id-type="pmid">22451520</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leitner</surname><given-names>WW</given-names></name><name><surname>Costero-Saint Denis</surname><given-names>A</given-names></name><name><surname>Wali</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Immunological consequences of arthropod vector-derived salivary factors</article-title><source>European Journal of Immunology</source><volume>41</volume><fpage>3396</fpage><lpage>3400</lpage><pub-id pub-id-type="doi">10.1002/eji.201190075</pub-id><pub-id pub-id-type="pmid">22125007</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Calvo</surname><given-names>E</given-names></name><name><surname>Marinotti</surname><given-names>O</given-names></name><name><surname>James</surname><given-names>AA</given-names></name><name><surname>Paskewitz</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Characterization of the c-type lysozyme gene family in Anopheles gambiae</article-title><source>Gene</source><volume>360</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2005.07.001</pub-id><pub-id pub-id-type="pmid">16137842</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Lanfrancotti</surname><given-names>A</given-names></name><name><surname>Mestres-Simón</surname><given-names>M</given-names></name><name><surname>Rizzo</surname><given-names>C</given-names></name><name><surname>Coluzzi</surname><given-names>M</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>At the interface between parasite and host: the salivary glands of the African malaria vector Anopheles gambiae</article-title><source>Parassitologia</source><volume>48</volume><fpage>573</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">17688179</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Rizzo</surname><given-names>C</given-names></name><name><surname>Mestres-Simòn</surname><given-names>M</given-names></name><name><surname>Lanfrancotti</surname><given-names>A</given-names></name><name><surname>Currà</surname><given-names>C</given-names></name><name><surname>Fiorentino</surname><given-names>G</given-names></name><name><surname>Bourgouin</surname><given-names>C</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name><name><surname>Petrarca</surname><given-names>V</given-names></name><name><surname>Ponzi</surname><given-names>M</given-names></name><name><surname>Coluzzi</surname><given-names>M</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The Anopheles gambiae salivary protein gSG6: an anopheline-specific protein with a blood-feeding role</article-title><source>Insect Biochemistry and Molecular Biology</source><volume>39</volume><fpage>457</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/j.ibmb.2009.04.006</pub-id><pub-id pub-id-type="pmid">19442731</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londono-Renteria</surname><given-names>BL</given-names></name><name><surname>Eisele</surname><given-names>TP</given-names></name><name><surname>Keating</surname><given-names>J</given-names></name><name><surname>James</surname><given-names>MA</given-names></name><name><surname>Wesson</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Antibody response against Anopheles albimanus (Diptera: Culicidae) salivary protein as a measure of mosquito bite exposure in Haiti</article-title><source>Journal of Medical Entomology</source><volume>47</volume><fpage>1156</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1603/me09240</pub-id><pub-id pub-id-type="pmid">21175067</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londono-Renteria</surname><given-names>B</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Weitzel</surname><given-names>T</given-names></name><name><surname>Rosas</surname><given-names>R</given-names></name><name><surname>Gripping</surname><given-names>C</given-names></name><name><surname>Cardenas</surname><given-names>JC</given-names></name><name><surname>Alvares</surname><given-names>M</given-names></name><name><surname>Wesson</surname><given-names>DM</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Colpitts</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>An gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas a pilot study</article-title><source>Parasites &amp; Vectors</source><volume>8</volume><elocation-id>533</elocation-id><pub-id pub-id-type="doi">10.1186/s13071-015-1160-3</pub-id><pub-id pub-id-type="pmid">26464073</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londono-Renteria</surname><given-names>B</given-names></name><name><surname>Patel</surname><given-names>JC</given-names></name><name><surname>Vaughn</surname><given-names>M</given-names></name><name><surname>Funkhauser</surname><given-names>S</given-names></name><name><surname>Ponnusamy</surname><given-names>L</given-names></name><name><surname>Grippin</surname><given-names>C</given-names></name><name><surname>Jameson</surname><given-names>SB</given-names></name><name><surname>Apperson</surname><given-names>C</given-names></name><name><surname>Mores</surname><given-names>CN</given-names></name><name><surname>Wesson</surname><given-names>DM</given-names></name><name><surname>Colpitts</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Long-lasting permethrin-impregnated clothing protects against mosquito bites in outdoor workers</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>93</volume><fpage>869</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.15-0130</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londono-Renteria</surname><given-names>B</given-names></name><name><surname>Cardenas</surname><given-names>JC</given-names></name><name><surname>Troupin</surname><given-names>A</given-names></name><name><surname>Colpitts</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Natural mosquito-pathogen hybrid IgG4 antibodies in vector-borne diseases: a hypothesis</article-title><source>Frontiers in Immunology</source><volume>7</volume><elocation-id>380</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2016.00380</pub-id><pub-id pub-id-type="pmid">27746778</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londono-Renteria</surname><given-names>B</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Montiel</surname><given-names>J</given-names></name><name><surname>Vasquez</surname><given-names>AM</given-names></name><name><surname>Tobón-Castaño</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>M</given-names></name><name><surname>Vizcaino</surname><given-names>L</given-names></name><name><surname>Lenhart</surname><given-names>AAE</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Identification and Pilot Evaluation of Salivary Peptides from Anopheles albimanus as Biomarkers for Bite Exposure and Malaria Infection in Colombia</article-title><source>International Journal of Molecular Sciences</source><volume>21</volume><elocation-id>E691</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21030691</pub-id><pub-id pub-id-type="pmid">31973044</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londono-Renteria</surname><given-names>B</given-names></name><name><surname>Montiel</surname><given-names>J</given-names></name><name><surname>Calvo</surname><given-names>E</given-names></name><name><surname>Tobón-Castaño</surname><given-names>A</given-names></name><name><surname>Valdivia</surname><given-names>HO</given-names></name><name><surname>Escobedo-Vargas</surname><given-names>K</given-names></name><name><surname>Romero</surname><given-names>L</given-names></name><name><surname>Bosantes</surname><given-names>M</given-names></name><name><surname>Fisher</surname><given-names>ML</given-names></name><name><surname>Conway</surname><given-names>MJ</given-names></name><name><surname>Vásquez</surname><given-names>GM</given-names></name><name><surname>Lenhart</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Antibody Responses Against Anopheles darlingi Immunogenic Peptides in Plasmodium Infected Humans</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>10</volume><elocation-id>455</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2020.00455</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>malERA Refresh Consultative Panel on Basic Science and Enabling Technologies</collab></person-group><year iso-8601-date="2017">2017</year><article-title>malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication</article-title><source>PLOS Medicine</source><volume>14</volume><elocation-id>e1002451</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1002451</pub-id><pub-id pub-id-type="pmid">29190277</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>malERA Refresh Consultative Panel on Characterising the Reservoir and Measuring Transmission</collab></person-group><year iso-8601-date="2017">2017</year><article-title>malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication</article-title><source>PLOS Medicine</source><volume>14</volume><elocation-id>e1002452</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1002452</pub-id><pub-id pub-id-type="pmid">29190279</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>malERA Refresh Consultative Panel on Tools for Malaria Elimination</collab></person-group><year iso-8601-date="2017">2017</year><article-title>malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication</article-title><source>PLOS Medicine</source><volume>14</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1002455</pub-id><pub-id pub-id-type="pmid">29190291</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>JE</given-names></name><name><surname>Oliveira</surname><given-names>F</given-names></name><name><surname>Coutinho-Abreu</surname><given-names>IV</given-names></name><name><surname>Herbert</surname><given-names>S</given-names></name><name><surname>Meneses</surname><given-names>C</given-names></name><name><surname>Kamhawi</surname><given-names>S</given-names></name><name><surname>Baus</surname><given-names>HA</given-names></name><name><surname>Han</surname><given-names>A</given-names></name><name><surname>Czajkowski</surname><given-names>L</given-names></name><name><surname>Rosas</surname><given-names>LA</given-names></name><name><surname>Cervantes-Medina</surname><given-names>A</given-names></name><name><surname>Athota</surname><given-names>R</given-names></name><name><surname>Reed</surname><given-names>S</given-names></name><name><surname>Mateja</surname><given-names>A</given-names></name><name><surname>Hunsberger</surname><given-names>S</given-names></name><name><surname>James</surname><given-names>E</given-names></name><name><surname>Pleguezuelos</surname><given-names>O</given-names></name><name><surname>Stoloff</surname><given-names>G</given-names></name><name><surname>Valenzuela</surname><given-names>JG</given-names></name><name><surname>Memoli</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial</article-title><source>Lancet</source><volume>395</volume><fpage>1998</fpage><lpage>2007</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31048-5</pub-id><pub-id pub-id-type="pmid">32534628</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marie</surname><given-names>A</given-names></name><name><surname>Holzmuller</surname><given-names>P</given-names></name><name><surname>Tchioffo</surname><given-names>MT</given-names></name><name><surname>Rossignol</surname><given-names>M</given-names></name><name><surname>Demettre</surname><given-names>E</given-names></name><name><surname>Seveno</surname><given-names>M</given-names></name><name><surname>Corbel</surname><given-names>V</given-names></name><name><surname>Awono-Ambéné</surname><given-names>P</given-names></name><name><surname>Morlais</surname><given-names>I</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Anopheles gambiae salivary protein expression modulated by wild <italic>Plasmodium falciparum</italic> infection: highlighting of new antigenic peptides as candidates of A gambiae bites</article-title><source>Parasites &amp; Vectors</source><volume>7</volume><elocation-id>599</elocation-id><pub-id pub-id-type="doi">10.1186/s13071-014-0599-y</pub-id><pub-id pub-id-type="pmid">25526764</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marie</surname><given-names>A</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Besnard</surname><given-names>P</given-names></name><name><surname>Le Mire</surname><given-names>J</given-names></name><name><surname>Fiorentino</surname><given-names>G</given-names></name><name><surname>Fortes</surname><given-names>F</given-names></name><name><surname>Carnevale</surname><given-names>P</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Anopheles gambiae cE5 salivary protein: a sensitive biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control</article-title><source>Microbes and Infection</source><volume>17</volume><fpage>409</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2015.01.002</pub-id><pub-id pub-id-type="pmid">25637950</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathema</surname><given-names>VB</given-names></name><name><surname>Na-Bangchang</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A brief review on biomarkers and proteomic approach for malaria research</article-title><source>Asian Pacific Journal of Tropical Medicine</source><volume>8</volume><fpage>253</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/S1995-7645(14)60327-8</pub-id><pub-id pub-id-type="pmid">25975495</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathenge</surname><given-names>EM</given-names></name><name><surname>Misiani</surname><given-names>GO</given-names></name><name><surname>Oulo</surname><given-names>DO</given-names></name><name><surname>Irungu</surname><given-names>LW</given-names></name><name><surname>Ndegwa</surname><given-names>PN</given-names></name><name><surname>Smith</surname><given-names>TA</given-names></name><name><surname>Killeen</surname><given-names>GF</given-names></name><name><surname>Knols</surname><given-names>BGJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Comparative performance of the Mbita trap, CDC light trap and the human landing catch in the sampling of Anopheles arabiensis, An funestus and culicine species in a rice irrigation in western Kenya</article-title><source>Malaria Journal</source><volume>4</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-4-7</pub-id><pub-id pub-id-type="pmid">15667666</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes-Sousa</surname><given-names>AF</given-names></name><name><surname>Vale</surname><given-names>VF</given-names></name><name><surname>Queiroz</surname><given-names>DC</given-names></name><name><surname>Pereira-Filho</surname><given-names>AA</given-names></name><name><surname>da Silva</surname><given-names>NCS</given-names></name><name><surname>Koerich</surname><given-names>LB</given-names></name><name><surname>Moreira</surname><given-names>LA</given-names></name><name><surname>Pereira</surname><given-names>MH</given-names></name><name><surname>Sant’Anna</surname><given-names>MR</given-names></name><name><surname>Araújo</surname><given-names>RN</given-names></name><name><surname>Andersen</surname><given-names>J</given-names></name><name><surname>Valenzuela</surname><given-names>JG</given-names></name><name><surname>Gontijo</surname><given-names>NF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inhibition of the complement system by saliva of Anopheles (Nyssorhynchus) aquasalis</article-title><source>Insect Biochemistry and Molecular Biology</source><volume>92</volume><fpage>12</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.ibmb.2017.11.004</pub-id><pub-id pub-id-type="pmid">29128668</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miot</surname><given-names>HA</given-names></name><name><surname>Lima</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Allergy to hematophagous arthropods bites</article-title><source>Current Dermatology Reports</source><volume>3</volume><fpage>6</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/s13671-013-0065-7</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><collab>PRISMA Group</collab></person-group><year iso-8601-date="2009">2009</year><article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title><source>PLOS Medicine</source><volume>6</volume><elocation-id>e1000097</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type="pmid">19621072</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monroe</surname><given-names>A</given-names></name><name><surname>Moore</surname><given-names>S</given-names></name><name><surname>Okumu</surname><given-names>F</given-names></name><name><surname>Kiware</surname><given-names>S</given-names></name><name><surname>Lobo</surname><given-names>NF</given-names></name><name><surname>Koenker</surname><given-names>H</given-names></name><name><surname>Sherrard-Smith</surname><given-names>E</given-names></name><name><surname>Gimnig</surname><given-names>J</given-names></name><name><surname>Killeen</surname><given-names>GF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Methods and indicators for measuring patterns of human exposure to malaria vectors</article-title><source>Malaria Journal</source><volume>19</volume><elocation-id>207</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-020-03271-z</pub-id><pub-id pub-id-type="pmid">32546166</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montiel</surname><given-names>J</given-names></name><name><surname>Carbal</surname><given-names>LF</given-names></name><name><surname>Tobón-Castaño</surname><given-names>A</given-names></name><name><surname>Vásquez</surname><given-names>GM</given-names></name><name><surname>Fisher</surname><given-names>ML</given-names></name><name><surname>Londono-Rentería</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>IgG antibody response against Anopheles salivary gland proteins in asymptomatic Plasmodium infections in Narino, Colombia</article-title><source>Malaria Journal</source><volume>19</volume><elocation-id>42</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-020-3128-9</pub-id><pub-id pub-id-type="pmid">31973737</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mwanziva</surname><given-names>C</given-names></name><name><surname>Manjurano</surname><given-names>A</given-names></name><name><surname>Mbugi</surname><given-names>E</given-names></name><name><surname>Mweya</surname><given-names>C</given-names></name><name><surname>Mkali</surname><given-names>H</given-names></name><name><surname>Kivuyo</surname><given-names>MP</given-names></name><name><surname>Sanga</surname><given-names>A</given-names></name><name><surname>Ndaro</surname><given-names>A</given-names></name><name><surname>Chambo</surname><given-names>W</given-names></name><name><surname>Mkwizu</surname><given-names>A</given-names></name><name><surname>Kitau</surname><given-names>J</given-names></name><name><surname>Kavishe</surname><given-names>R</given-names></name><name><surname>Dolmans</surname><given-names>W</given-names></name><name><surname>Chilongola</surname><given-names>J</given-names></name><name><surname>Mosha</surname><given-names>FW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Defining malaria burden from morbidity and mortality records, self treatment practices and serological data in Magugu, Babati District, northern Tanzania</article-title><source>Tanzania Journal of Health Research</source><volume>13</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.4314/thrb.v13i2.62980</pub-id><pub-id pub-id-type="pmid">25566606</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noukpo</surname><given-names>MH</given-names></name><name><surname>Damien</surname><given-names>GB</given-names></name><name><surname>Elanga-N’Dille</surname><given-names>E</given-names></name><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Chaffa</surname><given-names>E</given-names></name><name><surname>Boussari</surname><given-names>O</given-names></name><name><surname>Corbel</surname><given-names>V</given-names></name><name><surname>Akogbéto</surname><given-names>M</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Operational assessment of long-lasting insecticidal nets by using an anopheles salivary biomarker of human-vector contact</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>95</volume><fpage>1376</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.15-0541</pub-id><pub-id pub-id-type="pmid">27928087</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opasawatchai</surname><given-names>A</given-names></name><name><surname>Yolwong</surname><given-names>W</given-names></name><name><surname>Thuncharoen</surname><given-names>W</given-names></name><name><surname>Inrueangsri</surname><given-names>N</given-names></name><name><surname>Itsaradisaikul</surname><given-names>S</given-names></name><name><surname>Sasisakulporn</surname><given-names>C</given-names></name><name><surname>Jotikasthira</surname><given-names>W</given-names></name><name><surname>Matangkasombut</surname><given-names>O</given-names></name><name><surname>Reamtong</surname><given-names>O</given-names></name><name><surname>Manuyakorn</surname><given-names>W</given-names></name><name><surname>Songnuan</surname><given-names>W</given-names></name><name><surname>Matangkasombut</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Novel salivary gland allergens from tropical mosquito species and IgE reactivity in allergic patients</article-title><source>The World Allergy Organization Journal</source><volume>13</volume><elocation-id>100099</elocation-id><pub-id pub-id-type="doi">10.1016/j.waojou.2020.100099</pub-id><pub-id pub-id-type="pmid">32099589</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orlandi-Pradines</surname><given-names>E</given-names></name><name><surname>Almeras</surname><given-names>L</given-names></name><name><surname>Denis de Senneville</surname><given-names>L</given-names></name><name><surname>Barbe</surname><given-names>S</given-names></name><name><surname>Remoué</surname><given-names>F</given-names></name><name><surname>Villard</surname><given-names>C</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Penhoat</surname><given-names>K</given-names></name><name><surname>Pascual</surname><given-names>A</given-names></name><name><surname>Bourgouin</surname><given-names>C</given-names></name><name><surname>Fontenille</surname><given-names>D</given-names></name><name><surname>Bonnet</surname><given-names>J</given-names></name><name><surname>Corre-Catelin</surname><given-names>N</given-names></name><name><surname>Reiter</surname><given-names>P</given-names></name><name><surname>Pagés</surname><given-names>F</given-names></name><name><surname>Laffite</surname><given-names>D</given-names></name><name><surname>Boulanger</surname><given-names>D</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Pradines</surname><given-names>B</given-names></name><name><surname>Fusaï</surname><given-names>T</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa</article-title><source>Microbes and Infection</source><volume>9</volume><fpage>1454</fpage><lpage>1462</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2007.07.012</pub-id><pub-id pub-id-type="pmid">17913537</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owhashi</surname><given-names>M</given-names></name><name><surname>Harada</surname><given-names>M</given-names></name><name><surname>Suguri</surname><given-names>S</given-names></name><name><surname>Ohmae</surname><given-names>H</given-names></name><name><surname>Ishii</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The role of saliva of Anopheles stephensi in inflammatory response: identification of a high molecular weight neutrophil chemotactic factor</article-title><source>Parasitology Research</source><volume>87</volume><fpage>376</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1007/s004360000355</pub-id><pub-id pub-id-type="pmid">11403380</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owhashi</surname><given-names>M</given-names></name><name><surname>Harada</surname><given-names>M</given-names></name><name><surname>Suguri</surname><given-names>S</given-names></name><name><surname>Omae</surname><given-names>H</given-names></name><name><surname>Ishii</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Identification of an eosinophil chemotactic factor from anopheline mosquitoes as a chitinase family protein</article-title><source>Parasitology Research</source><volume>102</volume><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1007/s00436-007-0769-3</pub-id><pub-id pub-id-type="pmid">17940798</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>RK</given-names></name><name><surname>Bhatt</surname><given-names>TK</given-names></name><name><surname>Prajapati</surname><given-names>VK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Novel immunoinformatics approaches to design multi-epitope subunit vaccine for malaria by investigating anopheles salivary protein</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>1125</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-19456-1</pub-id><pub-id pub-id-type="pmid">29348555</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedro</surname><given-names>PM</given-names></name><name><surname>Sallum</surname><given-names>MAM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Spatial expansion and population structure of the neotropical malaria vector, Anopheles darlingi (Diptera: Culicidae)</article-title><source>Biological Journal of the Linnean Society</source><volume>97</volume><fpage>854</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1111/j.1095-8312.2009.01226.x</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>ZK</given-names></name><name><surname>Li</surname><given-names>HB</given-names></name><name><surname>Simons</surname><given-names>FER</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Immunoblot analysis of salivary allergens in 10 mosquito species with worldwide distribution and the human IgE responses as these allergens</article-title><source>The Journal of Allergy and Clinical Immunology</source><volume>101</volume><fpage>498</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/s0091-6749(98)70357-4</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Beckett</surname><given-names>AN</given-names></name><name><surname>Engler</surname><given-names>RJ</given-names></name><name><surname>Hoffman</surname><given-names>DR</given-names></name><name><surname>Ott</surname><given-names>NL</given-names></name><name><surname>Simons</surname><given-names>FER</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Immune responses to mosquito saliva in 14 individuals with acute systemic allergic reactions to mosquito bites</article-title><source>The Journal of Allergy and Clinical Immunology</source><volume>114</volume><fpage>1189</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2004.08.014</pub-id><pub-id pub-id-type="pmid">15536430</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Simons</surname><given-names>FER</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mosquito allergy: immune mechanisms and recombinant salivary allergens</article-title><source>International Archives of Allergy and Immunology</source><volume>133</volume><fpage>198</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1159/000076787</pub-id><pub-id pub-id-type="pmid">14963366</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Estelle</surname><given-names>F</given-names></name><name><surname>Simons</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mosquito allergy and mosquito salivary allergens</article-title><source>Protein Peptide Lett</source><volume>14</volume><fpage>975</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.2174/092986607782541088</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penneys</surname><given-names>NS</given-names></name><name><surname>Nayar</surname><given-names>JK</given-names></name><name><surname>Bernstein</surname><given-names>H</given-names></name><name><surname>Knight</surname><given-names>JW</given-names></name><name><surname>Leonardi</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Mosquito salivary gland antigens identified by circulating human antibodies</article-title><source>Archives of Dermatology</source><volume>125</volume><fpage>219</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1001/archderm.1989.01670140071012</pub-id><pub-id pub-id-type="pmid">2563325</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perraut</surname><given-names>R</given-names></name><name><surname>Varela</surname><given-names>ML</given-names></name><name><surname>Loucoubar</surname><given-names>C</given-names></name><name><surname>Niass</surname><given-names>O</given-names></name><name><surname>Sidibé</surname><given-names>A</given-names></name><name><surname>Tall</surname><given-names>A</given-names></name><name><surname>Trape</surname><given-names>JF</given-names></name><name><surname>Wotodjo</surname><given-names>AN</given-names></name><name><surname>Mbengue</surname><given-names>B</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Vigan-Womas</surname><given-names>I</given-names></name><name><surname>Touré</surname><given-names>A</given-names></name><name><surname>Richard</surname><given-names>V</given-names></name><name><surname>Mercereau-Puijalon</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0179146</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0179146</pub-id><pub-id pub-id-type="pmid">28609450</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phattanawiboon</surname><given-names>B</given-names></name><name><surname>Jariyapan</surname><given-names>N</given-names></name><name><surname>Mano</surname><given-names>C</given-names></name><name><surname>Roytrakul</surname><given-names>S</given-names></name><name><surname>Paemanee</surname><given-names>A</given-names></name><name><surname>Sor-Suwan</surname><given-names>S</given-names></name><name><surname>Sriwichai</surname><given-names>P</given-names></name><name><surname>Saeung</surname><given-names>A</given-names></name><name><surname>Bates</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Salivary gland proteome during adult development and after blood feeding of female anopheles dissidens mosquitoes (Diptera: Culicidae)</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0163810</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0163810</pub-id><pub-id pub-id-type="pmid">27669021</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pingen</surname><given-names>M</given-names></name><name><surname>Schmid</surname><given-names>MA</given-names></name><name><surname>Harris</surname><given-names>E</given-names></name><name><surname>McKimmie</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mosquito biting modulates skin response to virus infection</article-title><source>Trends in Parasitology</source><volume>33</volume><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2017.04.003</pub-id><pub-id pub-id-type="pmid">28495485</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirone</surname><given-names>L</given-names></name><name><surname>Ripoll-Rozada</surname><given-names>J</given-names></name><name><surname>Leone</surname><given-names>M</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Fiorentino</surname><given-names>G</given-names></name><name><surname>Andersen</surname><given-names>JF</given-names></name><name><surname>Pereira</surname><given-names>PJB</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Pedone</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Functional analyses yield detailed insight into the mechanism of thrombin inhibition by the antihemostatic salivary protein cE5 from Anopheles gambiae</article-title><source>The Journal of Biological Chemistry</source><volume>292</volume><fpage>12632</fpage><lpage>12642</lpage><pub-id pub-id-type="doi">10.1074/jbc.M117.788042</pub-id><pub-id pub-id-type="pmid">28592490</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Mestres-Simon</surname><given-names>M</given-names></name><name><surname>Lanfrancotti</surname><given-names>A</given-names></name><name><surname>Rossignol</surname><given-names>M</given-names></name><name><surname>Boulanger</surname><given-names>D</given-names></name><name><surname>Cisse</surname><given-names>B</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008a</year><article-title>Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e2472</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0002472</pub-id><pub-id pub-id-type="pmid">18575604</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Mestres-Simon</surname><given-names>M</given-names></name><name><surname>Lanfrancotti</surname><given-names>A</given-names></name><name><surname>Rossignol</surname><given-names>M</given-names></name><name><surname>Boulanger</surname><given-names>D</given-names></name><name><surname>Cisse</surname><given-names>B</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Arca</surname><given-names>B</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008b</year><article-title>Human IgG response to Anopheles gambiae salivary proteins as an immuno-epidemiological marker of exposure to malaria vector bites</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>79</volume><elocation-id>218</elocation-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Ba</surname><given-names>F</given-names></name><name><surname>Boulanger</surname><given-names>D</given-names></name><name><surname>Sow</surname><given-names>C</given-names></name><name><surname>Rossignol</surname><given-names>M</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Cisse</surname><given-names>B</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites</article-title><source>Malaria Journal</source><volume>8</volume><elocation-id>198</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-8-198</pub-id><pub-id pub-id-type="pmid">19674487</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Samb</surname><given-names>B</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Sow</surname><given-names>C</given-names></name><name><surname>Dia</surname><given-names>I</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name><name><surname>Konate</surname><given-names>L</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Remoue</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2010">2010a</year><article-title>Development of a new biomarker of exposure to Anopheles bites based on human antibody responses to salivary proteins: From the concept to the applications</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>83</volume><elocation-id>184</elocation-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Samb</surname><given-names>B</given-names></name><name><surname>Doucoure</surname><given-names>S</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Sarr</surname><given-names>JB</given-names></name><name><surname>Sow</surname><given-names>C</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Maiga</surname><given-names>S</given-names></name><name><surname>Thiam</surname><given-names>C</given-names></name><name><surname>Rogerie</surname><given-names>F</given-names></name><name><surname>Guindo</surname><given-names>S</given-names></name><name><surname>Hermann</surname><given-names>E</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Dia</surname><given-names>I</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name><name><surname>Konate</surname><given-names>L</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010b</year><article-title>First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites</article-title><source>Tropical Medicine &amp; International Health</source><volume>15</volume><fpage>1198</fpage><lpage>1203</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3156.2010.02611.x</pub-id><pub-id pub-id-type="pmid">20723184</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Marie</surname><given-names>A</given-names></name><name><surname>Noukpo</surname><given-names>H</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Development of a biomarker of exposure to Anopheles bites based on human antibody response to salivary proteins: From concept to application in the field</article-title><source>Pathogens and Global Health</source><volume>107</volume><elocation-id>455</elocation-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollard</surname><given-names>EJM</given-names></name><name><surname>Patterson</surname><given-names>C</given-names></name><name><surname>Russell</surname><given-names>TL</given-names></name><name><surname>Apairamo</surname><given-names>A</given-names></name><name><surname>Oscar</surname><given-names>J</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Burkot</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Human exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae</article-title><source>Malaria Journal</source><volume>18</volume><elocation-id>334</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-019-2975-8</pub-id><pub-id pub-id-type="pmid">31570113</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proietti</surname><given-names>C</given-names></name><name><surname>Verra</surname><given-names>F</given-names></name><name><surname>Bretscher</surname><given-names>MT</given-names></name><name><surname>Stone</surname><given-names>W</given-names></name><name><surname>Kanoi</surname><given-names>BN</given-names></name><name><surname>Balikagala</surname><given-names>B</given-names></name><name><surname>Egwang</surname><given-names>TG</given-names></name><name><surname>Corran</surname><given-names>P</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Riley</surname><given-names>EM</given-names></name><name><surname>Crisanti</surname><given-names>A</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Bousema</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda</article-title><source>Parasite Immunology</source><volume>35</volume><fpage>164</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1111/pim.12031</pub-id><pub-id pub-id-type="pmid">23473542</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabe-Hesketh</surname><given-names>S</given-names></name><name><surname>Pickles</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Generalized linear latent and mixed models</article-title><source>Stata Technical Bulletin</source><volume>53</volume><fpage>293</fpage><lpage>307</lpage></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawal</surname><given-names>R</given-names></name><name><surname>Vijay</surname><given-names>S</given-names></name><name><surname>Kadian</surname><given-names>K</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Pande</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Towards a proteomic catalogue and differential annotation of salivary gland proteins in blood fed malaria vector anopheles culicifacies by mass spectrometry</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0161870</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0161870</pub-id><pub-id pub-id-type="pmid">27602567</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Cisse</surname><given-names>B</given-names></name><name><surname>Ba</surname><given-names>F</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Herve</surname><given-names>JP</given-names></name><name><surname>Boulanger</surname><given-names>D</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria</article-title><source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source><volume>100</volume><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.trstmh.2005.06.032</pub-id><pub-id pub-id-type="pmid">16310235</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>JMC</given-names></name><name><surname>Francischetti</surname><given-names>IMB</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives</article-title><source>Annual Review of Entomology</source><volume>48</volume><fpage>73</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1146/annurev.ento.48.060402.102812</pub-id><pub-id pub-id-type="pmid">12194906</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>C</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Fiorentino</surname><given-names>G</given-names></name><name><surname>Mangano</surname><given-names>VD</given-names></name><name><surname>Sirima</surname><given-names>SB</given-names></name><name><surname>Nèbiè</surname><given-names>I</given-names></name><name><surname>Petrarca</surname><given-names>V</given-names></name><name><surname>Modiano</surname><given-names>D</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011a</year><article-title>Wide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa</article-title><source>Malaria Journal</source><volume>10</volume><elocation-id>206</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-10-206</pub-id><pub-id pub-id-type="pmid">21794142</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>C</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Fiorentino</surname><given-names>G</given-names></name><name><surname>Verra</surname><given-names>F</given-names></name><name><surname>Mangano</surname><given-names>V</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Sirima</surname><given-names>SB</given-names></name><name><surname>Nèbiè</surname><given-names>I</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Coluzzi</surname><given-names>M</given-names></name><name><surname>Petrarca</surname><given-names>V</given-names></name><name><surname>Modiano</surname><given-names>D</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011b</year><article-title>Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e17980</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0017980</pub-id><pub-id pub-id-type="pmid">21437289</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>C</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Mangano</surname><given-names>V</given-names></name><name><surname>Sirima</surname><given-names>SB</given-names></name><name><surname>Nèbiè</surname><given-names>I</given-names></name><name><surname>Fiorentino</surname><given-names>G</given-names></name><name><surname>Modiano</surname><given-names>D</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors</article-title><source>Parasites &amp; Vectors</source><volume>7</volume><elocation-id>549</elocation-id><pub-id pub-id-type="doi">10.1186/s13071-014-0549-8</pub-id><pub-id pub-id-type="pmid">25428638</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>C</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Mangano</surname><given-names>V</given-names></name><name><surname>Sirima</surname><given-names>SB</given-names></name><name><surname>Nèbiè</surname><given-names>I</given-names></name><name><surname>Fiorentino</surname><given-names>G</given-names></name><name><surname>Troye-Blomberg</surname><given-names>M</given-names></name><name><surname>Modiano</surname><given-names>D</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>IgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e96130</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0096130</pub-id><pub-id pub-id-type="pmid">24760038</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Kotsyfakis</surname><given-names>M</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Rizzo</surname><given-names>C</given-names></name><name><surname>Currà</surname><given-names>C</given-names></name><name><surname>Ponzi</surname><given-names>M</given-names></name><name><surname>Fiorentino</surname><given-names>G</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The Anopheles gambiae cE5, a tight- and fast-binding thrombin inhibitor with post-transcriptionally regulated salivary-restricted expression</article-title><source>Insect Biochemistry and Molecular Biology</source><volume>42</volume><fpage>610</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1016/j.ibmb.2012.04.008</pub-id><pub-id pub-id-type="pmid">22617725</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sá-Nunes</surname><given-names>A</given-names></name><name><surname>De Oliveira</surname><given-names>CJF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Sialogenins and immunomodulators derived from blood feeding parasites</article-title><source>Toxins and Hemostasis</source><volume>1</volume><fpage>131</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1007/978-90-481-9295-3</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadia-Kacou</surname><given-names>CAM</given-names></name><name><surname>Yobo</surname><given-names>CM</given-names></name><name><surname>Adja</surname><given-names>MA</given-names></name><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Ndille</surname><given-names>EE</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Tano</surname><given-names>Y</given-names></name><name><surname>Koudou</surname><given-names>BG</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Use of Anopheles salivary biomarker to assess seasonal variation of human exposure to Anopheles bites in children living near rubber and oil palm cultivations in Côte d’Ivoire</article-title><source>Parasite Epidemiology and Control</source><volume>5</volume><elocation-id>e00102</elocation-id><pub-id pub-id-type="doi">10.1016/j.parepi.2019.e00102</pub-id><pub-id pub-id-type="pmid">30923754</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Gaayeb</surname><given-names>L</given-names></name><name><surname>Sarr</surname><given-names>JB</given-names></name><name><surname>Senghor</surname><given-names>S</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Boutouaba-Combe</surname><given-names>S</given-names></name><name><surname>Schacht</surname><given-names>AM</given-names></name><name><surname>Hermann</surname><given-names>E</given-names></name><name><surname>Faye</surname><given-names>N</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title><italic>Plasmodium falciparum</italic> infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal</article-title><source>Malaria Journal</source><volume>12</volume><elocation-id>301</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-12-301</pub-id><pub-id pub-id-type="pmid">23988032</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Sarr</surname><given-names>JB</given-names></name><name><surname>Gaayeb</surname><given-names>L</given-names></name><name><surname>Drame</surname><given-names>PM</given-names></name><name><surname>Ndiath</surname><given-names>MO</given-names></name><name><surname>Senghor</surname><given-names>S</given-names></name><name><surname>Sow</surname><given-names>CS</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Seck</surname><given-names>M</given-names></name><name><surname>Hermann</surname><given-names>E</given-names></name><name><surname>Schacht</surname><given-names>AM</given-names></name><name><surname>Faye</surname><given-names>N</given-names></name><name><surname>Sokhna</surname><given-names>C</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to <italic>Anopheles</italic> bites in low and seasonal malaria areas</article-title><source>Parasites &amp; Vectors</source><volume>6</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.1186/1756-3305-6-68</pub-id><pub-id pub-id-type="pmid">23497646</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagna</surname><given-names>A</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Wikel</surname><given-names>SK</given-names></name><name><surname>Aksoy</surname><given-names>S</given-names></name><name><surname>Dimopoulos</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epidemiological applications of assessing mosquito exposure in a malaria-endemic area</article-title><source>Arthropod Vector: Controller of Disease Transmission, Vector Saliva-Host Pathogen Interactions2017</source><volume>2</volume><fpage>209</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-805360-7.00012-5</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Kassie</surname><given-names>D</given-names></name><name><surname>Couvray</surname><given-names>A</given-names></name><name><surname>Hermann</surname><given-names>E</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name><name><surname>Salem</surname><given-names>G</given-names></name><name><surname>Fournet</surname><given-names>F</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Spatial risk of urban exposure to <italic>Anopheles</italic> and <italic>Aedes</italic> mosquito bites in Africa using salivary antibody-based biomarkers</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>99</volume><elocation-id>47</elocation-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Kassié</surname><given-names>D</given-names></name><name><surname>Couvray</surname><given-names>A</given-names></name><name><surname>Adja</surname><given-names>AM</given-names></name><name><surname>Hermann</surname><given-names>E</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name><name><surname>Salem</surname><given-names>G</given-names></name><name><surname>Fournet</surname><given-names>F</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Spatial assessment of contact between humans and anopheles and aedes mosquitoes in a medium-sized African urban setting, using salivary antibody-based biomarkers</article-title><source>The Journal of Infectious Diseases</source><volume>220</volume><fpage>1199</fpage><lpage>1208</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiz289</pub-id><pub-id pub-id-type="pmid">31152664</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandfort</surname><given-names>M</given-names></name><name><surname>Vantaux</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Obadia</surname><given-names>T</given-names></name><name><surname>Pepey</surname><given-names>A</given-names></name><name><surname>Gardais</surname><given-names>S</given-names></name><name><surname>Khim</surname><given-names>N</given-names></name><name><surname>Lek</surname><given-names>D</given-names></name><name><surname>White</surname><given-names>M</given-names></name><name><surname>Robinson</surname><given-names>LJ</given-names></name><name><surname>Witkowski</surname><given-names>B</given-names></name><name><surname>Mueller</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Forest malaria in Cambodia: the occupational and spatial clustering of Plasmodium vivax and <italic>Plasmodium falciparum</italic> infection risk in a cross-sectional survey in Mondulkiri province, Cambodia</article-title><source>Malaria Journal</source><volume>19</volume><elocation-id>413</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-020-03482-4</pub-id><pub-id pub-id-type="pmid">33213471</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarr</surname><given-names>JB</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Samb</surname><given-names>B</given-names></name><name><surname>Dia</surname><given-names>I</given-names></name><name><surname>Guindo</surname><given-names>S</given-names></name><name><surname>Sow</surname><given-names>C</given-names></name><name><surname>Maiga</surname><given-names>S</given-names></name><name><surname>Tine</surname><given-names>S</given-names></name><name><surname>Thiam</surname><given-names>C</given-names></name><name><surname>Schacht</surname><given-names>AM</given-names></name><name><surname>Simondon</surname><given-names>F</given-names></name><name><surname>Konate</surname><given-names>L</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Evaluation of antibody response to <italic>Plasmodium falciparum</italic> in children according to exposure of Anopheles gambiae s.l or Anopheles funestus vectors</article-title><source>Malaria Journal</source><volume>6</volume><elocation-id>117</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-6-117</pub-id><pub-id pub-id-type="pmid">17764568</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarr</surname><given-names>JB</given-names></name><name><surname>Orlandi-Pradines</surname><given-names>E</given-names></name><name><surname>Fortin</surname><given-names>S</given-names></name><name><surname>Sow</surname><given-names>C</given-names></name><name><surname>Cornelie</surname><given-names>S</given-names></name><name><surname>Rogerie</surname><given-names>F</given-names></name><name><surname>Guindo</surname><given-names>S</given-names></name><name><surname>Konate</surname><given-names>L</given-names></name><name><surname>Fusaï</surname><given-names>T</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name><name><surname>Rogier</surname><given-names>C</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Assessment of exposure to <italic>Plasmodium falciparum</italic> transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assays</article-title><source>Parasites &amp; Vectors</source><volume>4</volume><elocation-id>212</elocation-id><pub-id pub-id-type="doi">10.1186/1756-3305-4-212</pub-id><pub-id pub-id-type="pmid">22059951</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarr</surname><given-names>JB</given-names></name><name><surname>Samb</surname><given-names>B</given-names></name><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Fortin</surname><given-names>S</given-names></name><name><surname>Doucoure</surname><given-names>S</given-names></name><name><surname>Sow</surname><given-names>C</given-names></name><name><surname>Senghor</surname><given-names>S</given-names></name><name><surname>Gaayeb</surname><given-names>L</given-names></name><name><surname>Guindo</surname><given-names>S</given-names></name><name><surname>Schacht</surname><given-names>AM</given-names></name><name><surname>Rogerie</surname><given-names>F</given-names></name><name><surname>Hermann</surname><given-names>E</given-names></name><name><surname>Dia</surname><given-names>I</given-names></name><name><surname>Konate</surname><given-names>L</given-names></name><name><surname>Riveau</surname><given-names>G</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differential acquisition of human antibody responses to <italic>Plasmodium falciparum</italic> according to intensity of exposure to Anopheles bites</article-title><source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source><volume>106</volume><fpage>460</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/j.trstmh.2012.05.006</pub-id><pub-id pub-id-type="pmid">22721883</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoguina</surname><given-names>J</given-names></name><name><surname>Walther</surname><given-names>B</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Nwakanma</surname><given-names>D</given-names></name><name><surname>Oriero</surname><given-names>EC</given-names></name><name><surname>Correa</surname><given-names>S</given-names></name><name><surname>Corran</surname><given-names>P</given-names></name><name><surname>Conway</surname><given-names>DJ</given-names></name><name><surname>Walther</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau</article-title><source>Malaria Journal</source><volume>8</volume><elocation-id>274</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-8-274</pub-id><pub-id pub-id-type="pmid">19954532</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scarpassa</surname><given-names>VM</given-names></name><name><surname>Debat</surname><given-names>HJ</given-names></name><name><surname>Alencar</surname><given-names>RB</given-names></name><name><surname>Saraiva</surname><given-names>JF</given-names></name><name><surname>Calvo</surname><given-names>E</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Ribeiro</surname><given-names>JMC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An insight into the sialotranscriptome and virome of Amazonian anophelines</article-title><source>BMC Genomics</source><volume>20</volume><elocation-id>166</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-019-5545-0</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinden</surname><given-names>RE</given-names></name><name><surname>Blagborough</surname><given-names>AM</given-names></name><name><surname>Churcher</surname><given-names>T</given-names></name><name><surname>Ramakrishnan</surname><given-names>C</given-names></name><name><surname>Biswas</surname><given-names>S</given-names></name><name><surname>Delves</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The design and interpretation of laboratory assays measuring mosquito transmission of Plasmodium</article-title><source>Trends in Parasitology</source><volume>28</volume><fpage>457</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2012.07.005</pub-id><pub-id pub-id-type="pmid">22980759</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinka</surname><given-names>ME</given-names></name><name><surname>Rubio-Palis</surname><given-names>Y</given-names></name><name><surname>Manguin</surname><given-names>S</given-names></name><name><surname>Patil</surname><given-names>AP</given-names></name><name><surname>Temperley</surname><given-names>WH</given-names></name><name><surname>Gething</surname><given-names>PW</given-names></name><name><surname>Van Boeckel</surname><given-names>T</given-names></name><name><surname>Kabaria</surname><given-names>CW</given-names></name><name><surname>Harbach</surname><given-names>RE</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The dominant Anopheles vectors of human malaria in the Americas: occurrence data, distribution maps and bionomic précis</article-title><source>Parasites &amp; Vectors</source><volume>3</volume><elocation-id>72</elocation-id><pub-id pub-id-type="doi">10.1186/1756-3305-3-72</pub-id><pub-id pub-id-type="pmid">20712879</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinka</surname><given-names>ME</given-names></name><name><surname>Bangs</surname><given-names>MJ</given-names></name><name><surname>Manguin</surname><given-names>S</given-names></name><name><surname>Rubio-Palis</surname><given-names>Y</given-names></name><name><surname>Chareonviriyaphap</surname><given-names>T</given-names></name><name><surname>Coetzee</surname><given-names>M</given-names></name><name><surname>Mbogo</surname><given-names>CM</given-names></name><name><surname>Hemingway</surname><given-names>J</given-names></name><name><surname>Patil</surname><given-names>AP</given-names></name><name><surname>Temperley</surname><given-names>WH</given-names></name><name><surname>Gething</surname><given-names>PW</given-names></name><name><surname>Kabaria</surname><given-names>CW</given-names></name><name><surname>Burkot</surname><given-names>TR</given-names></name><name><surname>Harbach</surname><given-names>RE</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A global map of dominant malaria vectors</article-title><source>Parasites &amp; Vectors</source><volume>5</volume><elocation-id>69</elocation-id><pub-id pub-id-type="doi">10.1186/1756-3305-5-69</pub-id><pub-id pub-id-type="pmid">22475528</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinka</surname><given-names>ME</given-names></name><name><surname>Pironon</surname><given-names>S</given-names></name><name><surname>Massey</surname><given-names>NC</given-names></name><name><surname>Longbottom</surname><given-names>J</given-names></name><name><surname>Hemingway</surname><given-names>J</given-names></name><name><surname>Moyes</surname><given-names>CL</given-names></name><name><surname>Willis</surname><given-names>KJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A new malaria vector in Africa: Predicting the expansion range of Anopheles stephensi and identifying the urban populations at risk</article-title><source>PNAS</source><volume>117</volume><fpage>24900</fpage><lpage>24908</lpage><pub-id pub-id-type="doi">10.1073/pnas.2003976117</pub-id><pub-id pub-id-type="pmid">32929020</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smithuis</surname><given-names>FM</given-names></name><name><surname>Kyaw</surname><given-names>MK</given-names></name><name><surname>Phe</surname><given-names>UO</given-names></name><name><surname>van der Broek</surname><given-names>I</given-names></name><name><surname>Katterman</surname><given-names>N</given-names></name><name><surname>Rogers</surname><given-names>C</given-names></name><name><surname>Almeida</surname><given-names>P</given-names></name><name><surname>Kager</surname><given-names>PA</given-names></name><name><surname>Stepniewska</surname><given-names>K</given-names></name><name><surname>Lubell</surname><given-names>Y</given-names></name><name><surname>Simpson</surname><given-names>JA</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Entomological determinants of insecticide-treated bed net effectiveness in Western Myanmar</article-title><source>Malaria Journal</source><volume>12</volume><elocation-id>364</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-12-364</pub-id><pub-id pub-id-type="pmid">24119994</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snow</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A geo-coded inventory of anophelines in the Afrotropical Region south of the Sahara: 1898-2016</article-title><source>Wellcome Open Research</source><volume>2</volume><elocation-id>6CUN</elocation-id><pub-id pub-id-type="doi">10.7910/DVN/NQ6CUN</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soma</surname><given-names>DD</given-names></name><name><surname>Kassié</surname><given-names>D</given-names></name><name><surname>Sanou</surname><given-names>S</given-names></name><name><surname>Karama</surname><given-names>FB</given-names></name><name><surname>Ouari</surname><given-names>A</given-names></name><name><surname>Mamai</surname><given-names>W</given-names></name><name><surname>Ouédraogo</surname><given-names>GA</given-names></name><name><surname>Salem</surname><given-names>G</given-names></name><name><surname>Dabiré</surname><given-names>RK</given-names></name><name><surname>Fournet</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Uneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso</article-title><source>Parasites &amp; Vectors</source><volume>11</volume><elocation-id>296</elocation-id><pub-id pub-id-type="doi">10.1186/s13071-018-2857-x</pub-id><pub-id pub-id-type="pmid">29751825</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>P</given-names></name><name><surname>Rudan</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Fowkes</surname><given-names>FJI</given-names></name><name><surname>Rahimi</surname><given-names>K</given-names></name><name><surname>Fowkes</surname><given-names>FGR</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis</article-title><source>The Lancet. Global Health</source><volume>7</volume><fpage>e1020</fpage><lpage>e1030</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(19)30255-4</pub-id><pub-id pub-id-type="pmid">31303293</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sor-Suwan</surname><given-names>S</given-names></name><name><surname>Jariyapan</surname><given-names>N</given-names></name><name><surname>Roytrakul</surname><given-names>S</given-names></name><name><surname>Paemanee</surname><given-names>A</given-names></name><name><surname>Saeung</surname><given-names>A</given-names></name><name><surname>Thongsahuan</surname><given-names>S</given-names></name><name><surname>Phattanawiboon</surname><given-names>B</given-names></name><name><surname>Bates</surname><given-names>PA</given-names></name><name><surname>Poovorawan</surname><given-names>Y</given-names></name><name><surname>Choochote</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Salivary gland proteome of the human malaria vector, Anopheles campestris-like (Diptera: Culicidae)</article-title><source>Parasitology Research</source><volume>112</volume><fpage>1065</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1007/s00436-012-3233-y</pub-id><pub-id pub-id-type="pmid">23263250</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sor-suwan</surname><given-names>S</given-names></name><name><surname>Jariyapan</surname><given-names>N</given-names></name><name><surname>Roytrakul</surname><given-names>S</given-names></name><name><surname>Paemanee</surname><given-names>A</given-names></name><name><surname>Phumee</surname><given-names>A</given-names></name><name><surname>Phattanawiboon</surname><given-names>B</given-names></name><name><surname>Intakhan</surname><given-names>N</given-names></name><name><surname>Chanmol</surname><given-names>W</given-names></name><name><surname>Bates</surname><given-names>PA</given-names></name><name><surname>Saeung</surname><given-names>A</given-names></name><name><surname>Choochote</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Identification of salivary gland proteins depleted after blood feeding in the malaria vector Anopheles campestris-like mosquitoes (Diptera: Culicidae)</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e90809</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0090809</pub-id><pub-id pub-id-type="pmid">24599352</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>W</given-names></name><name><surname>Bousema</surname><given-names>T</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Gesase</surname><given-names>S</given-names></name><name><surname>Hashim</surname><given-names>R</given-names></name><name><surname>Gosling</surname><given-names>R</given-names></name><name><surname>Carneiro</surname><given-names>I</given-names></name><name><surname>Chandramohan</surname><given-names>D</given-names></name><name><surname>Theander</surname><given-names>T</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Modiano</surname><given-names>D</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e40170</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0040170</pub-id><pub-id pub-id-type="pmid">22768250</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroup</surname><given-names>DF</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><name><surname>Morton</surname><given-names>SC</given-names></name><name><surname>Olkin</surname><given-names>I</given-names></name><name><surname>Williamson</surname><given-names>GD</given-names></name><name><surname>Rennie</surname><given-names>D</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Becker</surname><given-names>BJ</given-names></name><name><surname>Sipe</surname><given-names>TA</given-names></name><name><surname>Thacker</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Meta-analysis of observational studies in epidemiology: a proposal for reporting Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group</article-title><source>JAMA</source><volume>283</volume><fpage>2008</fpage><lpage>2012</lpage><pub-id pub-id-type="doi">10.1001/jama.283.15.2008</pub-id><pub-id pub-id-type="pmid">10789670</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takken</surname><given-names>W</given-names></name><name><surname>Lindsay</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Increased threat of urban malaria from anopheles stephensi mosquitoes, Africa</article-title><source>Emerging Infectious Diseases</source><volume>25</volume><fpage>1431</fpage><lpage>1433</lpage><pub-id pub-id-type="doi">10.3201/eid2507.190301</pub-id><pub-id pub-id-type="pmid">31063455</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="web"><person-group person-group-type="author"><collab>The Malaria Atlas</collab></person-group><year iso-8601-date="2017">2017</year><article-title>The Malaria Atlas Project</article-title><ext-link ext-link-type="uri" xlink:href="https://malariaatlas.org">https://malariaatlas.org</ext-link><date-in-citation iso-8601-date="2020-10-13">October 13, 2020</date-in-citation></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traoré</surname><given-names>DF</given-names></name><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Adja</surname><given-names>AM</given-names></name><name><surname>Zoh</surname><given-names>DD</given-names></name><name><surname>Lingué</surname><given-names>KN</given-names></name><name><surname>Coulibaly</surname><given-names>I</given-names></name><name><surname>N’Cho Tchiekoi</surname><given-names>B</given-names></name><name><surname>Assi</surname><given-names>SB</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Dagnogo</surname><given-names>M</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Evaluation of malaria urban risk using an immuno-epidemiological biomarker of human exposure to anopheles bites</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>98</volume><fpage>1353</fpage><lpage>1359</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.17-0231</pub-id><pub-id pub-id-type="pmid">29512479</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traoré</surname><given-names>DF</given-names></name><name><surname>Sagna</surname><given-names>AB</given-names></name><name><surname>Adja</surname><given-names>AM</given-names></name><name><surname>Zoh</surname><given-names>DD</given-names></name><name><surname>Adou</surname><given-names>KA</given-names></name><name><surname>Lingué</surname><given-names>KN</given-names></name><name><surname>Coulibaly</surname><given-names>I</given-names></name><name><surname>Tchiekoi</surname><given-names>NB</given-names></name><name><surname>Assi</surname><given-names>SB</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Dagnogo</surname><given-names>M</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Exploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d’Ivoire, using an immuno-epidemiological biomarker</article-title><source>Malaria Journal</source><volume>18</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-019-2696-z</pub-id><pub-id pub-id-type="pmid">30857543</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trung</surname><given-names>HD</given-names></name><name><surname>Bortel</surname><given-names>WV</given-names></name><name><surname>Sochantha</surname><given-names>T</given-names></name><name><surname>Keokenchanh</surname><given-names>K</given-names></name><name><surname>Briët</surname><given-names>OJT</given-names></name><name><surname>Coosemans</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Behavioural heterogeneity of Anopheles species in ecologically different localities in Southeast Asia: a challenge for vector control</article-title><source>Tropical Medicine &amp; International Health</source><volume>10</volume><fpage>251</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3156.2004.01378.x</pub-id><pub-id pub-id-type="pmid">15730510</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ubillos</surname><given-names>I</given-names></name><name><surname>Campo</surname><given-names>JJ</given-names></name><name><surname>Jiménez</surname><given-names>A</given-names></name><name><surname>Dobaño</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Development of a high-throughput flexible quantitative suspension array assay for IgG against multiple <italic>Plasmodium falciparum</italic> antigens</article-title><source>Malaria Journal</source><volume>17</volume><elocation-id>216</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-018-2365-7</pub-id><pub-id pub-id-type="pmid">29843713</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Hoogen</surname><given-names>LL</given-names></name><name><surname>Présumé</surname><given-names>J</given-names></name><name><surname>Romilus</surname><given-names>I</given-names></name><name><surname>Mondélus</surname><given-names>G</given-names></name><name><surname>Elismé</surname><given-names>T</given-names></name><name><surname>Sepúlveda</surname><given-names>N</given-names></name><name><surname>Stresman</surname><given-names>G</given-names></name><name><surname>Druetz</surname><given-names>T</given-names></name><name><surname>Ashton</surname><given-names>RA</given-names></name><name><surname>Joseph</surname><given-names>V</given-names></name><name><surname>Eisele</surname><given-names>TP</given-names></name><name><surname>Hamre</surname><given-names>KES</given-names></name><name><surname>Chang</surname><given-names>MA</given-names></name><name><surname>Lemoine</surname><given-names>JF</given-names></name><name><surname>Tetteh</surname><given-names>KKA</given-names></name><name><surname>Boncy</surname><given-names>J</given-names></name><name><surname>Existe</surname><given-names>A</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Rogier</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Quality control of multiplex antibody detection in samples from large-scale surveys: the example of malaria in Haiti</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>1135</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-57876-0</pub-id><pub-id pub-id-type="pmid">31980693</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varela</surname><given-names>ML</given-names></name><name><surname>Koffi</surname><given-names>D</given-names></name><name><surname>White</surname><given-names>M</given-names></name><name><surname>Niang</surname><given-names>M</given-names></name><name><surname>Mbengue</surname><given-names>B</given-names></name><name><surname>Diene Sarr</surname><given-names>F</given-names></name><name><surname>Touré</surname><given-names>AO</given-names></name><name><surname>Perraut</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Practical example of multiple antibody screening for evaluation of malaria control strategies</article-title><source>Malaria Journal</source><volume>19</volume><elocation-id>117</elocation-id><pub-id pub-id-type="doi">10.1186/s12936-020-03186-9</pub-id><pub-id pub-id-type="pmid">32192514</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>MB</given-names></name><name><surname>Lahon</surname><given-names>A</given-names></name><name><surname>Arya</surname><given-names>RP</given-names></name><name><surname>Kneubehl</surname><given-names>AR</given-names></name><name><surname>Spencer Clinton</surname><given-names>JL</given-names></name><name><surname>Paust</surname><given-names>S</given-names></name><name><surname>Rico-Hesse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mosquito saliva alone has profound effects on the human immune system</article-title><source>PLOS Neglected Tropical Diseases</source><volume>12</volume><elocation-id>e0006439</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0006439</pub-id><pub-id pub-id-type="pmid">29771921</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waitayakul</surname><given-names>A</given-names></name><name><surname>Somsri</surname><given-names>S</given-names></name><name><surname>Sattabongkot</surname><given-names>J</given-names></name><name><surname>Looareesuwan</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Udomsangpetch</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Natural human humoral response to salivary gland proteins of Anopheles mosquitoes in Thailand</article-title><source>Acta Tropica</source><volume>98</volume><fpage>66</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.actatropica.2006.02.004</pub-id><pub-id pub-id-type="pmid">16530153</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>YO</given-names></name><name><surname>Li</surname><given-names>MWM</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Dragovic</surname><given-names>S</given-names></name><name><surname>Abraham</surname><given-names>NM</given-names></name><name><surname>Fikrig</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Anopheles gambiae circumsporozoite protein-binding protein facilitates plasmodium infection of mosquito salivary glands</article-title><source>The Journal of Infectious Diseases</source><volume>208</volume><fpage>1161</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit284</pub-id><pub-id pub-id-type="pmid">23801601</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanjala</surname><given-names>CL</given-names></name><name><surname>Kweka</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Impact of highland topography changes on exposure to malaria vectors and immunity in Western Kenya</article-title><source>Frontiers in Public Health</source><volume>4</volume><elocation-id>227</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2016.00227</pub-id><pub-id pub-id-type="pmid">27790610</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>MB</given-names></name><name><surname>Andrew</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Salivary gland cellular architecture in the Asian malaria vector mosquito Anopheles stephensi</article-title><source>Parasites &amp; Vectors</source><volume>8</volume><elocation-id>617</elocation-id><pub-id pub-id-type="doi">10.1186/s13071-015-1229-z</pub-id><pub-id pub-id-type="pmid">26627194</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="report"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><year iso-8601-date="2017">2017</year><source>Global Vector Control Response 2017-2030.</source><publisher-name>WHO</publisher-name><ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/handle/10665/259205">https://apps.who.int/iris/handle/10665/259205</ext-link></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ya-Umphan</surname><given-names>P</given-names></name><name><surname>Cerqueira</surname><given-names>D</given-names></name><name><surname>Parker</surname><given-names>DM</given-names></name><name><surname>Cottrell</surname><given-names>G</given-names></name><name><surname>Poinsignon</surname><given-names>A</given-names></name><name><surname>Remoue</surname><given-names>F</given-names></name><name><surname>Brengues</surname><given-names>C</given-names></name><name><surname>Chareonviriyaphap</surname><given-names>T</given-names></name><name><surname>Nosten</surname><given-names>F</given-names></name><name><surname>Corbel</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Use of an anopheles salivary biomarker to assess malaria transmission risk along the Thailand-Myanmar border</article-title><source>The Journal of Infectious Diseases</source><volume>215</volume><fpage>396</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw543</pub-id><pub-id pub-id-type="pmid">27932615</pub-id></element-citation></ref><ref id="bib180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ya-Umphan</surname><given-names>P</given-names></name><name><surname>Cerqueira</surname><given-names>D</given-names></name><name><surname>Cottrell</surname><given-names>G</given-names></name><name><surname>Parker</surname><given-names>DM</given-names></name><name><surname>Fowkes</surname><given-names>FJI</given-names></name><name><surname>Nosten</surname><given-names>F</given-names></name><name><surname>Corbel</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Anopheles salivary biomarker as a proxy for estimating <italic>Plasmodium falciparum</italic> malaria exposure on the Thailand–Myanmar border</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>99</volume><fpage>350</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.18-0081</pub-id><pub-id pub-id-type="pmid">29869601</pub-id></element-citation></ref><ref id="bib181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamba</surname><given-names>EI</given-names></name><name><surname>Tompkins</surname><given-names>AM</given-names></name><name><surname>Fink</surname><given-names>AH</given-names></name><name><surname>Ermert</surname><given-names>V</given-names></name><name><surname>Djouda</surname><given-names>A</given-names></name><name><surname>Amekudzi</surname><given-names>LK</given-names></name><name><surname>Briët</surname><given-names>OJT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Monthly entomological inoculation rates for studying malaria transmission seasonality in Africa</article-title><source>PANGAEA</source><volume>5</volume><elocation-id>5020031</elocation-id><pub-id pub-id-type="doi">10.3390/data5020031</pub-id></element-citation></ref><ref id="bib182"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yman</surname><given-names>V</given-names></name><name><surname>White</surname><given-names>MT</given-names></name><name><surname>Rono</surname><given-names>J</given-names></name><name><surname>Arcà</surname><given-names>B</given-names></name><name><surname>Osier</surname><given-names>FH</given-names></name><name><surname>Troye-Blomberg</surname><given-names>M</given-names></name><name><surname>Boström</surname><given-names>S</given-names></name><name><surname>Ronca</surname><given-names>R</given-names></name><name><surname>Rooth</surname><given-names>I</given-names></name><name><surname>Färnert</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>19472</elocation-id><pub-id pub-id-type="doi">10.1038/srep19472</pub-id><pub-id pub-id-type="pmid">26846726</pub-id></element-citation></ref><ref id="bib183"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zocevic</surname><given-names>A</given-names></name><name><surname>Carmi-Leroy</surname><given-names>A</given-names></name><name><surname>Sautereau</surname><given-names>J</given-names></name><name><surname>d’Alayer</surname><given-names>J</given-names></name><name><surname>Lenormand</surname><given-names>P</given-names></name><name><surname>Rousselle</surname><given-names>JC</given-names></name><name><surname>Namane</surname><given-names>A</given-names></name><name><surname>Choumet</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>New markers in Anopheles gambiae salivary glands after Plasmodium berghei infection</article-title><source>Vector Borne and Zoonotic Diseases</source><volume>13</volume><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1089/vbz.2012.0964</pub-id><pub-id pub-id-type="pmid">23289400</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec id="s8" sec-type="appendix"><title>Supplementary methodology</title><sec id="s8-1" sec-type="appendix"><title>Search strategy</title><p>We performed a systematic review with multilevel modelling of the published literature according to the MOOSE guidelines (<xref ref-type="bibr" rid="bib164">Stroup et al., 2000</xref>) and the PRISMA specifications (<xref ref-type="bibr" rid="bib103">Moher et al., 2009</xref>). The protocol was registered with PROSPERO (CRD42020185449).</p><p>The electronic databases PubMed, Scopus, Web of Science, African Index Medicus, and the Latin American and Caribbean Health Sciences Literature (LILACS) were searched for studies published before 30 June 2020 investigating <italic>Anopheles</italic> salivary antigens as a biomarker for mosquito exposure or malaria transmission. Search terms were as follows: <italic>Anophel</italic>* AND saliva* AND (antibod* OR sero* OR antigen OR marker* OR biomarker* OR gSG6* OR gSG* OR SG* OR cE5). The reference lists of included studies were screened for additional studies, and Google Scholar was used to identify additional works by key authors. No formal attempt was made to identify unpublished population studies as it would have required significant description of the design, methods, and analysis used in these studies, and a review of ethical issues.</p></sec><sec id="s8-2" sec-type="appendix"><title>Selection criteria</title><p>The primary criterion for inclusion in this systematic review was the reporting of observations of seroprevalence or total levels of Ig antibodies (including all isotypes and subclasses) in human sera against recombinant or synthetic peptide <italic>Anopheles</italic> salivary antigens. We considered for inclusion cross-sectional studies, cohort studies, intervention studies, and case–control studies of individuals or populations (including sub-populations) living in all geographies with natural exposure to <italic>Anopheles</italic> mosquitoes. Studies that were solely performed in participants not representative of the wider population (i.e. mosquito-allergic patients, soldiers, returned travellers) were excluded. The minimum quality criteria for inclusion in this review were antibody detection performed using enzyme-linked immunosorbent assay (ELISA), multiplex or Luminex assays.</p><p>The exposure variables of interest included entomological and malariometric parameters, including (i) HBR, defined as the number of bites received per person per unit of time; (ii) EIR, defined as the number of infectious bites per person per unit of time, calculated as the HBR multiplied by the sporozoite index; (iii) estimates of malaria prevalence; and (iv) population-level seroprevalence estimates against <italic>Plasmodium</italic> spp. malarial antigens. To ensure HBR estimates were given for the same unit of time (bites per person per night), biting rates given per week were divided by 7, and biting rates given per month we multiplied by 12 and divided by 365. Similar approaches were employed to ensure consistent units for EIR (infectious bites per person per year). <italic>Plasmodium</italic> spp. infections had to be confirmed by either microscopy, RDT, or molecular methods (PCR). <italic>Plasmodium</italic> spp. diagnosis was included for all <italic>Plasmodium</italic> spp. combined and the species level if provided. Where exposure estimates were not provided, we attempted to source data from other publications by the authors or used the site geolocation and year to obtain estimates of EIR from the Pangaea dataset (<xref ref-type="bibr" rid="bib181">Yamba et al., 2018</xref>). <italic>P. falciparum</italic> rates in 2–10 year olds (globally, 2000–2017) and DVS from the MAP (<xref ref-type="bibr" rid="bib166">The Malaria Atlas, 2017</xref>). Studies of salivary antigens where exposure variables could not be sourced and data that could not be extracted were excluded.</p></sec><sec id="s8-3" sec-type="appendix"><title>Selection of studies</title><p>One author performed database searches and screened reference lists to identify possible studies. One author screened studies against inclusion criteria, with discussion and input from a second reviewer.</p></sec><sec id="s8-4" sec-type="appendix"><title>Approaches to include all available studies</title><p>The authors of any studies that did not contain relevant information on the study design, populations, eligibility criteria, or key study data were contacted and relevant data requested. Authors were contacted via an initial email detailing the precise nature of the systematic review and the data required. If the authors did not reply to three email requests or were unable to provide relevant data, the studies were deemed to insufficiently meet inclusion/quality criteria and were excluded. As measurement of antibody levels does not produce a common metric between studies, authors were asked to classify their participants as ‘responders’ or ‘no-responders’ according to seropositivity (antibody level relative to unexposed sera) within each study to allow comparisons of seroprevalence between studies (<xref ref-type="bibr" rid="bib35">Cutts et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Cutts et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Fowkes et al., 2010</xref>). Studies that were only able to provide antibody levels or categorised seropositivity based upon arbitrary cut-offs were excluded from multilevel modelling analyses and included in narrative terms. Where the salivary antibody response and exposure variable were measured in the same population and reported in multiple publications, the study with the largest sample size was included, otherwise the earliest study was included.</p></sec><sec id="s8-5" sec-type="appendix"><title>Data extraction</title><p>Data were extracted using a data collection form by one reviewer. Any data that was provided at the sub-population level was extracted at the lowest level, that is, if a study was performed across multiple sites, and an estimate for both salivary antibody seroprevalence/levels and the exposure of interest is given for each site, it was included the site level, rather than an aggregated level.</p></sec></sec><sec id="s9" sec-type="appendix"><title>Measures</title><sec id="s9-1" sec-type="appendix"><title>Outcomes</title><p>The primary outcome of interest of our systematic review was the reported antibody response (both seroprevalence and levels of all Ig subclasses and isotypes) to <italic>Anopheles</italic> salivary antigens. Multilevel modelling analyses were performed where the seroprevalence of antibodies against the same antigen and the exposure of interest were reported in more than one study.</p></sec><sec id="s9-2" sec-type="appendix"><title>Exposures</title><p>The primary exposures of interest included in the multilevel modelling analyses were the HBR and EIR, a measure of the average number of bites received per person per night and infectious bites received per person per year, respectively. Secondary exposures assessed include the prevalence of any <italic>Plasmodium</italic> spp. infection (including <italic>P. falciparum</italic> only, <italic>P. vivax</italic> only, or untyped infections). Additional secondary exposures include the <italic>P. falciparum</italic> infection rate in 2–10 year olds extracted from MAP, as well as the seroprevalence of antimalarial antibodies against pre-erythrocytic and blood stage antigens.</p><p>Clinical and methodological heterogeneity were explored using prespecified variables to minimise spurious findings. Variables considered for inclusion were study design (cohort, cross-sectional, repeated cross-sectional), DVS, study participants (adults only, children only, adults and children), preparation of salivary antigen (recombinant full-length protein, synthetic peptide), malaria detection methodology (light microscopy, RDT, PCR), and entomological vector collection methodology (human landing catch, light traps, and spray catches).</p></sec><sec id="s9-3" sec-type="appendix"><title>Statistical analysis</title><p>Where there were sufficient data to pool observations of the same exposure and outcome measures, generalised linear multilevel modelling was used to undertake analyses quantifying associations between the exposures of interest and salivary antibody seroprevalence measurements. Models were generalised through use of the logit link function and binomial distribution (statistical notation for HBR model shown below as Equation 1). Seroprevalence was modelled in binomial form as the number of individuals seropositive to the total sample size. A three-level random effects model with a nested framework was used to account for dependency in the data, with random intercepts for country (level 3) and study (level 2) estimated. Hence, level 1 units represented multiple salivary antibody observations within a study induced by the study design (i.e<italic>.</italic> multiple time points, sites, age categories). Additionally, study-level random slopes for entomological and malariometric exposures were estimated to permit the effects to vary across studies. Model structure was determined empirically through likelihood ratio tests (p&lt;0.05), with the exception of country at the third,level which was included in HBR and EIR analyses to estimate country-specific seroprevalence estimates of anti-salivary antibodies. The associations between the various exposures and the different salivary antigens were analysed separately; however, observations of IgG seroprevalence against the recombinant full-length protein (gSG6) and synthetic peptide (gSG6-P1, the one peptide determined in all studies utilising peptides) form of the gSG6 antigen were analysed together, with a fixed term for antigen construct considered for inclusion in the model. Of note, gSG6 peptide 2 (gSG6-P2) was excluded from being analysed with gSG6 and gSG6-P1 as the two studies that reported anti-gSG6-P2 IgG seroprevalence also reported the seroprevalence of anti-gSG6-P1 IgG and only one could be included. Potential effect modification of the associations between the exposures of interest and the anti-<italic>Anopheles</italic> salivary antibody responses was explored and undertaken by estimating interaction terms for DVS (<italic>An. gambiae </italic>s.l<italic>.</italic> only, <italic>An. gambiae</italic> s.l. and other DVS, or <italic>An. gambiae</italic> s.l<italic>.</italic> absent) and for vector collection method (human landing catch or other indirect measures, e.g. light traps, spray catches, etc.). For the association between <italic>Plasmodium</italic> spp. prevalence and gSG6 IgG seropositivity, interaction terms for malaria detection methodology (light microscopy or PCR), and malarial species type (<italic>P. falciparum</italic> only, or <italic>P. falciparum</italic> and <italic>P. vivax</italic>) were estimated. Other variables considered for inclusion in adjusted models were study design, participant, and salivary antigen construct; however, these variables showed no association with anti-gSG6 IgG and were thus excluded.</p><p>AIC and BIC fit indices were used to determine the best-fitting functional forms for the association between log odds of gSG6 IgG seropositivity and HBR, EIR, and <italic>Plasmodium</italic> spp. prevalence – linear, log, quadratic, and cubic functions were fitted, with a log transformation exhibiting superior model fit (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>). To aid interpretation, we present our results as a relative increase in the odds of the gSG6 IgG seropositivity for a twofold (100% relative) increase in the exposures. Additional relative percent changes in HBR and EIR are also presented.</p><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>Model selection process, showing the log likelihood, Akaike’s information criterion (AIC), and Bayesian information criterion (BIC) fit indices for each model estimating different functional forms for the association between gSG6 IgG seropositivity and respective exposures.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Model</th><th align="left" valign="bottom">Log likelihood</th><th align="left" valign="bottom">AIC</th><th align="left" valign="bottom">BIC</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>HBR</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Linear</td><td align="char" char="." valign="bottom">–1533.3</td><td align="char" char="." valign="bottom">3076.6</td><td align="char" char="." valign="bottom">3091.2</td></tr><tr><td align="left" valign="bottom"><italic>Log</italic></td><td align="char" char="." valign="bottom">–<bold>1492.8</bold></td><td align="char" char="." valign="bottom"><bold>2995.7</bold></td><td align="char" char="." valign="bottom"><bold>3010.1</bold></td></tr><tr><td align="left" valign="bottom">Quadratic</td><td align="char" char="." valign="bottom">–1523.7</td><td align="char" char="." valign="bottom">3059.4</td><td align="char" char="." valign="bottom">3077.0</td></tr><tr><td align="left" valign="bottom">Cubic</td><td align="char" char="." valign="bottom">–1523.7</td><td align="char" char="." valign="bottom">3061.3</td><td align="char" char="." valign="bottom">3081.9</td></tr><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>EIR</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Linear</td><td align="char" char="." valign="bottom">–1003.40</td><td align="char" char="." valign="bottom">2016.80</td><td align="char" char="." valign="bottom">2027.27</td></tr><tr><td align="left" valign="bottom"><italic>Log</italic></td><td align="char" char="." valign="bottom">–<bold>530.65</bold></td><td align="char" char="." valign="bottom"><bold>1071.30</bold></td><td align="char" char="." valign="bottom"><bold>1079.49</bold></td></tr><tr><td align="left" valign="bottom">Quadratic</td><td align="char" char="." valign="bottom">–1002.65</td><td align="char" char="." valign="bottom">2017.30</td><td align="char" char="." valign="bottom">2029.87</td></tr><tr><td align="left" valign="bottom">Cubic</td><td align="char" char="." valign="bottom">–976.36</td><td align="char" char="." valign="bottom">1966.72</td><td align="char" char="." valign="bottom">1981.38</td></tr><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>Plasmodium</italic> spp<italic>. prevalence</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Linear</td><td align="char" char="." valign="bottom">–2777.45</td><td align="char" char="." valign="bottom">5564.91</td><td align="char" char="." valign="bottom">5582.03</td></tr><tr><td align="left" valign="bottom"><italic>Log</italic></td><td align="char" char="." valign="bottom">–<bold>2597.24</bold></td><td align="char" char="." valign="bottom"><bold>5202.47</bold></td><td align="char" char="." valign="bottom"><bold>5215.90</bold></td></tr><tr><td align="left" valign="bottom">Quadratic</td><td align="char" char="." valign="bottom">–2775.47</td><td align="char" char="." valign="bottom">5562.95</td><td align="char" char="." valign="bottom">5583.50</td></tr><tr><td align="left" valign="bottom">Cubic</td><td align="char" char="." valign="bottom">–2769.91</td><td align="char" char="." valign="bottom">5553.82</td><td align="char" char="." valign="bottom">5577.80</td></tr></tbody></table><table-wrap-foot><fn><p>HBR: human biting rate; EIR: entomological inoculation rate.</p></fn></table-wrap-foot></table-wrap><p>Empirical Bayes BLUPs were used to estimate the probability of gSG6 IgG seropositivity in the average study and country, which is equivalent to an estimated gSG6 IgG seroprevalence. In order to maximise the number of included studies in our modelling, we predicted anti-gSG6 seroprevalence according to endemicity class, derived by applying established endemicity cut-offs to <italic>Pf</italic>PR<sub>2-10</sub> estimates (<xref ref-type="bibr" rid="bib17">Bhatt et al., 2015</xref>) extracted from MAP using site year and geolocation (if MAP data unavailable endemicity as stated in study). ICCs and 95% reference ranges were estimated for country-, study-, and slope-specific heterogeneity (where appropriate) using estimated model variance components.</p></sec></sec><sec id="s10" sec-type="appendix"><title>Statistical notation for the generalised linear multilevel model (mixed effects, logistic) used to estimate the association between <italic>An. gambiae</italic> gSG6 IgG seropositivity and HBR</title><p>The model can be formally written as<disp-formula id="equ1">,<label> (1)</label><mml:math id="m1"><mml:msub><mml:mrow><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mo>{</mml:mo><mml:mtext>Pr(</mml:mtext><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo><mml:mfenced close="}" open="|" separators="|"><mml:mrow><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi> </mml:mi><mml:mi> </mml:mi></mml:mrow></mml:msub><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mi>H</mml:mi><mml:mi>B</mml:mi><mml:mi>R</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mi>H</mml:mi><mml:mi>B</mml:mi><mml:mi>R</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mi>H</mml:mi><mml:mi>B</mml:mi><mml:mi>R</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula></p><p>where</p><p><inline-formula><mml:math id="inf1"><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>~ <italic>N</italic>(0, <inline-formula><mml:math id="inf2"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>), <inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> ~ <italic>N</italic>(0, <inline-formula><mml:math id="inf4"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>) and <inline-formula><mml:math id="inf5"><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mi>H</mml:mi><mml:mi>B</mml:mi><mml:mi>R</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> ~ <italic>N</italic>(0, <inline-formula><mml:math id="inf6"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>), (2)</p><p>where <inline-formula><mml:math id="inf7"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the vector of model covariates, <inline-formula><mml:math id="inf8"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is the model constant and represents the log odds (probability) of gSG6 IgG seropositivity for a log HBR of zero, <inline-formula><mml:math id="inf9"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is the fixed effect for log HBR for country <italic>j</italic> and study <italic>i</italic>, <inline-formula><mml:math id="inf10"><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the random effect (i.e. intercept) for between-country heterogeneity in probability of gSG6 IgG seropositivity, <inline-formula><mml:math id="inf11"><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>i</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:msub></mml:math></inline-formula> is the random effect (i.e. intercept) for between-study heterogeneity in probability of gSG6 IgG seropositivity, and <inline-formula><mml:math id="inf12"><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the random effect (i.e. coefficient) for between-study heterogeneity in the effect of log HBR.</p><sec id="s10-1" sec-type="appendix"><title>Risk of bias in individual studies</title><p>For cross-sectional, cohort or intervention studies, selection bias was assessed by reviewing the studies’ inclusion and exclusion criteria. Any case–control studies or studies that presented salivary antibody data stratified by malaria infection status were included in narrative terms only. Risk of bias was assessed by one reviewer using the Risk of Bias in Prevalence Studies tool (<xref ref-type="bibr" rid="bib64">Hoy et al., 2012</xref>). The risk of bias pertains to the reported observations of anti-<italic>Anopheles</italic> salivary antibody seroprevalence included in the multilevel modelling.</p></sec></sec></app><app id="appendix-2"><title>Appendix 2</title><sec id="s11" sec-type="appendix"><title>Risk of bias assessment</title><p>Risk of bias was assessed for each study by one independent reviewer using the Risk of Bias in Prevalence Studies tool (<xref ref-type="bibr" rid="bib64">Hoy et al., 2012</xref>). This tool comprises 10 items and a summary assessment to assess the external validity (selection and non-response bias) and internal validity (measurement bias) of the study’s seroprevalence observations. The risk of bias pertains to the reported observations of anti-<italic>Anopheles</italic> salivary antibody seroprevalence included in the multilevel modelling.</p><p>With regard to external validity, seven of the studies included in the review were performed in specific populations (i.e<italic>.</italic> children only) that were not representative of the national population and were deemed to be at high risk of selection bias. Only seven studies included some form of random sampling, and frequently insufficient detail was provided on the sampling frame; as such most studies were included as high risk of selection bias. Furthermore, no studies reported participant response rate, and as such were indicated as high risk of non-response bias.</p><p>In terms of internal validity, all studies had an acceptable case definition, with the same mode of data collection, a valid instrument, and an acceptable prevalence period, so were all deemed to be of low risk. However, 12 studies did not include a denominator, instead only reporting the study sample size and prevalence estimate, and were included as high risk.</p><p>Overall, due to the specific nature of some of the sample populations for which these prevalence observations are given (i.e<italic>.</italic> children only) and as participant non-response rate is not given, we conclude that there is a moderate risk of study bias. According to the Risk of Bias in Prevalence Studies tool (<xref ref-type="bibr" rid="bib64">Hoy et al., 2012</xref>), this implies that future research is likely to have an impact on our confidence in the prevalence observations.</p><fig id="app2fig1" position="float"><label>Appendix 2—figure 1.</label><caption><title>Risk of bias assessment.</title><p>Red, high risk; orange, moderate risk; green, low risk.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-app2-fig1-v2.tif"/></fig></sec></app><app id="appendix-3"><title>Appendix 3</title><sec id="s12" sec-type="appendix"><title>Reasons for study exclusion</title><table-wrap id="app3table1" position="float"><label>Appendix 3—table 1.</label><caption><title>Reasons for study exclusion.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Studies</th><th align="left" valign="bottom">Reason</th><th align="left" valign="bottom">References</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom">30</td><td align="left" valign="bottom">Does not measure anti-salivary antibody responses in individuals/populations</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib11">Arcà et al., 2017</xref>; <xref ref-type="bibr" rid="bib5">Alvarenga et al., 2010</xref>; <xref ref-type="bibr" rid="bib10">Arcà et al., 2005</xref>; <xref ref-type="bibr" rid="bib23">Calvo et al., 2007</xref>; <xref ref-type="bibr" rid="bib22">Calvo et al., 2006</xref>; <xref ref-type="bibr" rid="bib28">Choumet et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Das et al., 2010</xref>; <xref ref-type="bibr" rid="bib38">Di Gaetano et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Dixit et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Francischetti et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Francischetti et al., 2002</xref>; <xref ref-type="bibr" rid="bib60">Ghosh et al., 2009</xref>; <xref ref-type="bibr" rid="bib67">Isaacs et al., 2018</xref>; <xref ref-type="bibr" rid="bib69">Jariyapan et al., 2010</xref>; <xref ref-type="bibr" rid="bib68">Jariyapan et al., 2006</xref>; <xref ref-type="bibr" rid="bib70">Jariyapan et al., 2012</xref>; <xref ref-type="bibr" rid="bib72">Kamiya et al., 2017</xref>; <xref ref-type="bibr" rid="bib76">Khaireh et al., 2012</xref>; <xref ref-type="bibr" rid="bib80">Korochkina et al., 2006</xref>; <xref ref-type="bibr" rid="bib86">Lombardo et al., 2009</xref>; <xref ref-type="bibr" rid="bib112">Pandey et al., 2018</xref>; <xref ref-type="bibr" rid="bib113">Pedro and Sallum, 2009</xref>; <xref ref-type="bibr" rid="bib120">Phattanawiboon et al., 2016</xref>; <xref ref-type="bibr" rid="bib122">Pirone et al., 2017</xref>; <xref ref-type="bibr" rid="bib132">Rawal et al., 2016</xref>; <xref ref-type="bibr" rid="bib139">Ronca et al., 2012</xref>; <xref ref-type="bibr" rid="bib148">Sarr et al., 2007</xref>; <xref ref-type="bibr" rid="bib152">Scarpassa et al., 2019</xref>; <xref ref-type="bibr" rid="bib177">Wells and Andrew, 2015</xref>; <xref ref-type="bibr" rid="bib183">Zocevic et al., 2013</xref></td></tr><tr><td align="char" char="." valign="bottom">28</td><td align="left" valign="bottom">Review article</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib95">malERA Refresh Consultative Panel on Tools for Malaria Elimination, 2017</xref>; <xref ref-type="bibr" rid="bib93">malERA Refresh Consultative Panel on Basic Science and Enabling Technologies, 2017</xref>; <xref ref-type="bibr" rid="bib94">malERA Refresh Consultative Panel on Characterising the Reservoir and Measuring Transmission, 2017</xref>; <xref ref-type="bibr" rid="bib9">Andrade and Barral-Netto, 2011</xref>; <xref ref-type="bibr" rid="bib7">Andrade et al., 2005</xref>; <xref ref-type="bibr" rid="bib18">Billingsley et al., 2006</xref>; <xref ref-type="bibr" rid="bib24">Cantillo et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Coutinho-Abreu et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Domingos et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Doucoure et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Doucoure and Drame, 2015</xref>; <xref ref-type="bibr" rid="bib50">Drame et al., 2013b</xref>; <xref ref-type="bibr" rid="bib52">Fontaine et al., 2011a</xref>; <xref ref-type="bibr" rid="bib57">Foy et al., 2002</xref>; <xref ref-type="bibr" rid="bib61">Gillespie et al., 2000</xref>; <xref ref-type="bibr" rid="bib63">Hopp and Sinnis, 2015</xref>; <xref ref-type="bibr" rid="bib65">Hugo and Birrell, 2018</xref>; <xref ref-type="bibr" rid="bib83">Leitner et al., 2011</xref>; <xref ref-type="bibr" rid="bib85">Lombardo et al., 2006</xref>; <xref ref-type="bibr" rid="bib99">Mathema and Na-Bangchang, 2015</xref>; <xref ref-type="bibr" rid="bib117">Peng et al., 2007</xref>; <xref ref-type="bibr" rid="bib134">Ribeiro and Francischetti, 2003</xref>; <xref ref-type="bibr" rid="bib144">Sagna et al., 2017</xref>; <xref ref-type="bibr" rid="bib140">Sá-Nunes and De Oliveira, 2011</xref>; <xref ref-type="bibr" rid="bib102">Miot and Lima, 2014</xref>; <xref ref-type="bibr" rid="bib116">Peng and Simons, 2004</xref>; <xref ref-type="bibr" rid="bib121">Pingen et al., 2017</xref>; <xref ref-type="bibr" rid="bib153">Sinden et al., 2012</xref></td></tr><tr><td align="char" char="." valign="bottom">20</td><td align="left" valign="bottom"><italic>Anopheles</italic> salivary antigens not assessed</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib1">Abonuusum et al., 2011</xref>; <xref ref-type="bibr" rid="bib14">Badu et al., 2012a</xref>; <xref ref-type="bibr" rid="bib25">Chaccour et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Coulibaly et al., 2017</xref>; <xref ref-type="bibr" rid="bib37">Dhawan et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Fontaine et al., 2011c</xref>; <xref ref-type="bibr" rid="bib53">Fontaine et al., 2011b</xref>; <xref ref-type="bibr" rid="bib71">Jeon et al., 2001</xref>; <xref ref-type="bibr" rid="bib73">Kelly-Hope and McKenzie, 2009</xref>; <xref ref-type="bibr" rid="bib81">Kusi et al., 2014</xref>; <xref ref-type="bibr" rid="bib84">Li et al., 2005</xref>; <xref ref-type="bibr" rid="bib89">Londono-Renteria et al., 2015b</xref>; <xref ref-type="bibr" rid="bib106">Mwanziva et al., 2011</xref>; <xref ref-type="bibr" rid="bib149">Sarr et al., 2011</xref>; <xref ref-type="bibr" rid="bib151">Satoguina et al., 2009</xref>; <xref ref-type="bibr" rid="bib157">Smithuis et al., 2013</xref>; <xref ref-type="bibr" rid="bib170">Ubillos et al., 2018</xref>; <xref ref-type="bibr" rid="bib171">van den Hoogen et al., 2020</xref>; <xref ref-type="bibr" rid="bib172">Varela et al., 2020</xref>; <xref ref-type="bibr" rid="bib176">Wanjala and Kweka, 2016</xref></td></tr><tr><td align="char" char="." valign="bottom">10</td><td align="left" valign="bottom">Wrong antibody detection methodologies</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib13">Armiyanti et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Brummer-Korvenkontio et al., 1997</xref>; <xref ref-type="bibr" rid="bib30">Cornelie et al., 2007</xref>; <xref ref-type="bibr" rid="bib55">Fontaine et al., 2012</xref>; <xref ref-type="bibr" rid="bib97">Marie et al., 2014</xref>; <xref ref-type="bibr" rid="bib111">Owhashi et al., 2008</xref>; <xref ref-type="bibr" rid="bib118">Penneys et al., 1989</xref>; <xref ref-type="bibr" rid="bib162">Sor-suwan et al., 2014</xref>; <xref ref-type="bibr" rid="bib161">Sor-Suwan et al., 2013</xref>; <xref ref-type="bibr" rid="bib114">Peng et al., 1998</xref></td></tr><tr><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">Grey literature</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib31">Cornelie et al., 2008</xref>; <xref ref-type="bibr" rid="bib44">Drame et al., 2008</xref>; <xref ref-type="bibr" rid="bib47">Drame et al., 2010c</xref>; <xref ref-type="bibr" rid="bib124">Poinsignon et al., 2008b</xref>; <xref ref-type="bibr" rid="bib128">Poinsignon et al., 2013</xref>; <xref ref-type="bibr" rid="bib126">Poinsignon et al., 2010a</xref>; <xref ref-type="bibr" rid="bib145">Sagna et al., 2018</xref></td></tr><tr><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Not performed in humans</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib43">Dragovic et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">King et al., 2011</xref>; <xref ref-type="bibr" rid="bib173">Vogt et al., 2018</xref>; <xref ref-type="bibr" rid="bib175">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="bib4">Almeida and Billingsley, 1999</xref>; <xref ref-type="bibr" rid="bib19">Boulanger et al., 2011</xref></td></tr><tr><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Data already captured by our review from another publication</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib74">Kerkhof et al., 2015</xref>; <xref ref-type="bibr" rid="bib142">Sagna et al., 2013a</xref>; <xref ref-type="bibr" rid="bib180">Ya-Umphan et al., 2018</xref>; <xref ref-type="bibr" rid="bib2">Aka et al., 2020</xref></td></tr><tr><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Unable to determine appropriate exposure estimate</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib49">Drame et al., 2013a</xref>; <xref ref-type="bibr" rid="bib107">Noukpo et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Londono-Renteria et al., 2010</xref></td></tr><tr><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Not in population with natural exposure</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib96">Manning et al., 2020</xref>; <xref ref-type="bibr" rid="bib101">Mendes-Sousa et al., 2018</xref>; <xref ref-type="bibr" rid="bib115">Peng et al., 2004</xref></td></tr><tr><td align="char" char="." valign="bottom">1</td><td align="left" valign="bottom">Hypothesis study</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib90">Londono-Renteria et al., 2016</xref></td></tr><tr><td align="char" char="." valign="bottom">1</td><td align="left" valign="bottom">Pooled sera</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib110">Owhashi et al., 2001</xref></td></tr><tr><td align="char" char="." valign="bottom">1</td><td align="left" valign="bottom">Does not provide estimate of seroprevalence/total levels of antibodies against salivary proteins</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib12">Armiyanti et al., 2015</xref></td></tr><tr><td align="char" char="." valign="bottom">1</td><td align="left" valign="bottom">Study population not representative: mosquito-allergic patients</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib108">Opasawatchai et al., 2020</xref></td></tr><tr><td align="char" char="." valign="bottom">1</td><td align="left" valign="bottom">Study population not representative: soldiers with transient exposure</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib109">Orlandi-Pradines et al., 2007</xref></td></tr></tbody></table></table-wrap></sec></app><app id="appendix-4"><title>Appendix 4</title><sec id="s13" sec-type="appendix"><title>Association between gSG6 IgG seropositivity and HBR</title><table-wrap id="app4table1" position="float"><label>Appendix 4—table 1.</label><caption><title>Unadjusted association between gSG6 IgG seropositivity and log human biting rate (HBR).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Variable</th><th align="left" valign="bottom">log odds ratio (SE)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">p-Value</th><th align="left" valign="bottom">RE</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Fixed part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">log HBR*,<sup>†</sup></td><td align="char" char="." valign="bottom">0.29 (0.08)</td><td align="char" char="." valign="bottom">0.14–0.45</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>Random part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf13"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>‡</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1.29</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf14"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1.55</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf15"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.06</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf16"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>§</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.21</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf17"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>¶</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.47</td></tr><tr><td align="left" valign="bottom"><italic>ℓ</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">–1492.8</td></tr><tr><td align="left" valign="bottom"><italic>Model fit indices</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Akaike’s information criterion</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">2995.7</td></tr><tr><td align="left" valign="bottom">Bayesian information criterion</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">3010.1</td></tr></tbody></table><table-wrap-foot><fn><p>HBR association: log odds ratio and standard error (SE), 95% confidence interval (95% CI), p-value, random-effect components (RE): variances (ψ), conditional intraclass correlation coefficient ICC (ρ),* and model log likelihood (<italic>ℓ</italic>) from generalised linear multilevel modelling (mixed effects, logistic).<sup>†</sup> This analysis is based upon n = 132 study-specific observations from 12 studies. Of note, five studies that measured HBR and IgG antibodies to gSG6 were excluded from this analysis as they only reported gSG6 IgG levels.</p></fn><fn><p>*<italic>ρ</italic> = <inline-formula><mml:math id="inf18"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></inline-formula> , where <inline-formula><mml:math id="inf19"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> through <inline-formula><mml:math id="inf20"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are random-effect variance estimates pertaining to each of the respective variance components (see table notes <sup>‡–¶</sup>) from the generalised linear multilevel modelling (mixed effects, logistic) for a specific ICC estimate.</p></fn><fn><p>†Generalised linear multilevel modelling (mixed effects, logistic) estimating the association between log transformed HBR and anti-gSG6 IgG seropositivity with random effects for country-specific and study-specific heterogeneity in gSG6 IgG seroprevalence and study-specific heterogeneity in effect of HBR.</p></fn><fn><p>‡<inline-formula><mml:math id="inf21"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf22"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>, and <inline-formula><mml:math id="inf23"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represent variances of the random effects for country, study, and effect of HBR, respectively.</p></fn><fn><p>§<inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents conditional ICC for salivary antibody observations from the same country but different study.</p></fn><fn><p>¶<inline-formula><mml:math id="inf25"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents conditional ICC for salivary antibody observations from the same country and study with the median HBR.</p></fn></table-wrap-foot></table-wrap></sec></app><app id="appendix-5"><title>Appendix 5</title><sec id="s14" sec-type="appendix"><title>Association between gSG6 IgG seropositivity and HBR, moderated by dominant vector species</title><table-wrap id="app5table1" position="float"><label>Appendix 5—table 1.</label><caption><title>Association between gSG6 IgG seropositivity and log human biting rate (HBR), moderated by dominant vector species.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Variable</th><th align="left" valign="bottom">log odds ratio (SE)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">p-Value</th><th align="left" valign="bottom">RE</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Fixed part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">log HBR</td><td align="char" char="." valign="bottom">0.46 (0.11)</td><td align="char" char="." valign="bottom">0.25–0.66</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">DVS</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">&lt;0.001**</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <italic>An. gambiae</italic> s.l<italic>.</italic> only</td><td align="left" valign="bottom">Ref.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <italic>An. gambiae</italic> s.l<italic>.</italic> and other DVS</td><td align="char" char="." valign="bottom">1.00 (0.18)</td><td align="char" char="." valign="bottom">0.65–1.25</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Non-<italic>An. gambiae</italic> s.l<italic>.</italic></td><td align="char" char="." valign="bottom">1.09 (0.68)</td><td align="char" char="." valign="bottom">–0.24 to 2.42</td><td align="char" char="." valign="bottom">0.109</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">log HBR by DVS</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">&lt;0.001**</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <italic>An. gambiae</italic> s.l<italic>.</italic> only</td><td align="left" valign="bottom">Ref.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <italic>An. gambiae</italic> s.l<italic>.</italic> and other DVS</td><td align="char" char="." valign="bottom">–0.26 (0.08)</td><td align="char" char="." valign="bottom">−0.41 to –0.11</td><td align="char" char="." valign="bottom">0.001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Non-<italic>An. gambiae</italic> s.l<italic>.</italic></td><td align="char" char="." valign="bottom">–0.38 (0.11)</td><td align="char" char="." valign="bottom">−0.59 to –0.17</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>Random part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf26"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>‡</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.96</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf27"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">2.32</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf28"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.08</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf29"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>§</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.14</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf30"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>¶</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.51</td></tr><tr><td align="left" valign="bottom"><italic>ℓ</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">–1488.8</td></tr><tr><td align="left" valign="bottom"><italic>Model fit indices</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Akaike’s information criterion</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">2995.5</td></tr><tr><td align="left" valign="bottom">Bayesian information criterion</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">3021.5</td></tr></tbody></table><table-wrap-foot><fn><p>HBR × dominant vector species (DVS) association: log odds ratio and standard error (SE), 95% confidence interval (95% CI), p-value, random-effect components (RE): variances (ψ), conditional intraclass correlation coefficient (ICC) (ρ),* and model log likelihood (<italic>ℓ</italic>) from generalised linear multilevel modelling (mixed effects, logistic).<sup>†</sup> This analysis is based upon n = 132 study-specific observations from 12 studies. Of note, five studies that measured HBR and IgG antibodies to gSG6 were excluded from this analysis as they only reported gSG6 IgG levels.</p></fn><fn><p><sup>*</sup> <italic>ρ</italic> = <inline-formula><mml:math id="inf31"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></inline-formula> , where <inline-formula><mml:math id="inf32"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> through <inline-formula><mml:math id="inf33"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are random-effect variance estimates pertaining to each of the respective variance components (see table notes <sup>‡–¶</sup>) from the generalised linear multilevel modelling (mixed effects, logistic) for a specific ICC estimate.</p></fn><fn><p><sup>†</sup> Generalised linear multilevel modelling (mixed effects, logistic) estimating the association between log transformed HBR and anti-gSG6 IgG seropositivity including an interaction term between DVS and log HBR with random effects for country-specific and study-specific heterogeneity in gSG6 IgG seroprevalence and study-specific heterogeneity in effect of HBR.</p></fn><fn><p><sup>‡</sup> <inline-formula><mml:math id="inf34"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf35"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>, and <inline-formula><mml:math id="inf36"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represent variances of the random effects for country, study, and effect of HBR, respectively.</p></fn><fn><p><sup>§</sup> <inline-formula><mml:math id="inf37"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents the conditional ICC for salivary antibody observations from the same country but different study.</p></fn><fn><p><sup>¶</sup> <inline-formula><mml:math id="inf38"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents the conditional ICC for salivary antibody observations from the same country and study with the median HBR.</p></fn><fn><p>**indicates p-value from joint Wald test for polytomous variables.</p></fn></table-wrap-foot></table-wrap></sec></app><app id="appendix-6"><title>Appendix 6</title><sec id="s15" sec-type="appendix"><title>Association between gSG6 IgG seropositivity and EIR</title><table-wrap id="app6table1" position="float"><label>Appendix 6—table 1.</label><caption><title>Unadjusted association between gSG6 IgG seropositivity log entomological inoculation rate (EIR).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Variable</th><th align="left" valign="bottom">log odds ratio (SE)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">p-Value</th><th align="left" valign="bottom">RE</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Fixed part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">log EIR</td><td align="char" char="." valign="bottom">0.15 (0.04)</td><td align="char" char="." valign="bottom">0.07–0.23</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>Random part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf39"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>‡</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1.02</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf40"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">2.15</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf41"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.01</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf42"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>§</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.16</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf43"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>¶</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.49</td></tr><tr><td align="left" valign="bottom"><italic>ℓ</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">–530.7</td></tr><tr><td align="left" valign="bottom"><italic>Model fit indices</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Akaike’s information criterion</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1071.3</td></tr><tr><td align="left" valign="bottom">Bayesian information criterion</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1079.5</td></tr></tbody></table><table-wrap-foot><fn><p>Entomological inoculation rate (EIR) association: log odds ratio and standard error (SE), 95% confidence interval (95% CI), p-value, random-effect components (RE): variances (ψ), conditional intraclass correlation coefficient (ICC) (ρ)* and model log likelihood (<italic>ℓ</italic>) from generalised linear multilevel modelling (mixed effects, logistic).<sup>†</sup> This analysis is based upon n = 38 study-specific observations from eight studies.</p></fn><fn><p><sup>*</sup> <italic>ρ</italic> = <inline-formula><mml:math id="inf44"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></inline-formula> , where <inline-formula><mml:math id="inf45"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> through <inline-formula><mml:math id="inf46"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are random-effect variance estimates pertaining to each of the respective variance components (see table notes <sup>‡–¶</sup>) from the generalised linear multilevel (mixed effects, logistic) modelling for a specific ICC estimate.</p></fn><fn><p><sup>†</sup> Generalised linear multilevel modelling (mixed effects, logistic) estimating the association between log transformed EIR and anti-gSG6 IgG seropositivity with random effects for country-specific and study-specific heterogeneity in gSG6 IgG seroprevalence and study-specific heterogeneity in effect of EIR.</p></fn><fn><p><sup>‡</sup> <inline-formula><mml:math id="inf47"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf48"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>, and <inline-formula><mml:math id="inf49"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represent variances of the random effects for country, study, and effect of EIR, respectively.</p></fn><fn><p><sup>§</sup> <inline-formula><mml:math id="inf50"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents the conditional ICC for salivary antibody observations from the same country but different study.</p></fn><fn><p><sup>¶</sup> <inline-formula><mml:math id="inf51"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents the conditional ICC for salivary antibody observations from the same country and study with the median EIR</p></fn></table-wrap-foot></table-wrap></sec></app><app id="appendix-7"><title>Appendix 7</title><sec id="s16" sec-type="appendix"><title>Association between gSG6 IgG seropositivity and malaria prevalence</title><table-wrap id="app7table1" position="float"><label>Appendix 7—table 1.</label><caption><title>Unadjusted association between gSG6 IgG seropositivity and log <italic>Plasmodium</italic> spp prevalence.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Variable</th><th align="left" valign="bottom">log odds ratio (SE)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">p-Value</th><th align="left" valign="bottom">RE</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Fixed part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">log <italic>Plasmodium</italic> spp. prevalence</td><td align="char" char="." valign="bottom">0.46 (0.32)</td><td align="char" char="." valign="bottom">–0.16–1.08</td><td align="char" char="." valign="bottom">0.148</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>Random part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf52"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>‡</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">17.21</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf53"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">1.25</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf54"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>§</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.85</td></tr><tr><td align="left" valign="bottom"><italic>ℓ</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">–2597.2</td></tr><tr><td align="left" valign="bottom"><italic>Model fit indices</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Akaike’s information criterion</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">5202.5</td></tr><tr><td align="left" valign="bottom">Bayesian information criterion</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">5215.9</td></tr></tbody></table><table-wrap-foot><fn><p>Any <italic>Plasmodium</italic> species infections (including prevalence estimates of <italic>P. falciparum</italic> only<italic>, P. vivax</italic> only<italic>,</italic> both <italic>P. falciparum</italic> and <italic>P. vivax</italic> and untyped infections): log odds ratio and standard error (SE), 95% confidence interval (95% CI), p-value, random-effect components (RE): variances (ψ), conditional intraclass correlation coefficient (ICC) (ρ),* and model log likelihood (<italic>ℓ</italic>) from generalised linear multilevel modelling (mixed effects, logistic).<sup>†</sup> This analysis is based upon n = 212 study-specific observations from 14 studies. Of note, six studies that measured <italic>Plasmodium</italic> spp. prevalence and IgG antibodies to gSG6 were excluded from this analysis as five only reported gSG6 IgG levels and one was a case–control study.</p></fn><fn><p><sup>*</sup> <italic>ρ</italic> = <inline-formula><mml:math id="inf55"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></inline-formula> , where <inline-formula><mml:math id="inf56"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> through <inline-formula><mml:math id="inf57"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are random-effect variance estimates pertaining to each of the respective variance components (see table notes <sup>‡ and §</sup>) from the generalised linear multilevel modelling (mixed effects, logistic) for a specific ICC estimate.</p></fn><fn><p><sup>†</sup> Generalised linear multilevel modelling (mixed effects, logistic) estimating the association between the log prevalence of any <italic>Plasmodium</italic> spp. infection and anti-gSG6 IgG seropositivity with random effects for study-specific heterogeneity in gSG6 IgG seroprevalence and study-specific heterogeneity in effect of <italic>Plasmodium</italic> spp. prevalence.</p></fn><fn><p><sup>‡</sup> <inline-formula><mml:math id="inf58"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf59"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represent variances of the random effects for study and effect of <italic>Plasmodium</italic> spp. prevalence, respectively.</p></fn><fn><p><sup>§</sup> <inline-formula><mml:math id="inf60"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents the conditional ICC for salivary antibody observations from the same study and with the median <italic>Plasmodium</italic> spp. prevalence.</p></fn></table-wrap-foot></table-wrap></sec></app><app id="appendix-8"><title>Appendix 8</title><sec id="s17" sec-type="appendix"><title>Association between gSG6 IgG seropositivity and antimalarial antibody seroprevalence</title><sec id="s17-1" sec-type="appendix"><title>Antibodies against <italic>P. falciparum</italic> pre-erythrocytic stage antigens</title><p>The pooled analysis of 159 study-specific observations from eight studies showed that a twofold increase in PfCSP IgG seropositivity was associated with a 2.19-fold (OR: 2.19; 95% CI: 1.18–4.04; p=0.013) increase in odds of anti-gSG6 IgG seropositivity (<xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib130">Proietti et al., 2013</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>). Furthermore, we observed that gSG6 IgG levels increased with increasing PfCSP IgG seroprevalence in four studies (<xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>), with another study contributing only a single estimate (<xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>).</p></sec><sec id="s17-2" sec-type="appendix"><title>Antibodies against <italic>P. falciparum</italic> blood stage antigens</title><p>Furthermore, we observed a twofold increase PfAMA1 IgG seroprevalence was associated with a 2.47-fold (OR: 2.47; 95% CI: 2.25–2.71; p&lt;0.001) increase in odds of gSG6 IgG seropositivity based upon 62 study-specific observations from eight studies (<xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib182">Yman et al., 2016</xref>; <xref ref-type="bibr" rid="bib130">Proietti et al., 2013</xref>; <xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>). A similar association was observed for PfMSP1<sub>19</sub> IgG, with twofold increase in seroprevalence associated with 2.49-fold (OR: 2.49; 95% CI: 1.21–5.12; p=0.014) increase in odds of gSG6 IgG seropositivity. This association was derived from 163 study-specific observations from 10 studies (<xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib130">Proietti et al., 2013</xref>; <xref ref-type="bibr" rid="bib182">Yman et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Badu et al., 2015</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>; <xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>). Analysis of 47 study-specific observations from three studies indicated that a twofold increase in PfMSP2 IgG seroprevalence was associated with a 41% (OR: 1.41; 95% CI: 1.21–1.65; p&lt;0.001) increase in odds of gSG6 IgG seropositivity (<xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib182">Yman et al., 2016</xref>). While 17 study-specific observations from two studies showed a twofold increase in PfMSP3 IgG seroprevalence was associated with a 2.66-fold (OR: 2.66; 95% CI: 2.36–3.00; p&lt;0.001) increase in odds of gSG6 IgG seropositivity (<xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib182">Yman et al., 2016</xref>).</p><p>The pooled analysis of 128 study-specific observations from five studies showed that a twofold increase in PfGLURP IgG seroprevalence was associated with a 3.05-fold (OR: 3.05; 95% CI: 2.58–3.61; p&lt;0.001) increase in odds of gSG6 IgG seropositivity (<xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>). And 18 study-specific observations from five studies indicated that a twofold increase in <italic>P. falciparum</italic> schizont extract IgG seropositivity was associated with a 5.69-fold (OR: 5.69; 95% CI: 0.03–1188.69; p=0.523) increase in odds of gSG6 IgG seropositivity (<xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib150">Sarr et al., 2012</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>).</p><p>We observed that increasing seroprevalence of IgG antibodies against PfAMA1 saw increased levels of anti-gSG6 IgG in three studies (<xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>), but no association in another (<xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>). The levels of gSG6 IgG increased with increasing PfMSP1<sub>19</sub> IgG seroprevalence in three studies (<xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib16">Badu et al., 2015</xref>), but showed no association in three other studies (<xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>). No association between gSG6 IgG levels and MSP2 IgG seroprevalence was observed in one study (<xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>). PfGLURP IgG seroprevalence and gSG6 IgG antibody levels were reported in three studies, with one study reporting increased levels (<xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>), one study reporting no association (<xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>), and one study reporting decreased levels of anti-gSG6 IgG with increasing anti-PfGLURP seroprevalence (<xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>). One study showed increasing gSG6 IgG levels with increasing <italic>P. falciparum</italic> schizont extract IgG, while three other studies showed no association (<xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib150">Sarr et al., 2012</xref>). Of note, one study provided a single seroprevalence estimate of antibodies against PfAMA1, PfMSP1<sub>19</sub>, and PfMSP3 so no relationships can be drawn (<xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>).</p></sec><sec id="s17-3" sec-type="appendix"><title>Antibodies against <italic>P. vivax</italic> antigens</title><p>In pooled analyses of 115 study-specific observations from two studies (<xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>), we observed that a twofold increase in the seroprevalence of PvAMA1 was associated with a 3.87-fold (OR: 3.87; 95% CI: 3.46–4.32; p&lt;0.001) increase in the odds of anti-gSG6 IgG seropositivity. Furthermore, in 103 study-specific observations from two studies (<xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>), a twofold increase in PvMSP1<sub>19</sub> IgG seroprevalence was associated with a 2.37-fold (OR: 2.37; 95% CI: 2.26–2.50; p&lt;0.001) increase in the odds of anti-gSG6 IgG seropositivity. However, neither study showed an association between the levels of gSG6 IgG and the seroprevalence of PvAMA1 and PvMSP1<sub>19</sub> IgG (<xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>).</p><table-wrap id="app8table1" position="float"><label>Appendix 8—table 1.</label><caption><title>Associations between anti-gSG6 IgG seropositivity and log of antimalarial antibody seroprevalence.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Exposure</th><th align="left" valign="bottom">log odds ratio (SE)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">p-Value</th><th align="left" valign="bottom">Study-specific n</th><th align="left" valign="bottom">Studies</th><th align="left" valign="bottom">References</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Pre-erythrocytic antigens</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">log PfCSP IgG seroprevalence (%)</td><td align="char" char="." valign="bottom">1.13 (0.45)</td><td align="char" char="." valign="bottom">0.24–2.01</td><td align="char" char="." valign="bottom">0.013</td><td align="char" char="." valign="bottom">159</td><td align="char" char="." valign="bottom">8</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib130">Proietti et al., 2013</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref></td></tr><tr><td align="left" valign="bottom"><italic>Blood stage antigens</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">log PfAMA1 IgG seroprevalence (%)<sup>*</sup></td><td align="char" char="." valign="bottom">1.30 (0.07)</td><td align="char" char="." valign="bottom">1.17–1.44</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">62</td><td align="char" char="." valign="bottom">8</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib182">Yman et al., 2016</xref>; <xref ref-type="bibr" rid="bib130">Proietti et al., 2013</xref></td></tr><tr><td align="left" valign="bottom">log PfMSP1<sub>19</sub> IgG seroprevalence (%)</td><td align="char" char="." valign="bottom">1.31 (0.53)</td><td align="char" char="." valign="bottom">0.27–2.36</td><td align="char" char="." valign="bottom">0.014</td><td align="char" char="." valign="bottom">163</td><td align="char" char="." valign="bottom">10</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Badu et al., 2015</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib130">Proietti et al., 2013</xref>; <xref ref-type="bibr" rid="bib182">Yman et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref></td></tr><tr><td align="left" valign="bottom">log PfMSP2 IgG seroprevalence (%)</td><td align="char" char="." valign="bottom">0.50 (0.11)</td><td align="char" char="." valign="bottom">0.27–0.72</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">47</td><td align="char" char="." valign="bottom">3</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib179">Ya-Umphan et al., 2017</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib182">Yman et al., 2016</xref></td></tr><tr><td align="left" valign="bottom">log PfMSP3 IgG seroprevalence (%)<sup>*</sup></td><td align="char" char="." valign="bottom">1.41 (0.09)</td><td align="char" char="." valign="bottom">1.24–1.58</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">17</td><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib163">Stone et al., 2012</xref>; <xref ref-type="bibr" rid="bib182">Yman et al., 2016</xref></td></tr><tr><td align="left" valign="bottom">log PfGLURP IgG seroprevalence (%)</td><td align="char" char="." valign="bottom">1.61 (0.12)</td><td align="char" char="." valign="bottom">1.37–1.85</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">128</td><td align="char" char="." valign="bottom">5</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref></td></tr><tr><td align="left" valign="bottom">log PfSchizont extract IgG seroprevalence (%)</td><td align="char" char="." valign="bottom">2.51 (3.93)</td><td align="char" char="." valign="bottom">–5.20 to 10.22</td><td align="char" char="." valign="bottom">0.523</td><td align="char" char="." valign="bottom">18</td><td align="char" char="." valign="bottom">5</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Koffi et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Koffi et al., 2017</xref>; <xref ref-type="bibr" rid="bib150">Sarr et al., 2012</xref>; <xref ref-type="bibr" rid="bib119">Perraut et al., 2017</xref></td></tr><tr><td align="left" valign="bottom">log PvAMA1 IgG seroprevalence (%)</td><td align="char" char="." valign="bottom">1.95 (0.08)</td><td align="char" char="." valign="bottom">1.79–2.11</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">115</td><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref></td></tr><tr><td align="left" valign="bottom">log PvMSP1<sub>19</sub> IgG seroprevalence (%)</td><td align="char" char="." valign="bottom">1.25 (0.04)</td><td align="char" char="." valign="bottom">1.17–1.32</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">103</td><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib66">Idris et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Effects for each exposure represent separate generalised linear multilevel modelling (mixed effects, logistic) analyses estimating the association between the log of the seroprevalence of antimalarial antibodies and the seroprevalence of anti-gSG6 IgG, with the inclusion of a random intercept for study-specific heterogeneity and a random coefficient to allow the effect of the antimalarial antigen to vary across studies. Table shows log odds ratio and standard error (SE), 95% confidence interval (95% CI), and p-value, number of study-specific salivary antibody observations (Study-specific n) and studies, with associated references. Random effects not shown. Of note, one study that measured antimalarial antibody seroprevalence and IgG antibodies to gSG6 could not be included in analyses as it only reported gSG6 IgG levels.</p></fn><fn><p><sup>*</sup> Studies did not include a random coefficient (i.e<italic>.</italic> slope); as empirical support was not shown.</p></fn></table-wrap-foot></table-wrap></sec></sec></app><app id="appendix-9"><title>Appendix 9</title><sec id="s18" sec-type="appendix"><title>Country and study-specific predicted probability of gSG6 IgG seropositivity</title><p>In order to obtain estimates of gSG6 IgG seroprevalence for each country and study, an intercept-only three-level random-effects logistic regression was fitted to 301 study-specific observations from 22 studies. The predicted probability of gSG6 IgG seropositivity was calculated at the country level (<xref ref-type="fig" rid="app9fig1">Appendix 9—figure 1</xref>), indicating that the seroprevalence was lowest in the Pacific region (Vanuatu [31%] and Solomon Islands [32%]) and highest in Benin (72%) and Burkina Faso (65%). Furthermore, the predicted probability of gSG6 IgG seropositivity was calculated at the study level (<xref ref-type="fig" rid="app9fig2">Appendix 9—figure 2</xref>), indicating that the seroprevalence was lowest in <xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref> (13%) and highest in <xref ref-type="bibr" rid="bib51">Drame et al., 2015</xref> (91%).</p><fig id="app9fig1" position="float"><label>Appendix 9—figure 1.</label><caption><title>Predicted gSG6 IgG seroprevalence by country.</title><p>Predicted probabilities of gSG6 IgG seropositivity including country-specific random effects with 95% confidence intervals. Estimated from intercept-only three-level random-effects logistic regression to account for the hierarchical nature of the data, with study-specific anti-gSG6 IgG observation nested within study nested within country. Based upon n = 301 study-specific observations from 22 studies. Of note, nine studies that measured IgG antibodies to gSG6 were excluded from this analysis as eight only reported gSG6 IgG levels and one was a case–control study.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-app9-fig1-v2.tif"/></fig><fig id="app9fig2" position="float"><label>Appendix 9—figure 2.</label><caption><title>Predicted gSG6 IgG seroprevalence by study.</title><p>Predicted probabilities of gSG6 IgG seropositivity including study-specific random effects with 95% confidence intervals. Estimated from intercept-only three-level random-effects logistic regression to account for the hierarchical nature of the data, with study-specific anti-gSG6 IgG observation nested within study nested within country. Based upon n = 301 study-specific observations from 22 studies. Of note, nine studies that measured IgG antibodies to gSG6 were excluded from this analysis as eight only reported gSG6 IgG levels and one was a case–control study.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-73080-app9-fig2-v2.tif"/></fig></sec></app><app id="appendix-10"><title>Appendix 10</title><sec id="s19" sec-type="appendix"><title>Association between alternative salivary biomarkers and exposures of interest</title><p>Our systematic review identified a paucity of studies that assessed the relationship between our exposures of interest and most alternate <italic>Anopheles</italic> salivary biomarkers (i.e. non-<italic>An. gambiae</italic> gSG6 IgG), thus preventing the estimation of a pooled association. The exceptions being that we observed that a twofold increase in HBR was associated with a 12% increase (OR: 1.12; 95% CI: 1.02–1.24; p=0.017) in odds of anti-<italic>An. funestus</italic> fSG6 IgG seropositivity (six study-specific observations from two studies; <xref ref-type="bibr" rid="bib135">Rizzo et al., 2011a</xref>; <xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref>; <xref ref-type="table" rid="app10table1">Appendix 10—table 1</xref>), as well as a 12.97-fold (OR: 12.97; 95% CI: 10.95–15.36; p&lt;0.001) and 4.04-fold (OR: 4.04; 95% CI: 3.60–4.54; p&lt;0.001) increase in odds of anti-gSG6-P2 IgG seropositivity associated with a twofold increase in seroprevalence of PfCSP and PfGLURP IgG, respectively (115 and 116 study-specific observations from two studies, respectively; <xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>, <xref ref-type="table" rid="app10table2 app10table3">Appendix 10—tables 2 and 3</xref>). The associations between exposures of interest and the additional salivary biomarkers are further discussed in narrative terms in below.</p><table-wrap id="app10table1" position="float"><label>Appendix 10—table 1.</label><caption><title>Association between fSG6 IgG seropositivity and human biting rate (HBR).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Variable</th><th align="left" valign="bottom">log odds ratio (SE)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">p-Value</th><th align="left" valign="bottom">RE</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Fixed part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">log HBR</td><td align="char" char="." valign="bottom">0.17 (0.07)</td><td align="char" char="." valign="bottom">0.03–0.31</td><td align="char" char="." valign="bottom">0.017</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>Random part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf61"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>‡</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">0.47</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf62"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>§</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">0.13</td></tr></tbody></table><table-wrap-foot><fn><p>Association between HBR and fSG6 IgG: log odds ratio and standard error (SE), 95% confidence interval (95% CI), p-value, random-effect components (RE): variances (ψ), conditional intraclass correlation coefficient (ICC) (ψ)* and model log likelihood (<italic>ℓ</italic>) from generalised linear multilevel modelling (mixed effects, logistic).<sup>†</sup> This analysis is based upon n = 6 study-specific observations.</p></fn><fn><p><sup>*</sup> <italic>ρ</italic> = <inline-formula><mml:math id="inf63"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></inline-formula> , where <inline-formula><mml:math id="inf64"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> through <inline-formula><mml:math id="inf65"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are random-effect variance estimates pertaining to each of the respective variance components (see table notes <sup>‡ and §</sup>) from generalised linear multilevel model (mixed-effects, logistic) for a specific ICC estimate.</p></fn><fn><p><sup>†</sup> Generalised linear multilevel modelling (mixed effects, logistic) estimating the association between anti-<italic>An. funestus</italic> fSG6 IgG seropositivity and log transformed HBR with random effects for study-specific heterogeneity in fSG6 IgG seropositivity.</p></fn><fn><p><sup>‡</sup> <inline-formula><mml:math id="inf66"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents variance of the random effect for study.</p></fn><fn><p><sup>§</sup> <inline-formula><mml:math id="inf67"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents conditional ICC for salivary antibody observations from the same study.</p></fn></table-wrap-foot></table-wrap><sec id="s19-1" sec-type="appendix"><title>Human biting rate</title><p>In addition to the increased odds of <italic>An. funestus</italic> fSG6 seropositivity with increasing HBR, the majority of studies reported a positive association between HBR and the seroprevalence and levels of anti-gSG6-P1 IgM (<xref ref-type="bibr" rid="bib51">Drame et al., 2015</xref>), the levels of gSG6-P2 IgG (<xref ref-type="bibr" rid="bib123">Poinsignon et al., 2008a</xref>), the seroprevalence and levels of anti-cE5 IgG (<xref ref-type="bibr" rid="bib137">Rizzo et al., 2014a</xref>), the levels of anti-fSG6 IgG (<xref ref-type="bibr" rid="bib135">Rizzo et al., 2011a</xref>; <xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref>), the seroprevalence and levels of anti-f5’nuc IgG (<xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref>), and the median levels of anti-<italic>An. gambiae</italic> SGE IgG and IgG4 (<xref ref-type="bibr" rid="bib46">Drame et al., 2010b</xref>; <xref ref-type="bibr" rid="bib82">Lawaly et al., 2012</xref>; <xref ref-type="bibr" rid="bib133">Remoue et al., 2006</xref>). One study reported similar median levels of anti-gSG6 IgG1 across populations and time points, whilst reporting that anti-gSG6 IgG4 titre increased with increasing HBR in one of the populations, but not in the other (<xref ref-type="bibr" rid="bib138">Rizzo et al., 2014b</xref>). Similarly, there was no consistent association between HBR and the levels of anti-cE5 IgG (<xref ref-type="bibr" rid="bib98">Marie et al., 2015</xref>), levels of anti-<italic>An. gambiae</italic> SGE IgE (<xref ref-type="bibr" rid="bib82">Lawaly et al., 2012</xref>) and the seroprevalence and levels of anti-g5’nuc IgG (<xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref>).</p></sec><sec id="s19-2" sec-type="appendix"><title>Entomological inoculation rate</title><p><xref ref-type="bibr" rid="bib3">Ali et al., 2012</xref> reported higher seroprevalence and levels anti-fSG6 IgG and anti-f5’nuc IgG with increasing EIR, while anti-g5’nuc IgG seroprevalence and levels were not associated with EIR. An additional study reported gSG6-P2 IgG seroprevalence estimates of 0% for three sites, irrespective of EIR (<xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref>).</p></sec><sec id="s19-3" sec-type="appendix"><title>Malaria prevalence</title><p>Two studies showed that increased <italic>Plasmodium</italic> spp. prevalence was associated with higher median levels of anti-<italic>An. gambiae</italic> SGE IgG (<xref ref-type="bibr" rid="bib46">Drame et al., 2010b</xref>; <xref ref-type="bibr" rid="bib20">Brosseau et al., 2012</xref>), while another study showed different anti-<italic>An. gambiae</italic> SGE IgG levels for very similar prevalence of malaria and slightly lower levels of anti-<italic>An. gambiae</italic> SGE IgE and IgG4 for the time point with greater malaria prevalence (<xref ref-type="bibr" rid="bib82">Lawaly et al., 2012</xref>). <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref> showed increasing levels of anti-gSG6-P2 IgG for higher prevalence of any <italic>Plasmodium</italic> spp. infection, while <xref ref-type="bibr" rid="bib91">Londono-Renteria et al., 2020a</xref> showed lower levels of IgG antibodies against TRANS-P1, TRANS-P2, PEROX-P1, PEROX-P2, and PEROX-P3 in the site with higher PCR-confirmed malaria prevalence. Additionally, several case-controlled studies, and two cross-sectional study, reported median antibody levels stratified by malaria infection status. These studies show higher levels of anti-<italic>An. darlingi</italic> SGE IgG (<xref ref-type="bibr" rid="bib8">Andrade et al., 2009</xref>), anti-<italic>An. gambiae</italic> SGE IgG (<xref ref-type="bibr" rid="bib133">Remoue et al., 2006</xref>), anti-<italic>An. dirus</italic> SGE IgG and IgM (<xref ref-type="bibr" rid="bib174">Waitayakul et al., 2006</xref>), and IgG antibodies against SGEs of two Colombian strains of <italic>An. albimanus</italic> in <italic>Plasmodium</italic> spp.-infected individuals compared to non-infected (<xref ref-type="bibr" rid="bib105">Montiel et al., 2020</xref>). While <xref ref-type="bibr" rid="bib105">Montiel et al., 2020</xref> observed no association between anti-<italic>An. darlingi</italic> SGE IgG levels and infection status.</p></sec><sec id="s19-4" sec-type="appendix"><title>Antimalarial antibody seroprevalence</title><p>Our multilevel modelling indicated that there were 12.97-fold (OR: 12.97; 95% CI: 10.95–15.36; p&lt;0.001) and 4.04-fold (OR: 4.04; 95% CI: 3.60–4.54; p&lt;0.001) increase in odds of anti-gSG6-P2 IgG seropositivity associated with a twofold increase in the seroprevalence of PfCSP and PfGLURP IgG, respectively (<xref ref-type="bibr" rid="bib6">Ambrosino et al., 2010</xref>; <xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>; <xref ref-type="table" rid="app10table2">Appendix 10—table 2</xref> and <xref ref-type="table" rid="app10table3">Appendix 10—table 3</xref>). However, we observed weak positive associations between the levels of IgG antibodies against gSG6-P2 peptide and the seroprevalence of IgG antibodies against PfMSP1<sub>19</sub>, PfGLURP and PvMSP1<sub>19</sub>, but no association with PfCSP or PvAMA1 (<xref ref-type="bibr" rid="bib75">Kerkhof et al., 2016</xref>).</p><table-wrap id="app10table2" position="float"><label>Appendix 10—table 2.</label><caption><title>Association between gSG6-P2 IgG seropositivity and log PfCSP IgG seroprevalence.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Variable</th><th align="left" valign="bottom">log odds ratio (SE)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">p-Value</th><th align="left" valign="bottom">RE</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Fixed part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">log PfCSP IgG seroprevalence</td><td align="char" char="." valign="bottom">3.70 (0.12)</td><td align="char" char="." valign="bottom">3.45–3.94</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>Random part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf68"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>‡</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">25.2</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf69"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>§</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.88</td></tr></tbody></table><table-wrap-foot><fn><p>Association between log PfCSP seroprevalence and gSG6-P2 IgG: log odds ratio and standard error (SE), 95% confidence interval (95% CI), p-value, random-effect variances (ψ), conditional intraclass correlation coefficient (ICC) (ρ)* and model log likelihood (<italic>ℓ</italic>) from logistic mixed-effects modelling.<sup>†</sup> This analysis is based upon n = 115 study-specific observations.</p></fn><fn><p><sup>*</sup> <italic>ρ</italic> = <inline-formula><mml:math id="inf70"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></inline-formula> , where <inline-formula><mml:math id="inf71"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> through <inline-formula><mml:math id="inf72"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are random-effect (RE) variance estimates pertaining to each of the respective variance components (see table notes <sup>‡ and §</sup>) from generalised linear multilevel model (mixed effects, logistic) for a specific ICC estimate.</p></fn><fn><p><sup>†</sup> Generalised linear multilevel modelling (mixed effects, logistic) estimating the association between log PfCSP seroprevalence and anti-gSG6-P2 IgG seropositivity with random effects for study-specific heterogeneity in gSG6-P2 IgG seropositivity.</p></fn><fn><p><sup>‡</sup> <inline-formula><mml:math id="inf73"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents variance of the random effect for study.</p></fn><fn><p><sup>§</sup> <inline-formula><mml:math id="inf74"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> represents conditional ICC for salivary antibody observations from the same study.</p></fn></table-wrap-foot></table-wrap><table-wrap id="app10table3" position="float"><label>Appendix 10—table 3.</label><caption><title>Association between gSG6-P2 IgG seropositivity and log PfGLURP IgG seroprevalence.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Variable</th><th align="left" valign="bottom">log odds ratio (SE)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">p-Value</th><th align="left" valign="bottom">RE</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>Fixed part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">log PfGLURP IgG seroprevalence</td><td align="char" char="." valign="bottom">2.01 (0.09)</td><td align="char" char="." valign="bottom">1.85–2.18</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>Random part</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf75"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>‡</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">24.3</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf76"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><sup>§</sup></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.88</td></tr></tbody></table><table-wrap-foot><fn><p>Association between log PfGLURP seroprevalence and gSG6-P2 IgG: log odds ratio and standard error (SE), 95% confidence interval (95% CI), p-value, random-effect variances (ψ), conditional intraclass correlation coefficient (ICC) (ρ)* and model log likelihood (ℓ) from logistic mixed-effects modelling.<sup>†</sup> This analysis is based upon n = 116 study-specific observations.</p></fn><fn><p>*<italic>ρ</italic> = , where ψ<sub><italic>k</italic></sub> through ψ<sub><italic>nk</italic></sub> are random-effect (RE) variance estimates pertaining to each of the respective variance components (see table notes <sup>‡ and §</sup>) from generalised linear multilevel model (mixed effects, logistic) for a specific ICC estimate.</p></fn><fn><p><sup>†</sup>Generalised linear multilevel modelling (mixed effects, logistic) estimating the association between log PfGLURP seroprevalence and anti-gSG6-P2 IgG seropositivity with random effects for study-specific heterogeneity in gSG6-P2 IgG seropositivity.</p></fn><fn><p><sup>‡</sup>ψ<sub>1</sub> represents variance of the random effect for study.</p></fn><fn><p><sup>§</sup>ρ<sub>1</sub> represents conditional ICC for salivary antibody observations from the same study.</p></fn></table-wrap-foot></table-wrap></sec></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73080.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wesolowski</surname><given-names>Amy</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Johns Hopkins Bloomberg School of Public Health</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>We believe this systematic review on the use of serological data to monitor anopheline mosquito exposure will add to the existing literature and help provide important insight into how these markers may be used to understand malaria transmission.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73080.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Wesolowski</surname><given-names>Amy</given-names></name><role>Reviewing Editor</role><aff><institution>Johns Hopkins Bloomberg School of Public Health</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Bejon</surname><given-names>Philip</given-names></name><role>Reviewer</role><aff><institution>Kilifi KEMRI-Wellcome Trust Collaborative Research Programme</institution><country>Kenya</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;<italic>Anopheles</italic> salivary antigens as serological biomarkers of vector exposure and malaria transmission: A systematic review with multilevel modelling&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and David Serwadda as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Philip Bejon (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. The paper would be strengthened if it focused on Africa, with sub-group analyses between Africa and Asia, given the differences in vector behavior in both settings.</p><p>2. The overall conclusions often use phrasing such as 'strong' evidence/association, however in many instances this level of support is overly optimistic, given the noise in these types of data and issues with a number of the malaria metrics. Further, for some of the statistical analyses require additional justification and more robust model evaluation.</p><p>3. There are a number of points raised in both reviewers where the results should be clarified (ex. text and display of Figure 2; relationship between HBR and seroprevalence as a metric; etc.). In addition, the sources of data for each point of evidence – is it MAP estimates? Microscopy? Which type of study design? Should be clarified to help provide the reader with a better understanding of the pieces of information (and level of bias, etc.) are providing which types of evidence.</p><p><italic>Reviewer #1:</italic></p><p>This is an interesting paper highlighting the use of serological data for monitoring anopheline mosquito bites. The concept is good, rationale clear and the statistical modelling appears robust. Some of the stats could be better explained at times and the conclusions should be tapered somewhat as there is lots of &quot;strong&quot; evidence/association statements that seem overly optimistic given the noise in these types of data and the frailties of the malaria metrics. This meta-analyses will help crystalise thought on whether the technique should be further invested in.</p><p>(1) The study groups together cross-sectional and cohort data yet this was never really explored. How strong was the association in the cohort data and did it give the same trends? This is important if recommending using this method for surveillance as there is no mention of antibody decay.</p><p>(2) Abstract and through paper – not clear what a &quot;meta-observation&quot; is. Please clarify.</p><p>(3) Figure 2 could be improved. It plots the x-axis on the normal scale when it was fitted on the log. Statements about how it could be used in elimination settings were given but we cannot see how well the model behaves down this region. Consider putting on the log. Given (2) not clear what the size of the points are.</p><p>(4) Model fitting – a ln transformation was used which could do with a justification. It could be fine, but we cannot tell given the plotting outlined above. Given the choice of transformation determines values presented in figure 3 I would like to see either a more rigorous model selection or at least a plot which indicates this is a reasonable choice. This could be done by binning the data and including a repeat of Figure 2 and 5 with these binned data in the appendix.</p><p>(5) Table 1 is unwieldly and hard to understand what the breakdown of the different metrics are. This would benefit from either a summary table/figure or a narrative in the results (i.e. what % of studies/datapoints had HBR, EIR etc). What % datapoints were from longitudinal studies?</p><p>(6) Why is the figure for the relationship between sero-prevalence and EIR not shown, though model predictions are? Should this not go in the main text.</p><p>(7) The malaria data is a hodgepodge of microscopy, PBR and MAP estimated values. This is fine, though clearly some of these are more bias than others. The problem is that it isn't really differentiated in the Results section leaving me unsure of whether it was the data or the MAP predictions that were finding the association. Specifically, did the microscopy or PCR data predict a positive association alone or was it the modelled estimates which generate the positive association. Clearly, if it is the former, the story is stronger but given the narrative in lines 254-258 when 8 studies did not find an association, I am unsure. Could the points be coloured by the source of the prevalence estimate in Figure 5?</p><p>(8) The authors are conflating seropositivity for anopheles bites with malaria transmission. There are many reasons why this might not be so, but the most obvious is altitude and use of vector control. Altitude could explain why 20% people have mosquito bites but &lt;1% malaria and given you have geospatial information this could be easily tested (ie. Excluding sites over 2000m). The use of control interventions/treatment is harder to control for and could be discussed more thoroughly in light of comment (1)</p><p>(9) Finally, though the analyses is interesting, the frailties of using geospatial data should be discussed given that this is often based on a paucity of data.</p><p><italic>Reviewer #2:</italic></p><p>The problem to be addressed is well formulated, and there are sufficient secondary data available to conduct a useful analysis to address it. The statistical approach is careful and multi-level modelling is an appropriate way of dealing with the linked observations in this dataset.</p><p>I thought a stronger case would be made if the paper focused on Africa, as vector behaviour is so very different in Asia, and I would like to see a sub-group analysis of the two. There is good evidence for a non-linear relationship as reported by the authors, and the graph in Figure 2 is persuasive: but I found it difficult to follow the quantification of this in the text (details in private review). It is a matter of preference, but I would relegate more of the material after figure 2 to supplementary figures so as to focus the presentation more on this figure.</p><p>The authors are well justified in claiming a relationship between HBR and seroprevalence of mosquito salivary antigen, and this could be useful for vector surveillance. The shape of the line indicates a dynamic range where seroprevalence is a useful metric, and a statement of this range could be added.</p><p>In practice, the investment in this form of vector surveillance would need to be balanced against spending in other forms of disease or infection surveillance, and this could be mentioned as an issue in terms of a policy impact.</p><p>(1) Abstract: If the association is non-linear is it reasonable to represent it with a % in X leads to % in y? Also multi-level modelling in methods could usefully give an indication of what the levels used were.</p><p>(2) Introduction is well formulated and I have no comments</p><p>(3) Methods: I agree with the decision to use seropositivity rather than levels, and also to include studies that classify based on seronegative.</p><p>(4) Were estimates were taken from MAP or Pangea, at what level was geolocation used? Longitude/latitude or administrative category?</p><p>(5) MAP focuses on PfPR, how much data has fed into DVS?</p><p>(6) The random intercepts sentence has three levels, but gives same study and same country – please clarify which relates to which level?</p><p>(7) I think it would be worth examining Africa and outside-Africa separately, to get a sense of whether the relationships are different. (Or use an interacting term for continent and slope).</p><p>(8) The methods section does not help me understand how non-linearity was allowed for. Natural log transformations are mentioned, but if these are applied to both x's and y then we end up linear again. So a combination must have been selected. Was there any testing of whether the non-linear fit was superior to the linear fit?</p><p>(9) Results – Figure 1 – I would be interested in knowing how many studies were excluded because seroprevalence was described differently from the parameters set.</p><p>(10) Results – again I struggled with the description of non-linearity here. It seems like IgG was kept linear, HBR was log transformed. Therefore shouldn't there be a % increase in the log transformed variable for each unit of absolute increase in the untransformed variable?</p><p>(11) Figure 2 – a lot of the &quot;action&quot; is down below 1 HBR. This is expected, and I have no problem with the shape of the fit, but I would be interested in seeing this more clearly in a log-transformed x axis.</p><p>(12) Having struggled with the non-linearity up to Figure 3, I couldn't then cope with the increase Figure 3 was communicating. Isn't a percent increase just a linear factor away from an Odds Ratio?</p><p>(13) For figures 2 and 5 there is obviously a lot of variation left unexplained judging by the scatter – including some quite large studies. I think this should be commented on in the results and discussion. Did the authors check if the risk of bias tended to be linked with outlying observations?</p><p>(14) I felt uncomfortable in combining Asia and Africa.</p><p>(15) I thought the discussion was well balanced overall. As above, some discussion on the very wide scatter would be useful, and also the fact that the relationship between seroprevalence and HBR is flat above an HBR of 1.5 limits the usefulness of this method in that dynamic range. The authors could comment on how many malaria endemic regions would be covered in the 0-1.5 range. The authors could also comment on the advantage or complimentarity of malaria antigen serology for surveillance in comparison.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.73080.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. The paper would be strengthened if it focused on Africa, with sub-group analyses between Africa and Asia, given the differences in vector behavior in both settings.</p></disp-quote><p>Our systematic review has demonstrated that gSG6 serology has been used as a marker of <italic>Anopheles</italic> exposure globally and we agree that it is important to take into consideration heterogeneity in vector behaviour. In our manuscript we directly estimate effect modification by dominant vector species (DVS). The three categories of DVS serve as a proxy for region with Africa represented by 2 categories (<italic>An. gambiae s.l.</italic>; <italic>An gambiae s.l.</italic> + others) and other regions represented by the non <italic>An. gambiae</italic> category. We have therefore emphasised this and highlighted the African context throughout the manuscript. We provide further details in response to Reviewer 2’s Comments #7 and #14.</p><disp-quote content-type="editor-comment"><p>2. The overall conclusions often use phrasing such as 'strong' evidence/association, however in many instances this level of support is overly optimistic, given the noise in these types of data and issues with a number of the malaria metrics. Further, for some of the statistical analyses require additional justification and more robust model evaluation.</p></disp-quote><p>We have tempered the language of the conclusions and have provided justification of the model selection process and analyses (see Appendix 1 – Supplementary Methodology).</p><disp-quote content-type="editor-comment"><p>3. There are a number of points raised in both reviewers where the results should be clarified (ex. text and display of Figure 2; relationship between HBR and seroprevalence as a metric; etc.). In addition, the sources of data for each point of evidence – is it MAP estimates? Microscopy? Which type of study design? Should be clarified to help provide the reader with a better understanding of the pieces of information (and level of bias, etc.) are providing which types of evidence.</p></disp-quote><p>We have carefully considered this feedback and have improved the display of Figure 2 and provided a more in-depth narrative description of the study details to assist with interpretation of model parameters. We have also addressed all reviewers’ suggestions and included clarifications on model input where recommended.<italic>Reviewer #1:</italic></p><disp-quote content-type="editor-comment"><p>This is an interesting paper highlighting the use of serological data for monitoring anopheline mosquito bites. The concept is good, rationale clear and the statistical modelling appears robust. Some of the stats could be better explained at times and the conclusions should be tapered somewhat as there is lots of &quot;strong&quot; evidence/association statements that seem overly optimistic given the noise in these types of data and the frailties of the malaria metrics. This meta-analyses will help crystalise thought on whether the technique should be further invested in.</p></disp-quote><p>We have tempered the conclusions to remove references to “strong” evidence throughout and emphasised where confidence intervals were wide and study-specific heterogeneity was observed. We have also expanded our discussion of the limitations of the malaria metrics (see detailed response to point #9 below). We have already provided a cautious discussion about the limitations regarding the utility of this approach (Discussion, Page 23-25, Line 361-400), highlighting areas for further development and posing several key questions to answer (i.e. appropriateness as a biomarker of non-<italic>An. gambiae</italic>, individual-level exposure and antibody half-life) before it can be used as a tool for population- or individual-level predictions.</p><disp-quote content-type="editor-comment"><p>(1) The study groups together cross-sectional and cohort data yet this was never really explored. How strong was the association in the cohort data and did it give the same trends? This is important if recommending using this method for surveillance as there is no mention of antibody decay.</p></disp-quote><p>We explored the moderating effect of study design (longitudinal cohort versus cross-sectional) on the association between the log HBR and gSG6 IgG seroprevalence and found no significant effect modification by study type (<italic>p</italic>-value for interaction: 0.138).</p><p>(Results, Page 14 Line 210-213) “There was no evidence that the association between HBR and gSG6 IgG varied according to vector collection method (human landing catch or other indirect methods<bold>;</bold> <italic>p</italic>=0.443) or study design (longitudinal cohort or cross-sectional/repeated cross-sectional; <italic>p</italic>=0.138).”</p><p>The question of antibody decay is an interesting one, which unfortunately we cannot examine due to the structure of the data. Furthermore, given there are only 3 studies that report gSG6 and HBR longitudinally, we are unlikely to draw any conclusions about antibody decay dynamics beyond which were discussed in the original manuscripts.</p><p>This limitation has already been mentioned in the Discussion (Page 25, Line 391-395):</p><p>“However, the accuracy of salivary antibodies to measure individual-level exposure to <italic>Anopheles</italic> bites is yet to be validated; literature searches identified no studies investigating this association at the individual-level. Without detailed measurements of individual-level vector exposure, or a detailed knowledge of the half-life of <italic>Anopheles</italic> salivary antibodies post biting event, the true accuracy of salivary antibodies, such as SG6 IgG, to measure individual-level HBR remains unknown.”</p><disp-quote content-type="editor-comment"><p>(2) Abstract and through paper – Not clear what a &quot;meta-observation&quot; is. Please clarify.</p></disp-quote><p>Study reported observations of salivary antibody seroprevalence or levels were extracted at the most granular level for each study (i.e. for each site, time point). Each of these study-specific salivary antibody observations were included as the level-one units in our multilevel model, with study as level-two to account for multiple observations from the same study, and country as level-three to account for multiple studies from the same country.</p><p>To clarify, we have renamed meta-observations and Meta-N to be “study-specific observations (n)” in the text and study-specific n in Table 1.</p><p>In addition, we have now added to the outcome section of the methods (Page 4-5, Line 95-97):</p><p>“Study reported salivary antibody data was extracted at the most granular level (i.e. for each site; time point), with each observation of seroprevalence or levels included as a study-specific salivary antibody observation.”</p><disp-quote content-type="editor-comment"><p>(3) Figure 2 could be improved. It plots the x-axis on the normal scale when it was fitted on the log. Statements about how it could be used in elimination settings were given but we cannot see how well the model behaves down this region. Consider putting on the log. Given (2) not clear what the size of the points are.</p></disp-quote><p>To address both reviewers’ comments on Figure 2, we have modified the presentation and discussion of the results to be for a two-fold increase in HBR associated with an increase in gSG6 IgG seroprevalence. Figure 2 is now shown on the log base 2 scale, but with labels for the equivalent HBR values (e.g. labels 1, 2, 4, 8 for HBR values correspond to 0, 1, 2, 3 on log base 2 scale) to ensure interpretability and clinical relevance. We have also coloured the markers relative to sample size, as outlined in the figure legend.</p><p>(Results, Page 14, Line 199-207) “Generalised linear multilevel modelling (mixed-effects, logistic) of n=132 study-specific observations from 12 studies estimated a positive association between <italic>Anopheles</italic> spp.-HBR (log transformed) and seroprevalence of IgG to <italic>An. gambiae</italic> gSG6 salivary antigen [5, 7, 8, 10, 11, 13, 29, 33, 36, 38, 39, 53] (Figure 2 and Appendix 4 – Table 1). […] For example, the magnitude of the association was such that a 2-fold (100% relative) increase in HBR was associated with a 23% increase (OR: 1.23; 95%CI: 1.10-1.37, <italic>p</italic>&lt;0.001) in the odds of anti-gSG6 IgG seropositivity (Figure 2).”</p><disp-quote content-type="editor-comment"><p>(4) Model fitting – a ln transformation was used which could do with a justification. It could be fine, but we cannot tell given the plotting outlined above. Given the choice of transformation determines values presented in figure 3 I would like to see either a more rigorous model selection or at least a plot which indicates this is a reasonable choice. This could be done by binning the data and including a repeat of Figure 2 and 5 with these binned data in the appendix.</p></disp-quote><p>To address suggestions from both reviewers we have added further clarification of the model selection process to the methods and Supplementary Methods to show model selection process.</p><p>(Methods, Page 6, Lines 138-143) “For the exposure measures (HBR, EIR, malaria prevalence and antimalarial antibody seroprevalence), the data were log transformed since there were non-linear associations between the exposure measures on the original scale and seroprevalence – supported empirically by superior model fit as indicated by Akaike's information criterion (AIC) and Bayesian information criterion (BIC) fit indices (Appendix 1 – Table 1). To aid interpretation, we present our results as a relative increase in the odds of the gSG6 IgG seropositivity for a 2-fold or in other words a 100% relative increase in the exposures.”</p><p>(Appendix 1, Page 43, Lines 1161-1166) “Akaike's information criterion (AIC) and Bayesian information criterion (BIC) fit indices were used to determine the best fitting functional forms for the association between log odds of gSG6 IgG seropositivity and HBR, EIR and <italic>Plasmodium</italic> spp. prevalence – linear, log, quadratic and cubic functions were fitted, with a log transformation exhibiting superior model fit (Appendix 1 – Table 1).”</p><disp-quote content-type="editor-comment"><p>(5) Table 1 is unwieldly and hard to understand what the breakdown of the different metrics are. This would benefit from either a summary table/figure or a narrative in the results (i.e. what % of studies/datapoints had HBR, EIR etc). What % datapoints were from longitudinal studies?</p></disp-quote><p>We have chosen to further discuss these metrics in the first paragraph of the Results section.</p><p>(Results, Page 7-8, Lines 156-185) “Literature searches identified 158 potentially relevant studies, of which 42 studies were included in the systematic review (Figure 1) and are described in Table 1. […] The distributions of exposure estimates were: HBR (n=197 from 24 studies, median: 3.0 bites per person per night, IQR: 0.9-12.1; range: 0-121.4), EIR (n=60 from 8 studies, median: 7.3 infectious bites received per person per year, IQR: 0-36.4; range: 0-585.6), and <italic>Plasmodium</italic> spp. Prevalence (n=266 from 22 studies, median: 9.1%; IQR: 4-22%; range: 0-94.6%).”</p><disp-quote content-type="editor-comment"><p>(6) Why is the figure for the relationship between sero-prevalence and EIR not shown, though model predictions are? Should this not go in the main text.</p></disp-quote><p>We have now included a figure showing the relationship between seroprevalence and log<sub>2</sub> EIR as Figure 4, and discussed this in the main text as a 2-fold increase in EIR.</p><p>(Results, Page 17, Lines 246-250) “For <bold>a</bold> 2-fold increase in EIR, the odds of anti-gSG6 IgG seropositivity increased by 11% (OR: 1.11; 95%CI: 1.06-1.17; <italic>p</italic>&lt;0.001), with heterogeneity in the study-specific effects (95% reference range: 1.00-1.24; likelihood ratio χ<sup>2</sup> (1) = 15.02, <italic>p</italic>&lt;0.001).”</p><disp-quote content-type="editor-comment"><p>(7) The malaria data is a hodgepodge of microscopy, PBR and MAP estimated values. This is fine, though clearly some of these are more bias than others. The problem is that it isn't really differentiated in the Results section leaving me unsure of whether it was the data or the MAP predictions that were finding the association. Specifically, did the microscopy or PCR data predict a positive association alone or was it the modelled estimates which generate the positive association. Clearly, if it is the former, the story is stronger but given the narrative in lines 254-258 when 8 studies did not find an association, I am unsure. Could the points be coloured by the source of the prevalence estimate in Figure 5?</p></disp-quote><p>We have now clarified that the malaria data used in Figure 5 are study measured <italic>Plasmodium</italic> spp. prevalence estimates and not Malaria Atlas Project estimates. In addition, to be consistent, we have amended Figure 5 and the discussion to reflect a 2-fold increase in <italic>Plasmodium</italic> spp. prevalence.</p><p>(Results, Page 19, Line 265-271) “Generalised linear multilevel modelling (mixed-effects, logistic) of n=212 from 14 studies that measured <italic>Plasmodium</italic> spp. prevalence contemporaneously in their study [3, 5, 9, 13, 15, 29, 30, 33, 35, 36, 38, 41, 47, 51] showed that for a 2-fold increase in the prevalence of <italic>Plasmodium</italic> spp. infection the odds of gSG6 IgG seropositivity increased by 38%, although the confidence intervals were wide (OR: 1.38; 95%CI: 0.89-2.12; <italic>p</italic>=0.148) and heterogeneity in the study-specific effects was observed (95% reference range: 0.30-6.37; likelihood ratio χ<sup>2</sup> (1) = 235.5, <italic>p</italic>&lt;0.001) (Figure 5 and Appendix 7).”</p><disp-quote content-type="editor-comment"><p>(8) The authors are conflating seropositivity for anopheles bites with malaria transmission. There are many reasons why this might not be so, but the most obvious is altitude and use of vector control. Altitude could explain why 20% people have mosquito bites but &lt;1% malaria and given you have geospatial information this could be easily tested (ie. Excluding sites over 2000m). The use of control interventions/treatment is harder to control for and could be discussed more thoroughly in light of comment (1).</p></disp-quote><p>In many settings (especially those with low transmission) there would be instances where an individual would receive bites from uninfected mosquitoes, thus why estimates of seropositivity for antibodies against <italic>Anopheles</italic> salivary proteins would likely always be greater than parasite prevalence/endemicity. An analysis restricted due to altitude therefore would not necessarily change this (furthermore, all study sites are below 2000m). Instead, we discuss on Page 24 Lines 369-375 how a salivary antigen approach to measuring malaria transmission is limited in this sense, and would likely need to be combined with another measure (e.g. malaria prevalence, antimalarial antibody seroprevalence) to accurately estimate transmission intensity.</p><disp-quote content-type="editor-comment"><p>(9) Finally, though the analyses is interesting, the frailties of using geospatial data should be discussed given that this is often based on a paucity of data.We have now included a discussion of the limitations of geospatial data in our discussion.</p></disp-quote><p>(Discussion, Page 25-26, Line 415-423) “In light of this, we also chose to provide estimates of association and gSG6 IgG seroprevalence according to a selected range of epidemiologically relevant hypothetical HBR’s (no widely accepted HBR classification exists in the literature) and according to widely accepted, discrete, endemicity classes according to MAP estimates (which permitted inclusion of all studies) to provide epidemiological context. […] Any misclassification events may cause us to underestimate the standard error in the effect of malaria endemicity class and DVS on gSG6 IgG.”</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>(1) Abstract: If the association is non-linear is it reasonable to represent it with a % in X leads to % in y? Also multi-level modelling in methods could usefully give an indication of what the levels used were.</p></disp-quote><p>As we have log transformed the exposure variable, using exponentiated coefficients, the results should be interpreted as a relative per cent (i.e. a 100% (or a 2-fold)) increase in the exposure will be associated with a relative per cent increase in the odds of the outcome. However, to avoid confusion we now express it as a 2-fold increase in X leads to a % increase in Y.</p><p>We have amended the abstract to indicate model levels.</p><p>(Abstract, Page 2, Line 26-29) “Multilevel modelling (to account for multiple study-specific observations (level-one), nested within study (level-two), and study nested within country (level-three)) estimated associations between seroprevalence with Anopheles human biting rate (HBR) and malaria transmission measures.”</p><disp-quote content-type="editor-comment"><p>(2) Introduction is well formulated and I have no comments,</p></disp-quote><p>Noted, with thanks.</p><disp-quote content-type="editor-comment"><p>(3) Methods: I agree with the decision to use seropositivity rather than levels, and also to include studies that classify based on seronegative.</p></disp-quote><p>Noted, with thanks.</p><disp-quote content-type="editor-comment"><p>(4) Where estimates were taken from MAP or Pangea, at what level was geolocation used? Longitude/latitude or administrative category?</p></disp-quote><p>Longitude and Latitude were used. We have amended the Methods to reflect this</p><p>(Methods, Page 5, Line 108-112) “Where exposure estimates were not provided, we attempted to source data from other publications by the authors, or using the site geolocation (longitude and latitude) and year to obtain estimates of EIR from the Pangaea dataset [18], <italic>P. falciparum</italic> rates in 2-10 year olds (PfPR2-10) and dominant vector species (DVS) from the Malaria Atlas Project (MAP) [19].”</p><disp-quote content-type="editor-comment"><p>(5) MAP focuses on PfPR, how much data has fed into DVS?</p></disp-quote><p>The DVS occurrence data from the MAP is based upon a collated database of 15,837 vector occurrence data points using species-specific location information from over 4800 sources (collated and reported in Sinka <italic>et al.</italic> [1]). While there are several limitations associated with these maps (including sparse data for some areas, and that at time of use they are 10-years out of date), they are the best currently available indication of the distribution of dominant malaria vectors. We used MAP to inform DVS categories for only 7 (out of 42 studies). To address comments from both reviewers, we have included a brief discussion of the limitations of using MAP data in the discussion.</p><p>(Discussion, Page 25-26, Line 415-423) “In light of this, we also chose to provide estimates of association and gSG6 IgG seroprevalence according to a selected range of epidemiologically relevant hypothetical HBR’s (no widely accepted HBR classification exists in the literature) and according to widely accepted, discrete, endemicity classes according to MAP estimates (which permitted inclusion of all studies) to provide epidemiological context. […] Any misclassification events may cause us to underestimate the standard error in the effect of malaria endemicity class and DVS on gSG6 IgG.”</p><disp-quote content-type="editor-comment"><p>(6) The random intercepts sentence has three levels, but gives same study and same country – please clarify which relates to which level?</p></disp-quote><p>Please see (Methods, Page 5-6, Line 122-124) “Random intercepts for study and country were estimated to account for nested dependencies induced from multiple study-specific salivary antibody observations (level-one) from the same study (level-two) and studies from the same country (level-three).</p><disp-quote content-type="editor-comment"><p>(7) I think it would be worth examining Africa and outside-Africa separately, to get a sense of whether the relationships are different. (Or use an interacting term for continent and slope).</p></disp-quote><p>In the manuscript we chose to explore interactions with dominant vector species given the species-specific nature of the antibodies/antigens under investigation. However, region (Africa/non-Africa) is a proxy for dominant vector species – all non-African sites are represented by non-<italic>An. gambiae s.l.</italic>, and all African sites are represented as DVS: <italic>An. gambiae s.l.</italic> only or <italic>An. gambiae s.l.</italic> + others. (Note: while one African study reported <italic>An. funestus</italic> as the only DVS, this study only provided data on antibody levels and was not included in multilevel modelling). We have now emphasised the Africa/non-African context throughout the manuscript with the following notable examples:</p><p>(Introduction, Page 3-4, Lines 70-76) “We undertook a systematic review with multilevel modelling, to quantify the association between HBR, EIR, and other markers of malaria transmission, with anti-<italic>Anopheles</italic> salivary antibody responses and to understand how these associations vary according to transmission setting and dominant <italic>Anopheles</italic> vectors which can exhibit different biting behaviours. In particular, we were interested in comparing the African context (where <italic>An. gambiae</italic> and <italic>P. falciparum</italic> predominates) to non-African settings (where <italic>An. gambiae</italic> is absent and where both <italic>P. falciparum</italic> and <italic>P. vivax</italic> are prevalent).”</p><p>(Results, Page 7, Lines 159-166) “These studies were performed in 16 countries mostly in hypo or mesoendemic areas of Africa (32 studies), with a minority performed in South America (4 studies), Asia (4 studies), and the Pacific (2 studies). […] <italic>An. gambiae s.l.</italic> was a DVS in all African study sites (n=151 study-specific observations from 23 studies where <italic>An. gambiae s.l.</italic> was the only DVS and n=68 from 16 studies where <italic>An. gambiae s.l.</italic> was present with additional DVS (i.e. <italic>An. funestus</italic>, <italic>An. pharoensis</italic>)), with the exception of one study, which together with the 10 non-African studies contributed n=174 study-specific estimates where <italic>An. gambiae s.l.</italic> was absent.”</p><p>(Results, Page 14, Lines 213-226) “Given the global heterogeneity in the distribution of <italic>Anopheles</italic> species, we sought to quantify the extent to which the association between <italic>An. gambiae</italic> gSG6 IgG seropositivity and HBR is moderated by DVS. […] In African studies where <italic>An. gambiae s.l</italic> is the only DVS, predicted seroprevalence of <italic>An. gambiae</italic> gSG6 ranged from 8% (95%CI: 0-22%) to 86% (95%CI: 67-100%) for an HBR of 0.01 to 100 bites per person per night respectively (Figure 3 and Figure 3 – Supplement 1).”</p><p>(Results, Page 19, Lines 271-274) “In the association between gSG6 IgG seropositivity and <italic>Plasmodium</italic> spp. infection, there was no evidence for a moderating effect of <italic>Plasmodium</italic> spp. detection method (light microscopy, or PCR, <italic>p</italic>=0.968), or species (African studies with <italic>P. falciparum</italic> versus non-African studies where <italic>P. falciparum</italic> and <italic>P. vivax</italic> are co-prevalent<italic>, p</italic>=0.538).”</p><p>(Results, Page 21, 302-303) “Interactions with DVS or region (Africa/non-Africa) could not be explored due to collinearity with malaria endemicity class.”</p><disp-quote content-type="editor-comment"><p>(8) The methods section does not help me understand how non-linearity was allowed for. Natural log transformations are mentioned, but if these are applied to both x's and y then we end up linear again. So a combination must have been selected. Was there any testing of whether the non-linear fit was superior to the linear fit?</p></disp-quote><p>We have updated the text in the methods section to indicate model selection process. Natural log transformations were applied to the exposure data (HBR/EIR/ malaria prevalence and anti-malarial antibody seroprevalence) as the exposure data on the original scale had a non-linear association with the log odds of anti-gSG6 IgG seropositivity. See response to Comment #1 with respect to how exponentiated coefficients are interpreted where effects for a log transformed exposure are estimated in a logit regression model. As per Reviewer 1’s Comment #4, we have also included a more detailed description in Appendix 1 – Supplementary Methodology to demonstrate model selection process.</p><p>(Appendix 1, Page 42-43, Lines 1161-1166) “Akaike's information criterion (AIC) and Bayesian information criterion (BIC) fit indices were used to determine the best fitting functional forms for the association between log odds of gSG6 IgG seropositivity and HBR, EIR and <italic>Plasmodium</italic> spp. prevalence – linear, log, quadratic and cubic functions were fitted, with a log transformation exhibiting superior model fit (Appendix 1 – Table 1).”</p><disp-quote content-type="editor-comment"><p>(9) Results – Figure 1 – I would be interested in knowing how many studies were excluded because seroprevalence was described differently from the parameters set.</p></disp-quote><p>The studies that measured antibodies to <italic>Anopheles</italic> salivary proteins, but did not report seroprevalence at all or according to our parameter set, were included in narrative terms as per the study protocol. In total 20 studies were not able to be included in our multilevel modelling analyses: 15 only reported antibody levels, 3 were the only study reporting the seroprevalence of antibodies to that <italic>Anopheles</italic> salivary antigen, and 2 were case-control studies. We have clarified this in the footnotes of the modelling outputs in the various appendices.</p><disp-quote content-type="editor-comment"><p>(10) Results – again I struggled with the description of non-linearity here. It seems like IgG was kept linear, HBR was log transformed. Therefore shouldn't there be a % increase in the log transformed variable for each unit of absolute increase in the untransformed variable?</p></disp-quote><p>To clarify, we have undertaken logistic regression on a binary outcome (gSG6 IgG seropositivity), which is non-normal (binomial) and non-linear (logit). Therefore, interpretation of exponentiated coefficients is such that a relative percent (fold) increase in outcome is attributable to a relative percent (fold) increase in exposure. While the statistical methodology is outlined in detail in the Appendix 1 (see Page 40-45) we have added the following in the text throughout to clarify the use of the logit link to aid interpretation of model framework (i.e. generalised linear multilevel modelling (<italic>mixed-effects, logistic</italic>)).</p><disp-quote content-type="editor-comment"><p>(11) Figure 2 – a lot of the &quot;action&quot; is down below 1 HBR. This is expected, and I have no problem with the shape of the fit, but I would be interested in seeing this more clearly in a log-transformed x axis.</p></disp-quote><p>Noted, as outlined in our response to Reviewer 1’s Comment #3, we have plotted Figure 2 on the log base 2 scale, but have given equivalent HBR values as labels to retain interpretability and clinical relevance.</p><disp-quote content-type="editor-comment"><p>(12) Having struggled with the non-linearity up to Figure 3, I couldn't then cope with the increase Figure 3 was communicating. Isn't a percent increase just a linear factor away from an Odds Ratio?</p></disp-quote><p>As the associations between HBR/EIR and log odds of gSG6 IgG seropositivity is non-linear, we wanted to show the estimated odds ratio (x-axis) for varying relative per cent increases in the exposure (y-axis), as explained Page 14, Lines 203-205. However, we appreciate this may distract from the main messaging and have moved the HBR and EIR panels of (Previous) Figure 3 in the main manuscript to Figure 2 – Supplement 1 and Figure 4 – Supplement 1 respectively.</p><disp-quote content-type="editor-comment"><p>(13) For figures 2 and 5 there is obviously a lot of variation left unexplained judging by the scatter – including some quite large studies. I think this should be commented on in the results and discussion. Did the authors check if the risk of bias tended to be linked with outlying observations?</p></disp-quote><p>We assessed the risk of bias of outlying observations, and have now added to the manuscript:</p><p>(Methods, Page 6-7, Line 145-149) “In order to explore the presence of study-level influence in (HBR and EIR) effect estimate modelling, the Generalised Linear Latent and Mixed Models (gllamm) package [22] was used to produce Cooks distance statistics [23] at the study-level from the generalised linear multilevel models. A conservative cut-off threshold for Cooks distance (4/<italic>n</italic>) was used to guide sensitivity analyses, where studies were excluded, in-turn, to assess outlier influence.”</p><p>(Results, Page 22, Line 324-327) <bold>“</bold>Sensitivity analyses exploring potential study-level outlier influence on the estimated associations between anti-gSG6 IgG seroprevalence, HBR and EIR showed no evidence of bias (effect estimates for each sensitivity analysis were consistent with model estimates overall) for studies identified as exhibiting potential influence (HBR: n=6; EIR: n=6).”</p><disp-quote content-type="editor-comment"><p>(14) I felt uncomfortable in combining Asia and Africa</p></disp-quote><p>As outlined above to Comment #7, we chose to directly explore effect-modification of the association between gSG6 IgG seroprevalence and HBR by dominant vector species, rather than by region.</p><disp-quote content-type="editor-comment"><p>(15) I thought the discussion was well balanced overall. As above, some discussion on the very wide scatter would be useful, and also the fact that the relationship between seroprevalence and HBR is flat above an HBR of 1.5 limits the usefulness of this method in that dynamic range. The authors could comment on how many malaria endemic regions would be covered in the 0-1.5 range. The authors could also comment on the advantage or complimentarity of malaria antigen serology for surveillance in comparison.</p></disp-quote><p>We have included a discussion of the diminishing impact of HBR&gt;2 on gSG6 IgG seropositivity and the complementarity of this approach to malarial serosurveillance programs.</p><p>(Discussion, Page 22, Line 339-344) “<italic>An. gambiae</italic> gSG6 IgG seropositivity increased with increasing HBR, although these increases had diminishing impact on <italic>An. gambiae</italic> gSG6 IgG seropositivity at higher levels of HBR (approximately greater than 2 bites per person per night). In our study, 17 studies performed across Africa (Angola, Benin, Burkina Faso, Cote d’Ivoire, Senegal) and the Asia Pacific (Cambodia, Myanmar, and the Solomon Islands) reported an HBR &lt;2 demonstrating that the applicability of gSG6 as a biomarker of HBR across a broad range of malaria endemic regions.”</p><p>(Discussion, Page 23, Line 373-382) Indeed, positive associations between antibodies specific for <italic>Plasmodium</italic> spp. pre-erythrocytic and blood-stage antigens with gSG6 were demonstrated in analyses of data from diverse malaria endemic areas. […] In these areas, parasite prevalence may therefore overestimate ongoing malaria transmission, making vector surveillance tools essential to informing elimination strategies in the Asia Pacific and other regions where <italic>P. vivax</italic> is endemic.”</p><p>References:</p><p>1. Sinka ME, Bangs MJ, Manguin S, Rubio-Palis Y, Chareonviriyaphap T, Coetzee M, Mbogo CM, Hemingway J, Patil AP, Temperley WH. A global map of dominant malaria vectors. Parasit Vectors. 2012;5(1):69.</p><p>2. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, Battle K, Moyes CL, Henry A, Eckhoff PA, Wenger EA, Briët O, Penny MA, Smith TA, Bennett A, Yukich J, Eisele TP, Griffin JT, Fergus CA, Lynch M, Lindgren F, Cohen JM, Murray CLJ, Smith DL, Hay SI, Cibulskis RE, Gething PW. The effect of malaria control on <italic>Plasmodium falciparum</italic> in Africa between 2000 and 2015. Nature. 2015;526(7572):207-11. Epub 2015/09/16. doi: 10.1038/nature15535. PubMed PMID: 26375008.</p></body></sub-article></article>